| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.75 | 0.005 | 0.863 | 5 Hydroxytryptamine release stimulant | 0.654 0.01 DBMET02521 0.853 0.003 DBMET02535 0.767 0.004 DBMET02543 0.71 0.006 DBMET02530 0.685 0.008 DBMET02534 0.502 0.027 DBMET00764 0.686 0.008 DBMET02536 0.863 0.002 DBMET02537 0.667 0.009 DBMET02545 0.734 0.005 DBMET02531 0.538 0.022 DBMET02523 0.398 0.046 DBMET02529 0.799 0.004 DBMET02538 0.714 0.006 DBMET02541 0.502 0.027 DBMET02546 0.567 0.018 DBMET02532 0.443 0.037 DBMET02525 0.709 0.006 DBMET02539 0.563 0.019 DBMET02542 0.382 0.05 DBMET02533 | DBMET02537 | |
| 0.741 | 0.019 | 0.815 | Caspase 9 stimulant | 0.804 0.011 DBMET02521 0.644 0.031 DBMET02535 0.702 0.024 DBMET02543 0.592 0.037 DBMET02530 0.776 0.014 DBMET02534 0.743 0.019 DBMET00764 0.725 0.021 DBMET02536 0.571 0.041 DBMET02537 0.663 0.028 DBMET02545 0.532 0.049 DBMET02531 0.69 0.025 DBMET02523 0.815 0.009 DBMET02529 0.529 0.05 DBMET02538 0.658 0.029 DBMET02541 0.499 0.06 DBMET02546 0.499 0.06 DBMET02532 0.788 0.013 DBMET02525 0.419 0.1 DBMET02539 0.496 0.061 DBMET02542 0.39 0.117 DBMET02533 | DBMET02529 | |
| 0.612 | 0.015 | 0.612 | Vasodilator, peripheral | 0.473 0.034 DBMET02521 0.552 0.021 DBMET02535 0.603 0.016 DBMET02543 0.397 0.056 DBMET02530 0.448 0.041 DBMET02534 0.434 0.045 DBMET00764 0.502 0.027 DBMET02536 0.515 0.025 DBMET02537 0.582 0.018 DBMET02545 0.367 0.067 DBMET02531 0.403 0.054 DBMET02523 0.373 0.064 DBMET02529 0.456 0.039 DBMET02538 0.474 0.034 DBMET02541 0.389 0.059 DBMET02546 0.298 0.098 DBMET02532 0.34 0.078 DBMET02525 0.267 0.115 DBMET02539 0.288 0.103 DBMET02542 | ||
| 0.509 | 0.03 | 0.708 | 5 Hydroxytryptamine release inhibitor | 0.503 0.031 DBMET02521 0.637 0.007 DBMET02535 0.543 0.021 DBMET02543 0.577 0.014 DBMET02530 0.521 0.026 DBMET02534 0.582 0.014 DBMET00764 0.583 0.013 DBMET02536 0.655 0.005 DBMET02537 0.605 0.01 DBMET02545 0.595 0.012 DBMET02531 0.599 0.011 DBMET02523 0.531 0.024 DBMET02529 0.708 0.004 DBMET02538 0.614 0.009 DBMET02541 0.441 0.056 DBMET02546 0.645 0.006 DBMET02532 0.563 0.017 DBMET02525 0.547 0.02 DBMET02539 0.451 0.051 DBMET02542 0.484 0.038 DBMET02533 | DBMET02538 | |
| 0.516 | 0.042 | 0.849 | Transcription factor NF kappa B inhibitor | 0.382 0.068 DBMET02521 0.369 0.071 DBMET02535 0.594 0.032 DBMET02543 0.301 0.093 DBMET02530 0.436 0.056 DBMET02534 0.452 0.052 DBMET00764 0.731 0.017 DBMET02536 0.424 0.058 DBMET02537 0.849 0.01 DBMET02545 0.354 0.075 DBMET02531 0.503 0.044 DBMET02523 0.822 0.011 DBMET02529 0.71 0.019 DBMET02538 0.759 0.016 DBMET02541 0.705 0.02 DBMET02546 0.668 0.024 DBMET02532 0.848 0.01 DBMET02525 0.548 0.038 DBMET02539 0.606 0.03 DBMET02542 0.477 0.048 DBMET02533 | DBMET02545 | |
| 0.493 | 0.034 | 0.783 | Aldehyde oxidase inhibitor | 0.662 0.012 DBMET02521 0.716 0.007 DBMET02535 0.64 0.014 DBMET02543 0.706 0.008 DBMET02530 0.725 0.007 DBMET02534 0.648 0.013 DBMET00764 0.783 0.005 DBMET02537 0.772 0.005 DBMET02531 0.711 0.007 DBMET02523 | DBMET02537 | |
| 0.445 | 0.009 | 0.702 | Non-steroidal antiinflammatory agent | 0.231 0.052 DBMET02521 0.387 0.015 DBMET02535 0.425 0.011 DBMET02543 0.204 0.067 DBMET02530 0.208 0.065 DBMET02534 0.526 0.005 DBMET00764 0.434 0.01 DBMET02536 0.35 0.02 DBMET02537 0.688 0.004 DBMET02545 0.184 0.084 DBMET02531 0.485 0.007 DBMET02523 0.702 0.004 DBMET02529 0.599 0.004 DBMET02538 0.407 0.013 DBMET02541 0.534 0.005 DBMET02546 0.395 0.014 DBMET02532 0.663 0.004 DBMET02525 0.432 0.01 DBMET02539 0.248 0.044 DBMET02542 0.238 0.048 DBMET02533 | DBMET02529 | |
| 0.473 | 0.04 | 0.591 | Immunosuppressant | 0.426 0.054 DBMET02521 0.395 0.065 DBMET02535 0.508 0.031 DBMET02543 0.208 0.188 DBMET02530 0.457 0.045 DBMET02534 0.295 0.118 DBMET00764 0.54 0.023 DBMET02536 0.428 0.054 DBMET02537 0.591 0.014 DBMET02545 0.232 0.164 DBMET02531 0.33 0.097 DBMET02523 0.536 0.024 DBMET02529 0.547 0.021 DBMET02538 0.553 0.02 DBMET02541 0.522 0.027 DBMET02546 0.492 0.035 DBMET02532 0.55 0.021 DBMET02525 0.481 0.038 DBMET02539 0.488 0.036 DBMET02542 0.405 0.061 DBMET02533 | DBMET02545 | |
| 0.421 | 0.01 | 0.692 | Melanin inhibitor | 0.362 0.015 DBMET02521 0.432 0.01 DBMET02535 0.498 0.007 DBMET02543 0.308 0.021 DBMET02530 0.393 0.012 DBMET02534 0.323 0.019 DBMET00764 0.53 0.006 DBMET02536 0.47 0.008 DBMET02537 0.692 0.003 DBMET02545 0.338 0.017 DBMET02531 0.352 0.016 DBMET02523 0.433 0.01 DBMET02529 0.633 0.004 DBMET02538 0.54 0.005 DBMET02541 0.519 0.006 DBMET02546 0.509 0.006 DBMET02532 0.447 0.009 DBMET02525 0.474 0.008 DBMET02539 0.373 0.014 DBMET02542 0.341 0.017 DBMET02533 | DBMET02545 | |
| 0.497 | 0.089 | 0.825 | Antiinflammatory | 0.35 0.172 DBMET02535 0.615 0.049 DBMET02543 0.409 0.134 DBMET02530 0.329 0.19 DBMET02534 0.455 0.108 DBMET00764 0.74 0.024 DBMET02536 0.454 0.108 DBMET02537 0.825 0.012 DBMET02545 0.514 0.082 DBMET02531 0.57 0.062 DBMET02523 0.791 0.017 DBMET02529 0.778 0.018 DBMET02538 0.775 0.019 DBMET02541 0.718 0.028 DBMET02546 0.797 0.016 DBMET02532 0.823 0.012 DBMET02525 0.656 0.039 DBMET02539 0.652 0.04 DBMET02542 0.68 0.035 DBMET02533 | DBMET02545 | |
| 0.426 | 0.022 | 0.534 | Superoxide dismutase inhibitor | 0.364 0.033 DBMET02521 0.404 0.026 DBMET02535 0.465 0.017 DBMET02543 0.359 0.034 DBMET02530 0.375 0.031 DBMET02534 0.521 0.011 DBMET00764 0.415 0.024 DBMET02537 0.37 0.032 DBMET02531 0.534 0.01 DBMET02523 | DBMET02523 | |
| 0.414 | 0.026 | 0.663 | Free radical scavenger | 0.259 0.065 DBMET02521 0.255 0.066 DBMET02535 0.531 0.013 DBMET02543 0.202 0.096 DBMET02530 0.363 0.036 DBMET02534 0.289 0.055 DBMET00764 0.533 0.013 DBMET02536 0.362 0.036 DBMET02537 0.663 0.006 DBMET02545 0.305 0.05 DBMET02531 0.406 0.028 DBMET02523 0.582 0.009 DBMET02529 0.572 0.01 DBMET02538 0.58 0.01 DBMET02541 0.541 0.012 DBMET02546 0.549 0.012 DBMET02532 0.637 0.007 DBMET02525 0.462 0.02 DBMET02539 0.471 0.019 DBMET02542 0.44 0.023 DBMET02533 | DBMET02545 | |
| 0.416 | 0.034 | 0.483 | Lipoxygenase inhibitor | 0.231 0.113 DBMET02521 0.277 0.083 DBMET02535 0.483 0.021 DBMET02543 0.192 0.149 DBMET02530 0.254 0.098 DBMET02534 0.429 0.031 DBMET00764 0.302 0.07 DBMET02537 0.211 0.13 DBMET02531 0.457 0.025 DBMET02523 | DBMET02543 | |
| 0.399 | 0.016 | 0.484 | Anesthetic general | 0.301 0.033 DBMET02521 0.382 0.019 DBMET02535 0.454 0.011 DBMET02543 0.257 0.047 DBMET02530 0.331 0.027 DBMET02534 0.458 0.011 DBMET00764 0.319 0.029 DBMET02536 0.408 0.015 DBMET02537 0.428 0.013 DBMET02545 0.279 0.039 DBMET02531 0.484 0.009 DBMET02523 0.399 0.016 DBMET02529 0.37 0.021 DBMET02538 0.338 0.026 DBMET02541 0.231 0.059 DBMET02546 0.247 0.052 DBMET02532 0.414 0.015 DBMET02525 0.181 0.086 DBMET02539 0.161 0.103 DBMET02542 | DBMET02523 | |
| 0.382 | 0.004 | 0.465 | TRPA1 agonist | 0.233 0.006 DBMET02521 0.19 0.013 DBMET02535 0.465 0.003 DBMET02543 0.187 0.014 DBMET02530 0.293 0.005 DBMET02534 0.204 0.01 DBMET00764 0.112 0.069 DBMET02536 0.22 0.008 DBMET02537 0.223 0.007 DBMET02545 0.216 0.008 DBMET02531 0.241 0.006 DBMET02523 0.142 0.037 DBMET02529 0.154 0.029 DBMET02538 0.132 0.046 DBMET02541 0.153 0.029 DBMET02546 0.151 0.031 DBMET02532 0.164 0.023 DBMET02525 0.098 0.091 DBMET02539 | DBMET02543 | |
| 0.382 | 0.018 | 0.481 | 5 Hydroxytryptamine uptake stimulant | 0.315 0.038 DBMET02521 0.352 0.025 DBMET02535 0.412 0.012 DBMET02543 0.347 0.026 DBMET02530 0.347 0.026 DBMET02534 0.451 0.007 DBMET00764 0.386 0.017 DBMET02537 0.381 0.018 DBMET02531 0.481 0.005 DBMET02523 0.193 0.165 DBMET02525 | DBMET02523 | |
| 0.451 | 0.091 | 0.701 | Apoptosis agonist | 0.448 0.092 DBMET02521 0.365 0.131 DBMET02535 0.482 0.08 DBMET02543 0.328 0.153 DBMET02530 0.472 0.083 DBMET02534 0.315 0.162 DBMET00764 0.613 0.046 DBMET02536 0.387 0.12 DBMET02537 0.639 0.041 DBMET02545 0.345 0.142 DBMET02531 0.334 0.149 DBMET02523 0.683 0.034 DBMET02529 0.588 0.052 DBMET02538 0.628 0.043 DBMET02541 0.515 0.07 DBMET02546 0.573 0.055 DBMET02532 0.701 0.03 DBMET02525 0.468 0.085 DBMET02539 0.507 0.072 DBMET02542 0.452 0.09 DBMET02533 | DBMET02525 | |
| 0.36 | 0.008 | 0.535 | Neurotrophic factor enhancer | 0.319 0.014 DBMET02521 0.35 0.009 DBMET02535 0.525 0.004 DBMET02543 0.297 0.019 DBMET02530 0.436 0.005 DBMET02534 0.315 0.014 DBMET00764 0.359 0.008 DBMET02536 0.488 0.004 DBMET02537 0.535 0.004 DBMET02545 0.394 0.006 DBMET02531 0.429 0.005 DBMET02523 0.284 0.023 DBMET02529 0.489 0.004 DBMET02538 0.484 0.004 DBMET02541 0.497 0.004 DBMET02546 0.394 0.006 DBMET02532 0.357 0.008 DBMET02525 0.446 0.005 DBMET02539 0.44 0.005 DBMET02542 0.359 0.008 DBMET02533 | DBMET02545 | |
| 0.363 | 0.013 | 0.824 | Monophenol monooxygenase inhibitor | 0.234 0.026 DBMET02521 0.346 0.014 DBMET02535 0.551 0.006 DBMET02543 0.193 0.035 DBMET02530 0.313 0.016 DBMET02534 0.243 0.025 DBMET00764 0.773 0.003 DBMET02536 0.476 0.008 DBMET02537 0.804 0.003 DBMET02545 0.264 0.022 DBMET02531 0.323 0.016 DBMET02523 0.586 0.005 DBMET02529 0.74 0.004 DBMET02538 0.824 0.003 DBMET02541 0.598 0.005 DBMET02546 0.525 0.007 DBMET02532 0.66 0.004 DBMET02525 0.519 0.007 DBMET02539 0.632 0.005 DBMET02542 0.29 0.019 DBMET02533 | DBMET02541 | |
| 0.378 | 0.031 | 0.55 | Tumour necrosis factor alpha release inhibitor | 0.201 0.108 DBMET02521 0.393 0.028 DBMET02535 0.313 0.049 DBMET02543 0.218 0.094 DBMET02530 0.247 0.076 DBMET00764 0.55 0.01 DBMET02536 0.352 0.037 DBMET02537 0.505 0.013 DBMET02545 0.17 0.134 DBMET02523 0.524 0.012 DBMET02529 0.526 0.012 DBMET02538 0.537 0.011 DBMET02541 0.34 0.041 DBMET02546 0.42 0.024 DBMET02532 0.505 0.013 DBMET02525 0.36 0.035 DBMET02539 0.369 0.033 DBMET02542 0.26 0.071 DBMET02533 | DBMET02536 | |
| 0.359 | 0.018 | 0.508 | Platelet adhesion inhibitor | 0.375 0.015 DBMET02543 0.247 0.05 DBMET00764 0.345 0.021 DBMET02536 0.508 0.005 DBMET02545 0.269 0.043 DBMET02523 0.43 0.009 DBMET02529 0.366 0.016 DBMET02538 0.354 0.019 DBMET02541 0.382 0.014 DBMET02546 0.358 0.018 DBMET02532 0.447 0.008 DBMET02525 0.233 0.055 DBMET02539 0.215 0.063 DBMET02542 0.218 0.062 DBMET02533 | DBMET02545 | |
| 0.363 | 0.023 | 0.604 | Cyclic AMP phosphodiesterase inhibitor | 0.333 0.03 DBMET02521 0.464 0.009 DBMET02535 0.363 0.023 DBMET02543 0.313 0.037 DBMET02530 0.329 0.031 DBMET02534 0.374 0.021 DBMET00764 0.418 0.014 DBMET02536 0.461 0.009 DBMET02537 0.513 0.006 DBMET02545 0.31 0.038 DBMET02531 0.37 0.021 DBMET02523 0.381 0.019 DBMET02529 0.604 0.004 DBMET02538 0.411 0.015 DBMET02541 0.159 0.137 DBMET02546 0.454 0.01 DBMET02532 0.375 0.02 DBMET02525 0.226 0.077 DBMET02539 | DBMET02538 | |
| 0.402 | 0.075 | 0.777 | Histamine release inhibitor | 0.421 0.065 DBMET02521 0.632 0.008 DBMET02535 0.473 0.039 DBMET02543 0.493 0.031 DBMET02530 0.467 0.042 DBMET02534 0.584 0.012 DBMET00764 0.707 0.005 DBMET02536 0.689 0.005 DBMET02537 0.564 0.014 DBMET02545 0.536 0.019 DBMET02531 0.646 0.007 DBMET02523 0.606 0.01 DBMET02529 0.777 0.004 DBMET02538 0.76 0.004 DBMET02541 0.382 0.085 DBMET02546 0.632 0.008 DBMET02532 0.672 0.005 DBMET02525 0.561 0.014 DBMET02539 0.546 0.017 DBMET02542 0.443 0.053 DBMET02533 | DBMET02538 | |
| 0.365 | 0.042 | 0.697 | Antioxidant | 0.277 0.071 DBMET02521 0.289 0.066 DBMET02535 0.502 0.02 DBMET02543 0.309 0.058 DBMET02530 0.37 0.041 DBMET02534 0.284 0.068 DBMET00764 0.567 0.014 DBMET02536 0.387 0.037 DBMET02537 0.689 0.006 DBMET02545 0.419 0.032 DBMET02531 0.397 0.035 DBMET02523 0.645 0.008 DBMET02529 0.641 0.009 DBMET02538 0.62 0.01 DBMET02541 0.572 0.013 DBMET02546 0.655 0.008 DBMET02532 0.697 0.006 DBMET02525 0.517 0.018 DBMET02539 0.495 0.021 DBMET02542 0.533 0.017 DBMET02533 | DBMET02525 | |
| 0.402 | 0.08 | 0.489 | Calcium channel L-type activator | 0.358 0.111 DBMET02521 0.422 0.067 DBMET02535 0.484 0.034 DBMET02543 0.37 0.103 DBMET02530 0.433 0.06 DBMET02534 0.424 0.066 DBMET00764 0.248 0.207 DBMET02536 0.48 0.036 DBMET02537 0.24 0.217 DBMET02545 0.444 0.054 DBMET02531 0.489 0.032 DBMET02523 0.324 0.137 DBMET02541 0.284 0.171 DBMET02525 0.24 0.217 DBMET02542 | DBMET02523 | |
| 0.366 | 0.054 | 0.75 | Caspase 3 stimulant | 0.737 0.005 DBMET02521 0.259 0.104 DBMET02535 0.349 0.059 DBMET02543 0.297 0.08 DBMET02530 0.75 0.005 DBMET02534 0.336 0.064 DBMET00764 0.333 0.065 DBMET02536 0.237 0.125 DBMET02537 0.37 0.053 DBMET02545 0.276 0.093 DBMET02531 0.312 0.073 DBMET02523 0.378 0.051 DBMET02529 0.288 0.085 DBMET02538 0.312 0.073 DBMET02541 0.347 0.06 DBMET02546 0.319 0.07 DBMET02532 0.357 0.057 DBMET02525 0.282 0.088 DBMET02539 0.302 0.078 DBMET02542 0.306 0.076 DBMET02533 | DBMET02534 | |
| 0.324 | 0.023 | 0.577 | Tyrosine 3 hydroxylase inhibitor | 0.248 0.07 DBMET02521 0.302 0.032 DBMET02535 0.46 0.005 DBMET02543 0.264 0.056 DBMET02530 0.335 0.02 DBMET02534 0.409 0.007 DBMET00764 0.407 0.007 DBMET02537 0.356 0.015 DBMET02531 0.577 0.003 DBMET02523 0.18 0.177 DBMET02542 | DBMET02523 | |
| 0.306 | 0.01 | 0.352 | Succinate dehydrogenase inhibitor | 0.291 0.012 DBMET02521 0.241 0.026 DBMET02535 0.352 0.005 DBMET02543 0.232 0.029 DBMET02530 0.301 0.01 DBMET02534 0.329 0.007 DBMET00764 0.249 0.023 DBMET02537 0.19 0.058 DBMET02545 0.24 0.026 DBMET02531 0.341 0.006 DBMET02523 0.138 0.137 DBMET02546 0.142 0.128 DBMET02525 | DBMET02543 | |
| 0.352 | 0.063 | 0.739 | Cholesterol antagonist | 0.416 0.046 DBMET02521 0.565 0.023 DBMET02535 0.443 0.042 DBMET02543 0.491 0.034 DBMET02530 0.47 0.037 DBMET02534 0.52 0.029 DBMET00764 0.711 0.007 DBMET02536 0.6 0.019 DBMET02537 0.678 0.01 DBMET02545 0.534 0.027 DBMET02531 0.56 0.024 DBMET02523 0.679 0.01 DBMET02529 0.739 0.006 DBMET02538 0.728 0.006 DBMET02541 0.571 0.022 DBMET02546 0.7 0.008 DBMET02532 0.695 0.008 DBMET02525 0.652 0.012 DBMET02539 0.64 0.014 DBMET02542 0.606 0.018 DBMET02533 | DBMET02538 | |
| 0.342 | 0.055 | 0.417 | Calcium channel activator | 0.281 0.112 DBMET02521 0.373 0.036 DBMET02535 0.29 0.102 DBMET02543 0.344 0.054 DBMET02530 0.227 0.176 DBMET02534 0.417 0.019 DBMET00764 0.327 0.067 DBMET02537 0.298 0.094 DBMET02531 0.372 0.037 DBMET02523 | DBMET00764 | |
| 0.339 | 0.056 | 0.5 | Spasmolytic | 0.241 0.095 DBMET02521 0.366 0.048 DBMET02535 0.379 0.045 DBMET02543 0.261 0.087 DBMET02530 0.265 0.085 DBMET02534 0.268 0.083 DBMET00764 0.294 0.072 DBMET02536 0.392 0.042 DBMET02537 0.5 0.023 DBMET02545 0.283 0.077 DBMET02531 0.29 0.074 DBMET02523 0.311 0.066 DBMET02529 0.474 0.027 DBMET02538 0.323 0.062 DBMET02541 0.265 0.085 DBMET02546 0.352 0.052 DBMET02532 0.338 0.056 DBMET02525 0.239 0.096 DBMET02539 | DBMET02545 | |
| 0.324 | 0.042 | 0.369 | Pyruvate kinase inhibitor | 0.158 0.108 DBMET02521 0.187 0.089 DBMET02535 0.369 0.028 DBMET02543 0.186 0.089 DBMET02534 0.202 0.08 DBMET00764 0.217 0.072 DBMET02537 0.148 0.117 DBMET02531 0.238 0.065 DBMET02523 | DBMET02543 | |
| 0.288 | 0.015 | 0.328 | Phospholipase A2 inhibitor | 0.194 0.046 DBMET02521 0.227 0.03 DBMET02535 0.328 0.01 DBMET02543 0.159 0.066 DBMET02530 0.207 0.039 DBMET02534 0.303 0.013 DBMET00764 0.229 0.03 DBMET02536 0.241 0.026 DBMET02537 0.288 0.015 DBMET02545 0.174 0.057 DBMET02531 0.32 0.011 DBMET02523 0.229 0.03 DBMET02529 0.203 0.041 DBMET02538 0.244 0.025 DBMET02541 0.201 0.042 DBMET02546 0.14 0.085 DBMET02532 0.244 0.025 DBMET02525 0.133 0.096 DBMET02539 0.163 0.063 DBMET02542 | DBMET02543 | |
| 0.33 | 0.067 | 0.606 | Apoptosis antagonist | 0.3 0.085 DBMET02521 0.282 0.099 DBMET02535 0.384 0.043 DBMET02543 0.232 0.145 DBMET02530 0.335 0.064 DBMET02534 0.3 0.085 DBMET00764 0.582 0.012 DBMET02536 0.319 0.073 DBMET02537 0.556 0.014 DBMET02545 0.269 0.11 DBMET02531 0.341 0.06 DBMET02523 0.521 0.018 DBMET02529 0.493 0.021 DBMET02538 0.606 0.009 DBMET02541 0.522 0.017 DBMET02546 0.456 0.027 DBMET02532 0.563 0.013 DBMET02525 0.467 0.025 DBMET02539 0.579 0.012 DBMET02542 0.437 0.03 DBMET02533 | DBMET02541 | |
| 0.308 | 0.054 | 0.39 | Insulysin inhibitor | 0.276 0.075 DBMET02521 0.265 0.083 DBMET02535 0.362 0.03 DBMET02543 0.226 0.122 DBMET02530 0.332 0.041 DBMET02534 0.347 0.035 DBMET00764 0.324 0.045 DBMET02537 0.291 0.064 DBMET02531 0.39 0.024 DBMET02523 | DBMET02523 | |
| 0.326 | 0.074 | 0.797 | Antithrombotic | 0.34 0.068 DBMET02521 0.403 0.048 DBMET02535 0.39 0.052 DBMET02543 0.31 0.082 DBMET02530 0.377 0.056 DBMET02534 0.46 0.036 DBMET00764 0.708 0.008 DBMET02536 0.442 0.04 DBMET02537 0.789 0.005 DBMET02545 0.343 0.067 DBMET02531 0.496 0.029 DBMET02523 0.682 0.009 DBMET02529 0.797 0.004 DBMET02538 0.73 0.007 DBMET02541 0.719 0.007 DBMET02546 0.732 0.006 DBMET02532 0.706 0.008 DBMET02525 0.728 0.007 DBMET02539 0.654 0.011 DBMET02542 0.656 0.011 DBMET02533 | DBMET02538 | |
| 0.279 | 0.044 | 0.508 | Nitric oxide antagonist | 0.194 0.069 DBMET02521 0.229 0.058 DBMET02535 0.334 0.034 DBMET02543 0.169 0.082 DBMET02530 0.229 0.058 DBMET02534 0.186 0.073 DBMET00764 0.439 0.021 DBMET02536 0.266 0.047 DBMET02537 0.508 0.015 DBMET02545 0.199 0.068 DBMET02531 0.226 0.059 DBMET02523 0.445 0.02 DBMET02529 0.456 0.019 DBMET02538 0.469 0.018 DBMET02541 0.38 0.028 DBMET02546 0.419 0.023 DBMET02532 0.48 0.017 DBMET02525 0.339 0.033 DBMET02539 0.349 0.032 DBMET02542 0.305 0.04 DBMET02533 | DBMET02545 | |
| 0.255 | 0.022 | 0.255 | Cytokine production inhibitor | 0.113 0.096 DBMET02521 0.175 0.046 DBMET02543 0.106 0.105 DBMET02530 0.128 0.082 DBMET00764 | ||
| 0.286 | 0.053 | 0.433 | Vasodilator | 0.221 0.089 DBMET02521 0.319 0.042 DBMET02535 0.315 0.043 DBMET02543 0.198 0.106 DBMET02530 0.236 0.078 DBMET02534 0.186 0.116 DBMET00764 0.403 0.023 DBMET02536 0.345 0.034 DBMET02537 0.424 0.019 DBMET02545 0.214 0.094 DBMET02531 0.203 0.102 DBMET02523 0.41 0.021 DBMET02529 0.431 0.018 DBMET02538 0.422 0.02 DBMET02541 0.399 0.023 DBMET02546 0.352 0.033 DBMET02532 0.433 0.018 DBMET02525 0.405 0.022 DBMET02539 0.398 0.023 DBMET02542 0.34 0.036 DBMET02533 | DBMET02525 | |
| 0.275 | 0.044 | 0.275 | Sigma receptor agonist | 0.176 0.071 DBMET02535 0.23 0.053 DBMET02543 0.173 0.072 DBMET00764 0.159 0.079 DBMET02537 0.157 0.081 DBMET02523 | ||
| 0.244 | 0.019 | 0.372 | Aldehyde dehydrogenase inhibitor | 0.258 0.017 DBMET02521 0.253 0.018 DBMET02535 0.372 0.006 DBMET02543 0.209 0.026 DBMET02530 0.36 0.007 DBMET02534 0.239 0.02 DBMET00764 0.183 0.033 DBMET02536 0.354 0.007 DBMET02537 0.315 0.01 DBMET02545 0.307 0.011 DBMET02531 0.339 0.008 DBMET02523 0.153 0.046 DBMET02529 0.295 0.012 DBMET02538 0.263 0.016 DBMET02541 0.272 0.015 DBMET02546 0.249 0.018 DBMET02532 0.221 0.023 DBMET02525 0.253 0.018 DBMET02539 0.223 0.023 DBMET02542 0.209 0.026 DBMET02533 | DBMET02543 | |
| 0.23 | 0.007 | 0.284 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 DBMET02521 0.151 0.025 DBMET02535 0.279 0.004 DBMET02543 0.11 0.046 DBMET02530 0.162 0.021 DBMET02534 0.252 0.005 DBMET00764 0.185 0.015 DBMET02537 0.141 0.029 DBMET02531 0.284 0.004 DBMET02523 | DBMET02523 | |
| 0.267 | 0.045 | 0.357 | Platelet aggregation inhibitor | 0.193 0.086 DBMET02535 0.152 0.127 DBMET02543 0.357 0.024 DBMET00764 0.235 0.059 DBMET02523 0.176 0.101 DBMET02546 0.143 0.138 DBMET02539 | DBMET00764 | |
| 0.298 | 0.081 | 0.372 | 12-Lipoxygenase inhibitor | 0.235 0.118 DBMET02521 0.219 0.131 DBMET02535 0.372 0.048 DBMET02543 0.211 0.139 DBMET02530 0.283 0.09 DBMET02534 0.3 0.08 DBMET00764 0.265 0.1 DBMET02537 0.253 0.107 DBMET02531 0.345 0.059 DBMET02523 | DBMET02543 | |
| 0.244 | 0.028 | 0.42 | Lipid peroxidase inhibitor | 0.132 0.082 DBMET02521 0.224 0.033 DBMET02535 0.352 0.013 DBMET02543 0.196 0.043 DBMET02534 0.139 0.076 DBMET00764 0.265 0.024 DBMET02536 0.311 0.017 DBMET02537 0.42 0.009 DBMET02545 0.172 0.054 DBMET02531 0.214 0.036 DBMET02523 0.353 0.013 DBMET02529 0.386 0.01 DBMET02538 0.308 0.018 DBMET02541 0.289 0.02 DBMET02546 0.297 0.019 DBMET02532 0.415 0.009 DBMET02525 0.268 0.024 DBMET02539 0.206 0.039 DBMET02542 0.197 0.043 DBMET02533 | DBMET02545 | |
| 0.246 | 0.032 | 0.246 | Tumour necrosis factor antagonist | 0.13 0.126 DBMET02521 0.167 0.08 DBMET02535 0.144 0.108 DBMET02543 0.152 0.098 DBMET02530 0.229 0.038 DBMET00764 0.139 0.114 DBMET02523 | ||
| 0.213 | 0.005 | 0.415 | DOPA decarboxylase inhibitor | 0.171 0.013 DBMET02521 0.158 0.018 DBMET02535 0.329 0.002 DBMET02543 0.14 0.027 DBMET02530 0.251 0.004 DBMET02534 0.3 0.003 DBMET00764 0.233 0.004 DBMET02537 0.133 0.033 DBMET02545 0.207 0.005 DBMET02531 0.415 0.001 DBMET02523 0.107 0.063 DBMET02529 0.11 0.059 DBMET02541 0.151 0.021 DBMET02525 | DBMET02523 | |
| 0.202 | 0.008 | 0.239 | Electron transport complex I inhibitor | 0.239 0.006 DBMET02521 0.174 0.012 DBMET02535 0.155 0.018 DBMET02543 0.19 0.009 DBMET02530 0.184 0.01 DBMET02534 0.126 0.039 DBMET00764 0.096 0.091 DBMET02536 0.141 0.026 DBMET02537 0.104 0.073 DBMET02545 0.152 0.019 DBMET02531 0.099 0.085 DBMET02546 0.1 0.082 DBMET02532 0.095 0.093 DBMET02533 | DBMET02521 | |
| 0.289 | 0.097 | 0.604 | Vasodilator, coronary | 0.357 0.052 DBMET02521 0.424 0.029 DBMET02535 0.258 0.127 DBMET02543 0.435 0.026 DBMET02530 0.319 0.073 DBMET02534 0.337 0.062 DBMET00764 0.581 0.009 DBMET02536 0.383 0.041 DBMET02537 0.429 0.027 DBMET02545 0.393 0.038 DBMET02531 0.302 0.086 DBMET02523 0.512 0.014 DBMET02529 0.562 0.01 DBMET02538 0.532 0.012 DBMET02541 0.452 0.023 DBMET02546 0.575 0.009 DBMET02532 0.472 0.019 DBMET02525 0.589 0.008 DBMET02539 0.557 0.01 DBMET02542 0.604 0.008 DBMET02533 | DBMET02533 | |
| 0.199 | 0.007 | 0.444 | Vanilloid agonist | 0.388 0.004 DBMET02521 0.082 0.063 DBMET02535 0.246 0.005 DBMET02543 0.081 0.069 DBMET02530 0.444 0.004 DBMET02534 0.106 0.027 DBMET00764 0.09 0.047 DBMET02537 0.114 0.021 DBMET02545 0.088 0.051 DBMET02531 0.121 0.018 DBMET02523 0.096 0.038 DBMET02529 0.112 0.023 DBMET02546 0.1 0.033 DBMET02525 | DBMET02534 | |
| 0.314 | 0.122 | 0.394 | 15-Lipoxygenase inhibitor | 0.394 0.077 DBMET02543 0.322 0.116 DBMET00764 0.381 0.083 DBMET02523 | DBMET02543 | |
| 0.284 | 0.094 | 0.444 | Sodium/bile acid cotransporter inhibitor | 0.31 0.07 DBMET02521 0.347 0.042 DBMET02535 0.348 0.041 DBMET02543 0.323 0.06 DBMET02530 0.346 0.043 DBMET02534 0.42 0.012 DBMET00764 0.274 0.103 DBMET02536 0.376 0.026 DBMET02537 0.28 0.098 DBMET02545 0.357 0.035 DBMET02531 0.444 0.008 DBMET02523 0.315 0.066 DBMET02529 0.301 0.078 DBMET02538 0.295 0.084 DBMET02541 0.402 0.016 DBMET02546 0.273 0.105 DBMET02532 0.334 0.051 DBMET02525 0.407 0.015 DBMET02539 0.405 0.015 DBMET02542 0.4 0.017 DBMET02533 | DBMET02523 | |
| 0.212 | 0.022 | 0.256 | Arachidonic acid antagonist | 0.209 0.025 DBMET02521 0.206 0.028 DBMET02535 0.228 0.013 DBMET02543 0.2 0.033 DBMET02530 0.219 0.018 DBMET02534 0.248 0.006 DBMET00764 0.148 0.09 DBMET02536 0.216 0.019 DBMET02537 0.18 0.054 DBMET02545 0.211 0.023 DBMET02531 0.256 0.005 DBMET02523 0.185 0.048 DBMET02529 0.148 0.091 DBMET02538 0.16 0.076 DBMET02541 0.137 0.104 DBMET02532 0.193 0.04 DBMET02525 | DBMET02523 | |
| 0.201 | 0.013 | 0.218 | Calcium antagonist | 0.161 0.02 DBMET02521 0.218 0.011 DBMET02535 0.078 0.065 DBMET02543 0.171 0.018 DBMET02530 0.124 0.033 DBMET00764 0.103 0.046 DBMET02537 0.076 0.067 DBMET02531 | DBMET02535 | |
| 0.197 | 0.009 | 0.197 | Sphingosine 1-phosphate receptor 4 antagonist | 0.167 0.021 DBMET02521 0.178 0.015 DBMET02535 0.194 0.01 DBMET02543 0.147 0.036 DBMET02530 0.16 0.025 DBMET02534 0.197 0.009 DBMET00764 0.171 0.019 DBMET02537 0.14 0.043 DBMET02531 0.189 0.011 DBMET02523 | ||
| 0.267 | 0.086 | 0.315 | Hypoxia-inducible factor 1 alpha inhibitor | 0.189 0.165 DBMET02521 0.198 0.154 DBMET02535 0.28 0.077 DBMET02543 0.181 0.178 DBMET02530 0.189 0.166 DBMET02534 0.315 0.059 DBMET00764 0.202 0.15 DBMET02536 0.198 0.154 DBMET02537 0.313 0.06 DBMET02545 0.18 0.178 DBMET02531 0.315 0.059 DBMET02523 0.277 0.078 DBMET02529 0.221 0.128 DBMET02538 0.19 0.165 DBMET02541 0.197 0.155 DBMET02546 0.202 0.149 DBMET02532 0.264 0.088 DBMET02525 | DBMET02523 | |
| 0.231 | 0.052 | 0.333 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 DBMET02521 0.235 0.05 DBMET02535 0.273 0.033 DBMET02543 0.224 0.055 DBMET02530 0.245 0.045 DBMET02534 0.312 0.02 DBMET00764 0.181 0.091 DBMET02536 0.261 0.038 DBMET02537 0.192 0.079 DBMET02545 0.251 0.042 DBMET02531 0.333 0.015 DBMET02523 0.214 0.061 DBMET02529 0.172 0.105 DBMET02538 0.192 0.079 DBMET02541 0.166 0.115 DBMET02532 0.229 0.053 DBMET02525 | DBMET02523 | |
| 0.199 | 0.025 | 0.469 | Cystathionine beta-synthase inhibitor | 0.156 0.038 DBMET02521 0.207 0.023 DBMET02535 0.297 0.01 DBMET02543 0.171 0.032 DBMET02530 0.215 0.021 DBMET02534 0.361 0.006 DBMET00764 0.155 0.038 DBMET02536 0.271 0.012 DBMET02537 0.243 0.016 DBMET02545 0.232 0.018 DBMET02531 0.469 0.004 DBMET02523 0.228 0.019 DBMET02529 0.218 0.021 DBMET02538 0.193 0.026 DBMET02541 0.109 0.068 DBMET02546 0.181 0.029 DBMET02532 0.271 0.012 DBMET02525 0.095 0.083 DBMET02539 | DBMET02523 | |
| 0.189 | 0.015 | 0.204 | Vanilloid 1 agonist | 0.189 0.015 DBMET02521 0.161 0.029 DBMET02535 0.192 0.014 DBMET02543 0.156 0.033 DBMET02530 0.185 0.017 DBMET02534 0.198 0.012 DBMET00764 0.149 0.039 DBMET02536 0.158 0.031 DBMET02537 0.174 0.021 DBMET02545 0.153 0.035 DBMET02531 0.194 0.014 DBMET02523 0.186 0.016 DBMET02529 0.145 0.043 DBMET02538 0.144 0.045 DBMET02541 0.204 0.011 DBMET02546 0.141 0.049 DBMET02532 0.179 0.019 DBMET02525 0.169 0.024 DBMET02539 0.168 0.025 DBMET02542 0.164 0.027 DBMET02533 | DBMET02546 | |
| 0.2 | 0.029 | 0.215 | MAO A inhibitor | 0.215 0.026 DBMET02543 | DBMET02543 | |
| 0.248 | 0.077 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.23 0.097 DBMET02543 0.232 0.095 DBMET00764 0.169 0.167 DBMET02531 0.235 0.092 DBMET02523 | ||
| 0.185 | 0.015 | 0.213 | Phosphodiesterase IV inhibitor | 0.108 0.04 DBMET02535 0.213 0.011 DBMET00764 0.088 0.054 DBMET02523 | DBMET00764 | |
| 0.189 | 0.02 | 0.24 | Carbonic anhydrase XV inhibitor | 0.134 0.038 DBMET02521 0.142 0.034 DBMET02535 0.237 0.013 DBMET02543 0.129 0.04 DBMET02530 0.154 0.029 DBMET02534 0.206 0.018 DBMET00764 0.164 0.026 DBMET02537 0.148 0.031 DBMET02531 0.24 0.013 DBMET02523 | DBMET02523 | |
| 0.249 | 0.08 | 0.321 | Gastrin inhibitor | 0.207 0.138 DBMET02521 0.219 0.12 DBMET02535 0.251 0.078 DBMET02543 0.193 0.16 DBMET02530 0.206 0.14 DBMET02534 0.321 0.021 DBMET00764 0.218 0.122 DBMET02537 0.212 0.131 DBMET02545 0.192 0.162 DBMET02531 0.32 0.021 DBMET02523 0.21 0.134 DBMET02529 0.245 0.085 DBMET02546 0.216 0.125 DBMET02525 0.204 0.143 DBMET02539 | DBMET00764 | |
| 0.183 | 0.017 | 0.295 | Photosensitizer | 0.127 0.049 DBMET02521 0.145 0.034 DBMET02535 0.201 0.013 DBMET02543 0.117 0.061 DBMET02530 0.135 0.042 DBMET02534 0.237 0.007 DBMET00764 0.198 0.013 DBMET02536 0.154 0.029 DBMET02537 0.295 0.004 DBMET02545 0.124 0.053 DBMET02531 0.251 0.006 DBMET02523 0.263 0.005 DBMET02529 0.221 0.009 DBMET02538 0.21 0.011 DBMET02541 0.212 0.01 DBMET02546 0.176 0.019 DBMET02532 0.278 0.005 DBMET02525 0.158 0.027 DBMET02539 0.15 0.031 DBMET02542 0.127 0.049 DBMET02533 | DBMET02545 | |
| 0.191 | 0.028 | 0.276 | Toll-Like receptor 2 antagonist | 0.204 0.022 DBMET02521 0.25 0.009 DBMET02535 0.224 0.015 DBMET02543 0.231 0.013 DBMET02530 0.225 0.014 DBMET02534 0.245 0.01 DBMET00764 0.157 0.048 DBMET02536 0.276 0.006 DBMET02537 0.253 0.009 DBMET02531 0.27 0.007 DBMET02523 0.142 0.058 DBMET02529 0.138 0.061 DBMET02538 0.174 0.037 DBMET02541 0.102 0.101 DBMET02546 0.117 0.081 DBMET02532 0.16 0.046 DBMET02525 0.15 0.052 DBMET02539 0.184 0.032 DBMET02542 0.127 0.071 DBMET02533 | DBMET02537 | |
| 0.183 | 0.021 | 0.209 | Bronchodilator | 0.112 0.051 DBMET02521 0.208 0.017 DBMET02535 0.18 0.022 DBMET02543 0.105 0.059 DBMET02530 0.106 0.057 DBMET02534 0.157 0.029 DBMET00764 0.209 0.017 DBMET02537 0.097 0.068 DBMET02531 0.151 0.031 DBMET02523 | DBMET02537 | |
| 0.224 | 0.066 | 0.304 | Amyloid beta aggregation inhibitor | 0.14 0.116 DBMET02521 0.149 0.109 DBMET02535 0.304 0.044 DBMET02543 0.174 0.092 DBMET02534 0.19 0.083 DBMET00764 0.213 0.071 DBMET02536 0.186 0.085 DBMET02537 0.185 0.086 DBMET02545 0.146 0.111 DBMET02531 0.24 0.061 DBMET02523 0.168 0.096 DBMET02529 0.137 0.119 DBMET02538 0.228 0.065 DBMET02541 0.183 0.087 DBMET02546 0.18 0.089 DBMET02525 0.142 0.114 DBMET02539 0.217 0.069 DBMET02542 | DBMET02543 | |
| 0.192 | 0.039 | 0.204 | Tubulin antagonist | 0.119 0.08 DBMET02521 0.125 0.075 DBMET02535 0.12 0.08 DBMET02530 0.204 0.036 DBMET00764 | DBMET00764 | |
| 0.266 | 0.113 | 0.387 | Thyroid hormone antagonist | 0.228 0.139 DBMET02543 0.387 0.06 DBMET00764 0.355 0.072 DBMET02523 | DBMET00764 | |
| 0.261 | 0.112 | 0.347 | Thyroid hormone beta antagonist | 0.21 0.146 DBMET02543 0.347 0.07 DBMET00764 0.303 0.086 DBMET02523 | DBMET00764 | |
| 0.183 | 0.036 | 0.202 | Neurotrophic factor | 0.151 0.058 DBMET02521 0.145 0.064 DBMET02535 0.202 0.027 DBMET02543 0.166 0.046 DBMET02534 0.129 0.082 DBMET02536 0.16 0.051 DBMET02537 0.164 0.048 DBMET02545 0.118 0.098 DBMET02531 0.114 0.106 DBMET02523 0.135 0.075 DBMET02538 0.134 0.076 DBMET02541 0.113 0.107 DBMET02546 | DBMET02543 | |
| 0.151 | 0.005 | 0.182 | Granulocyte macrophage colony stimulating factor agonist | 0.124 0.013 DBMET02521 0.128 0.011 DBMET02535 0.123 0.014 DBMET02543 0.132 0.01 DBMET02530 0.101 0.034 DBMET02534 0.182 0.004 DBMET00764 0.104 0.03 DBMET02537 0.107 0.027 DBMET02531 0.149 0.005 DBMET02523 | DBMET00764 | |
| 0.227 | 0.087 | 0.227 | Calpain inhibitor | 0.226 0.088 DBMET02543 0.18 0.134 DBMET00764 0.192 0.122 DBMET02523 | ||
| 0.157 | 0.019 | 0.498 | Porphobilinogen synthase inhibitor | 0.498 0.003 DBMET02543 0.191 0.013 DBMET02534 0.128 0.026 DBMET00764 0.147 0.021 DBMET02537 0.104 0.034 DBMET02531 0.34 0.005 DBMET02523 | DBMET02543 | |
| 0.176 | 0.04 | 0.209 | CF transmembrane conductance regulator agonist | 0.141 0.094 DBMET02521 0.194 0.025 DBMET02535 0.194 0.025 DBMET02543 0.173 0.043 DBMET02530 0.154 0.069 DBMET02534 0.176 0.04 DBMET00764 0.193 0.026 DBMET02536 0.209 0.017 DBMET02537 0.142 0.091 DBMET02545 0.187 0.03 DBMET02531 0.191 0.027 DBMET02523 0.182 0.034 DBMET02529 0.156 0.066 DBMET02538 0.203 0.02 DBMET02541 0.137 0.102 DBMET02532 0.193 0.026 DBMET02525 0.161 0.059 DBMET02542 | DBMET02537 | |
| 0.183 | 0.046 | 0.183 | MAO inhibitor | 0.183 0.046 DBMET02543 0.097 0.094 DBMET02523 | ||
| 0.165 | 0.03 | 0.165 | Falcipain 3 inhibitor | 0.103 0.067 DBMET02521 0.126 0.05 DBMET02535 0.145 0.039 DBMET02543 0.089 0.082 DBMET02530 0.09 0.081 DBMET02534 0.117 0.056 DBMET00764 0.111 0.06 DBMET02537 0.103 0.068 DBMET02523 | ||
| 0.15 | 0.016 | 0.15 | Acetylcholine release stimulant | 0.105 0.077 DBMET02521 0.127 0.038 DBMET02535 0.113 0.061 DBMET02543 0.114 0.059 DBMET02530 0.127 0.038 DBMET00764 0.147 0.018 DBMET02536 0.101 0.086 DBMET02537 0.12 0.048 DBMET02545 0.101 0.086 DBMET02523 0.144 0.02 DBMET02529 0.118 0.051 DBMET02538 0.125 0.041 DBMET02541 0.105 0.076 DBMET02532 0.122 0.045 DBMET02525 | ||
| 0.169 | 0.035 | 0.232 | Farnesoid X receptor antagonist | 0.232 0.014 DBMET02543 0.134 0.075 DBMET02534 0.155 0.047 DBMET00764 0.139 0.067 DBMET02537 0.123 0.098 DBMET02545 0.121 0.102 DBMET02531 0.205 0.02 DBMET02523 0.125 0.094 DBMET02546 | DBMET02543 | |
| 0.267 | 0.137 | 0.267 | Calpain 2 inhibitor | 0.24 0.157 DBMET02543 | ||
| 0.167 | 0.037 | 0.328 | Cholesterol synthesis inhibitor | 0.233 0.02 DBMET02521 0.309 0.01 DBMET02535 0.204 0.026 DBMET02543 0.261 0.016 DBMET02530 0.258 0.017 DBMET02534 0.309 0.01 DBMET00764 0.22 0.022 DBMET02536 0.328 0.009 DBMET02537 0.149 0.045 DBMET02545 0.284 0.013 DBMET02531 0.328 0.009 DBMET02523 0.176 0.033 DBMET02529 0.234 0.02 DBMET02538 0.237 0.02 DBMET02541 0.105 0.08 DBMET02546 0.184 0.031 DBMET02532 0.189 0.03 DBMET02525 0.164 0.038 DBMET02539 0.165 0.038 DBMET02542 0.13 0.057 DBMET02533 | DBMET02523 | |
| 0.166 | 0.038 | 0.218 | Sphingosine 1-phosphate receptor 5 antagonist | 0.132 0.096 DBMET02521 0.17 0.034 DBMET02535 0.183 0.021 DBMET02543 0.143 0.073 DBMET02530 0.143 0.073 DBMET02534 0.208 0.008 DBMET00764 0.179 0.024 DBMET02537 0.154 0.055 DBMET02531 0.218 0.006 DBMET02523 | DBMET02523 | |
| 0.173 | 0.045 | 0.173 | Interleukin 1 antagonist | 0.137 0.068 DBMET02535 0.139 0.066 DBMET02543 0.162 0.05 DBMET00764 0.117 0.093 DBMET02537 0.136 0.069 DBMET02523 | ||
| 0.146 | 0.02 | 0.194 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.119 0.029 DBMET02521 0.095 0.04 DBMET02535 0.194 0.01 DBMET02543 0.09 0.043 DBMET02530 0.147 0.02 DBMET02534 0.146 0.02 DBMET00764 0.123 0.028 DBMET02537 0.117 0.03 DBMET02531 0.174 0.013 DBMET02523 | DBMET02543 | |
| 0.141 | 0.018 | 0.246 | Macrophage migration inhibitory factor inhibitor | 0.106 0.032 DBMET02521 0.106 0.032 DBMET02535 0.2 0.008 DBMET02543 0.09 0.041 DBMET02530 0.134 0.02 DBMET02534 0.195 0.008 DBMET00764 0.134 0.02 DBMET02537 0.116 0.027 DBMET02531 0.246 0.005 DBMET02523 0.098 0.036 DBMET02529 0.115 0.028 DBMET02525 | DBMET02523 | |
| 0.168 | 0.045 | 0.168 | Acetylcholinesterase inhibitor | 0.12 0.078 DBMET02543 | ||
| 0.134 | 0.012 | 0.149 | TRPA1 antagonist | 0.149 0.009 DBMET02543 0.062 0.041 DBMET02534 | DBMET02543 | |
| 0.19 | 0.071 | 0.35 | P-glycoprotein inhibitor | 0.22 0.053 DBMET02521 0.35 0.021 DBMET02535 0.154 0.111 DBMET02543 0.223 0.051 DBMET02530 0.182 0.078 DBMET02534 0.215 0.055 DBMET00764 0.258 0.039 DBMET02536 0.299 0.029 DBMET02537 0.171 0.089 DBMET02545 0.183 0.077 DBMET02531 0.171 0.088 DBMET02523 0.245 0.043 DBMET02529 0.247 0.042 DBMET02538 0.23 0.049 DBMET02541 0.182 0.078 DBMET02532 0.215 0.055 DBMET02525 0.176 0.084 DBMET02539 0.166 0.095 DBMET02542 | DBMET02535 | |
| 0.191 | 0.071 | 0.533 | Hepatoprotectant | 0.204 0.063 DBMET02521 0.231 0.05 DBMET02535 0.225 0.052 DBMET02543 0.181 0.079 DBMET02530 0.227 0.051 DBMET02534 0.193 0.07 DBMET00764 0.497 0.007 DBMET02536 0.263 0.04 DBMET02537 0.488 0.008 DBMET02545 0.201 0.065 DBMET02531 0.218 0.055 DBMET02523 0.432 0.011 DBMET02529 0.496 0.007 DBMET02538 0.533 0.006 DBMET02541 0.388 0.014 DBMET02546 0.462 0.009 DBMET02532 0.466 0.009 DBMET02525 0.396 0.014 DBMET02539 0.422 0.011 DBMET02542 0.367 0.017 DBMET02533 | DBMET02541 | |
| 0.196 | 0.077 | 0.374 | Insulin sensitizer | 0.263 0.028 DBMET02521 0.367 0.008 DBMET02535 0.208 0.065 DBMET02543 0.323 0.012 DBMET02530 0.262 0.028 DBMET02534 0.374 0.008 DBMET00764 0.268 0.025 DBMET02536 0.363 0.008 DBMET02537 0.202 0.071 DBMET02545 0.32 0.012 DBMET02531 0.37 0.008 DBMET02523 0.239 0.041 DBMET02529 0.319 0.013 DBMET02538 0.269 0.025 DBMET02541 0.2 0.073 DBMET02546 0.289 0.018 DBMET02532 0.24 0.04 DBMET02525 0.316 0.013 DBMET02539 0.267 0.026 DBMET02542 0.287 0.019 DBMET02533 | DBMET00764 | |
| 0.131 | 0.013 | 0.215 | Bile acid receptor antagonist | 0.106 0.038 DBMET02521 0.111 0.03 DBMET02535 0.156 0.007 DBMET02543 0.102 0.045 DBMET02530 0.115 0.024 DBMET02534 0.176 0.005 DBMET00764 0.121 0.019 DBMET02537 0.11 0.032 DBMET02545 0.111 0.029 DBMET02531 0.215 0.004 DBMET02523 0.097 0.056 DBMET02529 0.091 0.072 DBMET02541 0.1 0.05 DBMET02546 0.105 0.04 DBMET02525 | DBMET02523 | |
| 0.202 | 0.085 | 0.327 | Nitric-oxide synthase stimulant | 0.235 0.044 DBMET02521 0.258 0.027 DBMET02535 0.22 0.06 DBMET02543 0.274 0.019 DBMET02530 0.252 0.031 DBMET02534 0.244 0.037 DBMET00764 0.218 0.062 DBMET02536 0.276 0.019 DBMET02537 0.216 0.065 DBMET02545 0.293 0.013 DBMET02531 0.261 0.025 DBMET02523 0.23 0.048 DBMET02529 0.27 0.021 DBMET02538 0.23 0.049 DBMET02541 0.249 0.033 DBMET02546 0.287 0.015 DBMET02532 0.242 0.038 DBMET02525 0.309 0.009 DBMET02539 0.265 0.024 DBMET02542 0.327 0.007 DBMET02533 | DBMET02533 | |
| 0.197 | 0.081 | 0.349 | DNA methylase inhibitor | 0.191 0.085 DBMET02521 0.193 0.084 DBMET02535 0.198 0.08 DBMET02543 0.151 0.116 DBMET02530 0.177 0.095 DBMET02534 0.299 0.028 DBMET00764 0.287 0.032 DBMET02536 0.179 0.094 DBMET02537 0.316 0.023 DBMET02545 0.138 0.129 DBMET02531 0.286 0.032 DBMET02523 0.349 0.017 DBMET02529 0.285 0.033 DBMET02538 0.27 0.038 DBMET02541 0.175 0.097 DBMET02546 0.249 0.049 DBMET02532 0.331 0.02 DBMET02525 0.141 0.125 DBMET02539 | DBMET02529 | |
| 0.132 | 0.016 | 0.166 | Aromatase inhibitor | 0.166 0.011 DBMET02543 0.064 0.039 DBMET00764 0.064 0.039 DBMET02537 0.081 0.027 DBMET02523 | DBMET02543 | |
| 0.153 | 0.037 | 0.26 | 5-Lipoxygenase inhibitor | 0.226 0.02 DBMET02543 0.104 0.06 DBMET02534 0.202 0.024 DBMET00764 0.111 0.056 DBMET02537 0.091 0.071 DBMET02531 0.26 0.014 DBMET02523 | DBMET02523 | |
| 0.158 | 0.042 | 0.572 | Cyclooxygenase 3 inhibitor | 0.157 0.043 DBMET02521 0.185 0.025 DBMET02535 0.156 0.043 DBMET02543 0.215 0.014 DBMET02530 0.153 0.046 DBMET02534 0.309 0.005 DBMET00764 0.348 0.005 DBMET02536 0.181 0.027 DBMET02537 0.399 0.004 DBMET02545 0.21 0.015 DBMET02531 0.299 0.006 DBMET02523 0.572 0.003 DBMET02529 0.478 0.003 DBMET02538 0.34 0.005 DBMET02541 0.186 0.025 DBMET02546 0.56 0.003 DBMET02532 0.566 0.003 DBMET02525 0.209 0.016 DBMET02539 0.168 0.034 DBMET02542 0.245 0.009 DBMET02533 | DBMET02529 | |
| 0.143 | 0.029 | 0.299 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.179 0.019 DBMET02521 0.23 0.012 DBMET02535 0.168 0.022 DBMET02543 0.197 0.016 DBMET02530 0.182 0.019 DBMET02534 0.248 0.01 DBMET00764 0.25 0.01 DBMET02536 0.233 0.011 DBMET02537 0.243 0.01 DBMET02545 0.201 0.016 DBMET02531 0.251 0.01 DBMET02523 0.232 0.011 DBMET02529 0.299 0.006 DBMET02538 0.259 0.009 DBMET02541 0.096 0.058 DBMET02546 0.262 0.009 DBMET02532 0.241 0.01 DBMET02525 0.123 0.038 DBMET02539 0.103 0.051 DBMET02542 0.105 0.05 DBMET02533 | DBMET02538 | |
| 0.152 | 0.039 | 0.177 | Interleukin 1b antagonist | 0.138 0.049 DBMET02521 0.177 0.025 DBMET02535 0.108 0.072 DBMET02530 0.177 0.026 DBMET00764 0.1 0.081 DBMET02536 0.132 0.053 DBMET02537 0.122 0.061 DBMET02523 0.107 0.073 DBMET02538 | DBMET00764 | |
| 0.135 | 0.023 | 0.168 | Thioredoxin inhibitor | 0.151 0.017 DBMET02543 0.168 0.013 DBMET02545 0.083 0.076 DBMET02523 0.09 0.062 DBMET02529 0.101 0.047 DBMET02538 0.082 0.078 DBMET02541 0.142 0.019 DBMET02546 0.093 0.057 DBMET02532 0.096 0.053 DBMET02525 0.089 0.063 DBMET02539 0.083 0.075 DBMET02533 | DBMET02545 | |
| 0.138 | 0.025 | 0.17 | Anabolic | 0.119 0.04 DBMET02521 0.117 0.042 DBMET02535 0.17 0.01 DBMET02543 0.107 0.053 DBMET02530 0.151 0.017 DBMET02534 0.122 0.038 DBMET00764 0.149 0.018 DBMET02537 0.112 0.048 DBMET02545 0.141 0.023 DBMET02531 0.153 0.016 DBMET02523 0.093 0.073 DBMET02541 0.101 0.062 DBMET02525 | DBMET02543 | |
| 0.166 | 0.057 | 0.183 | Thiol protease inhibitor | 0.183 0.047 DBMET02543 0.132 0.092 DBMET02534 0.127 0.102 DBMET02537 0.132 0.092 DBMET02523 | DBMET02543 | |
| 0.138 | 0.03 | 0.196 | Sphingomyelinase inhibitor | 0.154 0.023 DBMET02521 0.196 0.01 DBMET02535 0.095 0.065 DBMET02543 0.172 0.017 DBMET02530 0.101 0.058 DBMET02534 0.138 0.03 DBMET00764 0.174 0.016 DBMET02536 0.138 0.03 DBMET02537 0.086 0.077 DBMET02545 0.116 0.044 DBMET02531 0.09 0.073 DBMET02523 0.128 0.036 DBMET02529 0.119 0.042 DBMET02538 0.126 0.037 DBMET02541 0.099 0.06 DBMET02532 0.089 0.074 DBMET02525 0.089 0.073 DBMET02539 0.095 0.066 DBMET02542 | DBMET02535 | |
| 0.127 | 0.019 | 0.236 | Keratolytic | 0.12 0.021 DBMET02521 0.117 0.022 DBMET02535 0.207 0.008 DBMET02543 0.111 0.025 DBMET02530 0.166 0.012 DBMET02534 0.18 0.01 DBMET00764 0.162 0.013 DBMET02537 0.152 0.014 DBMET02531 0.236 0.006 DBMET02523 | DBMET02523 | |
| 0.176 | 0.069 | 0.176 | 3C-like protease (Human coronavirus) inhibitor | 0.15 0.102 DBMET02521 0.155 0.093 DBMET02535 0.137 0.125 DBMET02543 0.16 0.085 DBMET02530 0.167 0.078 DBMET00764 0.137 0.125 DBMET02531 0.142 0.115 DBMET02523 | ||
| 0.165 | 0.059 | 0.387 | Protein kinase stimulant | 0.165 0.058 DBMET02521 0.22 0.035 DBMET02535 0.201 0.041 DBMET02543 0.176 0.052 DBMET02530 0.182 0.049 DBMET02534 0.24 0.029 DBMET00764 0.262 0.023 DBMET02536 0.241 0.029 DBMET02537 0.366 0.01 DBMET02545 0.194 0.044 DBMET02531 0.26 0.024 DBMET02523 0.272 0.021 DBMET02529 0.387 0.009 DBMET02538 0.276 0.02 DBMET02541 0.221 0.035 DBMET02546 0.321 0.014 DBMET02532 0.286 0.019 DBMET02525 0.236 0.03 DBMET02539 0.161 0.061 DBMET02542 0.19 0.045 DBMET02533 | DBMET02538 | |
| 0.117 | 0.015 | 0.159 | T cell inhibitor | 0.114 0.016 DBMET02543 0.08 0.065 DBMET00764 0.142 0.01 DBMET02545 0.078 0.072 DBMET02523 0.084 0.052 DBMET02529 0.094 0.031 DBMET02538 0.159 0.009 DBMET02546 0.092 0.035 DBMET02532 0.083 0.054 DBMET02525 0.106 0.02 DBMET02539 0.08 0.067 DBMET02542 0.104 0.021 DBMET02533 | DBMET02546 | |
| 0.125 | 0.025 | 0.127 | CYP2A6 inhibitor | 0.066 0.065 DBMET02521 0.127 0.024 DBMET02543 0.082 0.047 DBMET02534 0.078 0.05 DBMET02537 0.069 0.06 DBMET02531 0.068 0.061 DBMET02523 | DBMET02543 | |
| 0.148 | 0.048 | 0.178 | Cathepsin H inhibitor | 0.161 0.039 DBMET02521 0.165 0.037 DBMET02535 0.147 0.049 DBMET02543 0.173 0.033 DBMET02530 0.166 0.036 DBMET02534 0.131 0.062 DBMET00764 0.17 0.034 DBMET02537 0.178 0.03 DBMET02531 0.136 0.057 DBMET02523 | DBMET02531 | |
| 0.199 | 0.1 | 0.408 | Antiamyloidogenic | 0.204 0.097 DBMET02535 0.209 0.094 DBMET02543 0.268 0.063 DBMET00764 0.393 0.029 DBMET02536 0.2 0.099 DBMET02537 0.299 0.052 DBMET02545 0.264 0.065 DBMET02523 0.408 0.027 DBMET02529 0.282 0.058 DBMET02538 0.38 0.033 DBMET02541 0.207 0.095 DBMET02546 0.204 0.097 DBMET02532 0.392 0.03 DBMET02525 0.193 0.105 DBMET02539 0.275 0.06 DBMET02542 | DBMET02529 | |
| 0.126 | 0.028 | 0.218 | Carbonic anhydrase XIII inhibitor | 0.11 0.033 DBMET02521 0.194 0.015 DBMET02535 0.162 0.019 DBMET02543 0.108 0.034 DBMET02530 0.128 0.027 DBMET02534 0.18 0.017 DBMET00764 0.171 0.018 DBMET02536 0.218 0.012 DBMET02537 0.166 0.019 DBMET02545 0.126 0.028 DBMET02531 0.205 0.013 DBMET02523 0.144 0.023 DBMET02529 0.218 0.012 DBMET02538 0.191 0.015 DBMET02541 0.074 0.055 DBMET02546 0.126 0.028 DBMET02532 0.163 0.019 DBMET02525 0.104 0.036 DBMET02539 0.087 0.045 DBMET02542 | DBMET02538 | |
| 0.101 | 0.003 | 0.119 | Melatonin receptor 1A agonist | 0.04 0.014 DBMET02521 0.059 0.005 DBMET02535 0.035 0.02 DBMET02543 0.044 0.01 DBMET02530 0.119 0.003 DBMET00764 0.044 0.01 DBMET02523 | DBMET00764 | |
| 0.104 | 0.009 | 0.133 | Glutamate (mGluR7) antagonist | 0.083 0.024 DBMET02521 0.098 0.011 DBMET02535 0.086 0.021 DBMET02543 0.089 0.019 DBMET02530 0.066 0.05 DBMET02534 0.133 0.004 DBMET00764 0.081 0.026 DBMET02537 0.072 0.04 DBMET02531 0.115 0.005 DBMET02523 | DBMET00764 | |
| 0.107 | 0.013 | 0.182 | Peroxisome proliferator-activated receptor gamma antagonist | 0.099 0.016 DBMET02521 0.144 0.006 DBMET02535 0.101 0.015 DBMET02543 0.108 0.012 DBMET02530 0.088 0.025 DBMET02534 0.182 0.004 DBMET00764 0.089 0.023 DBMET02536 0.12 0.01 DBMET02537 0.066 0.064 DBMET02545 0.095 0.019 DBMET02531 0.148 0.006 DBMET02523 0.071 0.05 DBMET02529 0.071 0.051 DBMET02538 0.084 0.029 DBMET02541 0.067 0.062 DBMET02525 0.074 0.044 DBMET02542 | DBMET00764 | |
| 0.109 | 0.016 | 0.154 | Estrogen-related receptor beta agonist | 0.099 0.026 DBMET02521 0.107 0.018 DBMET02535 0.137 0.005 DBMET02543 0.104 0.02 DBMET02530 0.116 0.012 DBMET02534 0.129 0.007 DBMET00764 0.125 0.008 DBMET02537 0.122 0.009 DBMET02531 0.154 0.004 DBMET02523 | DBMET02523 | |
| 0.175 | 0.083 | 0.289 | DNA methyltransferase I inhibitor | 0.181 0.079 DBMET02521 0.151 0.103 DBMET02535 0.179 0.081 DBMET02543 0.168 0.088 DBMET02534 0.289 0.03 DBMET00764 0.193 0.073 DBMET02536 0.142 0.113 DBMET02537 0.289 0.03 DBMET02545 0.28 0.034 DBMET02523 0.288 0.031 DBMET02529 0.239 0.051 DBMET02538 0.174 0.084 DBMET02541 0.135 0.123 DBMET02546 0.201 0.068 DBMET02532 0.274 0.037 DBMET02525 | DBMET02545 | |
| 0.106 | 0.014 | 0.106 | Alpha tubulin antagonist | 0.049 0.042 DBMET02521 0.049 0.042 DBMET02535 0.086 0.018 DBMET02543 0.08 0.02 DBMET00764 0.065 0.027 DBMET02523 | ||
| 0.247 | 0.157 | 0.465 | GABA C receptor rho-3 antagonist | 0.43 0.049 DBMET02543 0.272 0.136 DBMET02534 0.27 0.138 DBMET00764 0.315 0.106 DBMET02537 0.305 0.112 DBMET02531 0.465 0.036 DBMET02523 | DBMET02523 | |
| 0.099 | 0.009 | 0.099 | Oleamide hydrolase inhibitor | 0.077 0.014 DBMET02535 0.076 0.014 DBMET02543 0.062 0.019 DBMET00764 0.071 0.015 DBMET02537 0.057 0.022 DBMET02523 | ||
| 0.123 | 0.033 | 0.164 | Interleukin 1 beta converting enzyme inhibitor | 0.139 0.023 DBMET02543 0.084 0.083 DBMET02534 0.157 0.015 DBMET00764 0.084 0.083 DBMET02537 0.164 0.013 DBMET02523 0.104 0.053 DBMET02546 | DBMET02523 | |
| 0.123 | 0.033 | 0.435 | Alcohol dehydrogenase inhibitor | 0.117 0.037 DBMET02521 0.234 0.009 DBMET02535 0.29 0.005 DBMET02543 0.128 0.03 DBMET02530 0.243 0.008 DBMET02534 0.17 0.016 DBMET00764 0.13 0.029 DBMET02536 0.435 0.004 DBMET02537 0.218 0.01 DBMET02545 0.268 0.006 DBMET02531 0.357 0.004 DBMET02523 0.101 0.052 DBMET02529 0.34 0.005 DBMET02538 0.247 0.008 DBMET02541 0.162 0.018 DBMET02546 0.193 0.013 DBMET02532 0.173 0.016 DBMET02525 0.27 0.006 DBMET02539 0.191 0.013 DBMET02542 0.146 0.022 DBMET02533 | DBMET02537 | |
| 0.107 | 0.019 | 0.202 | Leukotriene antagonist | 0.1 0.022 DBMET02521 0.166 0.008 DBMET02535 0.115 0.016 DBMET02543 0.106 0.019 DBMET02530 0.096 0.023 DBMET02534 0.202 0.005 DBMET00764 0.139 0.012 DBMET02536 0.161 0.009 DBMET02537 0.107 0.019 DBMET02545 0.103 0.021 DBMET02531 0.195 0.006 DBMET02523 0.12 0.015 DBMET02529 0.133 0.013 DBMET02538 0.133 0.013 DBMET02541 0.085 0.029 DBMET02532 0.115 0.016 DBMET02525 0.059 0.052 DBMET02539 0.059 0.052 DBMET02542 | DBMET00764 | |
| 0.154 | 0.067 | 0.294 | Cyclooxygenase inhibitor | 0.157 0.064 DBMET02543 0.278 0.021 DBMET00764 0.12 0.099 DBMET02545 0.294 0.018 DBMET02523 0.2 0.042 DBMET02529 0.204 0.04 DBMET02525 | DBMET02523 | |
| 0.094 | 0.007 | 0.166 | Calcium channel P-type blocker | 0.12 0.004 DBMET02521 0.164 0.003 DBMET02535 0.06 0.057 DBMET02543 0.166 0.003 DBMET02530 0.072 0.024 DBMET02534 0.104 0.005 DBMET00764 0.092 0.008 DBMET02537 0.092 0.008 DBMET02531 0.065 0.039 DBMET02523 | DBMET02530 | |
| 0.154 | 0.068 | 0.204 | GABA C receptor rho-2 antagonist | 0.171 0.05 DBMET02543 0.123 0.12 DBMET02530 0.129 0.107 DBMET02534 0.182 0.041 DBMET00764 0.139 0.09 DBMET02537 0.14 0.088 DBMET02531 0.204 0.027 DBMET02523 | DBMET02523 | |
| 0.115 | 0.029 | 0.251 | Phosphodiesterase 6D inhibitor | 0.096 0.061 DBMET02521 0.149 0.01 DBMET02535 0.126 0.02 DBMET02543 0.106 0.042 DBMET02530 0.104 0.044 DBMET02534 0.177 0.005 DBMET02536 0.164 0.007 DBMET02537 0.189 0.005 DBMET02545 0.115 0.03 DBMET02531 0.092 0.071 DBMET02523 0.114 0.03 DBMET02529 0.251 0.004 DBMET02538 0.197 0.005 DBMET02541 0.122 0.023 DBMET02546 0.163 0.007 DBMET02532 0.124 0.021 DBMET02525 0.154 0.009 DBMET02539 0.126 0.02 DBMET02542 0.109 0.037 DBMET02533 | DBMET02538 | |
| 0.099 | 0.016 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 DBMET02521 0.061 0.05 DBMET02535 0.104 0.014 DBMET02543 0.071 0.035 DBMET02534 0.064 0.045 DBMET00764 0.071 0.035 DBMET02537 0.065 0.044 DBMET02531 0.075 0.032 DBMET02523 | DBMET02543 | |
| 0.159 | 0.075 | 0.383 | Thrombolytic | 0.145 0.086 DBMET02521 0.21 0.047 DBMET02543 0.124 0.106 DBMET02530 0.178 0.063 DBMET02534 0.183 0.061 DBMET00764 0.25 0.033 DBMET02536 0.125 0.105 DBMET02537 0.383 0.013 DBMET02545 0.158 0.076 DBMET02531 0.224 0.041 DBMET02523 0.314 0.022 DBMET02529 0.322 0.02 DBMET02538 0.282 0.027 DBMET02541 0.359 0.016 DBMET02546 0.346 0.017 DBMET02532 0.348 0.017 DBMET02525 0.304 0.023 DBMET02539 0.27 0.029 DBMET02542 0.325 0.02 DBMET02533 | DBMET02545 | |
| 0.139 | 0.056 | 0.139 | Antibacterial (Helicobacter pylori) | 0.115 0.089 DBMET02535 0.135 0.061 DBMET02543 0.128 0.069 DBMET00764 0.114 0.09 DBMET02537 0.128 0.07 DBMET02523 0.137 0.059 DBMET02529 0.138 0.058 DBMET02525 | ||
| 0.181 | 0.098 | 0.181 | Histone acetyltransferase inhibitor | 0.173 0.11 DBMET02543 0.147 0.144 DBMET00764 | ||
| 0.125 | 0.042 | 0.477 | Beta glucuronidase inhibitor | 0.164 0.019 DBMET02543 0.093 0.081 DBMET02534 0.095 0.079 DBMET00764 0.164 0.019 DBMET02536 0.477 0.004 DBMET02545 0.119 0.047 DBMET02523 0.35 0.005 DBMET02529 0.182 0.015 DBMET02538 0.202 0.012 DBMET02541 0.144 0.028 DBMET02546 0.184 0.015 DBMET02532 0.438 0.004 DBMET02525 | DBMET02545 | |
| 0.111 | 0.03 | 0.143 | Glutamate release inhibitor | 0.115 0.025 DBMET02521 0.128 0.017 DBMET02535 0.09 0.061 DBMET02543 0.128 0.018 DBMET02530 0.096 0.049 DBMET02534 0.143 0.012 DBMET00764 0.137 0.013 DBMET02536 0.105 0.035 DBMET02537 0.098 0.045 DBMET02545 0.105 0.036 DBMET02531 0.116 0.024 DBMET02523 0.139 0.013 DBMET02529 0.111 0.029 DBMET02538 0.117 0.024 DBMET02541 0.111 0.029 DBMET02532 0.118 0.023 DBMET02525 | DBMET00764 | |
| 0.166 | 0.085 | 0.219 | Lipocortins synthesis antagonist | 0.171 0.079 DBMET02521 0.193 0.061 DBMET02543 0.182 0.069 DBMET02534 0.202 0.055 DBMET00764 0.139 0.123 DBMET02537 0.173 0.078 DBMET02545 0.136 0.128 DBMET02531 0.219 0.045 DBMET02523 0.149 0.107 DBMET02529 0.139 0.123 DBMET02546 0.151 0.103 DBMET02525 | DBMET02523 | |
| 0.178 | 0.098 | 0.419 | Interleukin antagonist | 0.157 0.113 DBMET02521 0.311 0.045 DBMET02535 0.282 0.052 DBMET02543 0.205 0.081 DBMET02530 0.24 0.065 DBMET02534 0.307 0.046 DBMET00764 0.411 0.029 DBMET02537 0.301 0.048 DBMET02531 0.419 0.028 DBMET02523 0.204 0.082 DBMET02538 0.141 0.125 DBMET02541 0.163 0.109 DBMET02525 0.181 0.095 DBMET02539 | DBMET02523 | |
| 0.124 | 0.044 | 0.124 | Butyrylcholinesterase inhibitor | 0.083 0.078 DBMET02543 | ||
| 0.147 | 0.068 | 0.218 | Adenylate cyclase stimulant | 0.154 0.057 DBMET02521 0.171 0.034 DBMET02535 0.187 0.021 DBMET02543 0.163 0.043 DBMET02530 0.186 0.022 DBMET02534 0.182 0.024 DBMET00764 0.126 0.111 DBMET02536 0.205 0.011 DBMET02537 0.131 0.099 DBMET02545 0.196 0.015 DBMET02531 0.218 0.008 DBMET02523 0.141 0.08 DBMET02529 0.142 0.077 DBMET02538 0.153 0.058 DBMET02541 0.13 0.102 DBMET02546 0.133 0.094 DBMET02532 0.167 0.038 DBMET02525 0.14 0.08 DBMET02539 0.152 0.06 DBMET02542 0.132 0.098 DBMET02533 | DBMET02523 | |
| 0.091 | 0.012 | 0.19 | Leukotriene B4 antagonist | 0.077 0.016 DBMET02521 0.143 0.005 DBMET02535 0.102 0.01 DBMET02543 0.075 0.017 DBMET02530 0.075 0.017 DBMET02534 0.174 0.004 DBMET00764 0.151 0.005 DBMET02536 0.139 0.005 DBMET02537 0.166 0.004 DBMET02545 0.073 0.018 DBMET02531 0.171 0.004 DBMET02523 0.132 0.006 DBMET02529 0.19 0.004 DBMET02538 0.144 0.005 DBMET02541 0.052 0.041 DBMET02546 0.104 0.009 DBMET02532 0.127 0.006 DBMET02525 0.057 0.031 DBMET02539 | DBMET02538 | |
| 0.115 | 0.036 | 0.141 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.045 DBMET02521 0.108 0.044 DBMET02535 0.141 0.015 DBMET02543 0.092 0.068 DBMET02530 0.132 0.02 DBMET02534 0.111 0.04 DBMET00764 0.132 0.02 DBMET02537 0.118 0.032 DBMET02531 0.136 0.018 DBMET02523 | DBMET02543 | |
| 0.159 | 0.081 | 0.254 | Neurotensin receptor agonist | 0.153 0.095 DBMET02535 0.183 0.047 DBMET02543 0.147 0.11 DBMET02530 0.151 0.099 DBMET02534 0.224 0.026 DBMET00764 0.171 0.061 DBMET02537 0.165 0.071 DBMET02531 0.254 0.02 DBMET02523 | DBMET02523 | |
| 0.199 | 0.121 | 0.231 | Neuropeptide Y2 antagonist | 0.191 0.136 DBMET02535 0.231 0.075 DBMET02543 0.18 0.159 DBMET02530 0.197 0.125 DBMET02534 0.226 0.081 DBMET02537 0.215 0.096 DBMET02531 0.189 0.14 DBMET02523 | DBMET02543 | |
| 0.129 | 0.051 | 0.294 | Interleukin 8 antagonist | 0.188 0.016 DBMET02543 0.113 0.072 DBMET02534 0.215 0.01 DBMET00764 0.124 0.056 DBMET02537 0.112 0.073 DBMET02531 0.294 0.004 DBMET02523 | DBMET02523 | |
| 0.132 | 0.057 | 0.158 | Proteasome inhibitor | 0.117 0.068 DBMET02521 0.146 0.049 DBMET02535 0.145 0.049 DBMET02543 0.143 0.051 DBMET02530 0.132 0.057 DBMET02534 0.114 0.071 DBMET00764 0.158 0.042 DBMET02537 0.156 0.043 DBMET02531 0.129 0.059 DBMET02523 | DBMET02537 | |
| 0.108 | 0.036 | 0.138 | Ornithine decarboxylase inhibitor | 0.106 0.038 DBMET02521 0.112 0.032 DBMET02535 0.133 0.018 DBMET02543 0.095 0.05 DBMET02530 0.123 0.024 DBMET02534 0.12 0.026 DBMET00764 0.129 0.02 DBMET02537 0.11 0.034 DBMET02545 0.112 0.032 DBMET02531 0.138 0.015 DBMET02523 0.101 0.043 DBMET02538 0.081 0.067 DBMET02541 0.078 0.07 DBMET02546 0.082 0.065 DBMET02532 0.081 0.067 DBMET02525 | DBMET02523 | |
| 0.135 | 0.065 | 0.169 | Sphingosine 1-phosphate receptor 2 antagonist | 0.14 0.055 DBMET02535 0.149 0.042 DBMET02543 0.114 0.111 DBMET02530 0.114 0.112 DBMET02534 0.16 0.029 DBMET00764 0.149 0.042 DBMET02537 0.124 0.088 DBMET02531 0.169 0.022 DBMET02523 | DBMET02523 | |
| 0.118 | 0.049 | 0.396 | Mediator release inhibitor | 0.092 0.079 DBMET02521 0.094 0.077 DBMET02535 0.15 0.029 DBMET02543 0.114 0.054 DBMET02534 0.123 0.045 DBMET00764 0.221 0.012 DBMET02536 0.115 0.052 DBMET02537 0.396 0.005 DBMET02545 0.104 0.065 DBMET02531 0.15 0.028 DBMET02523 0.152 0.028 DBMET02529 0.258 0.009 DBMET02538 0.298 0.007 DBMET02541 0.274 0.008 DBMET02546 0.219 0.012 DBMET02532 0.185 0.018 DBMET02525 0.182 0.018 DBMET02539 0.201 0.014 DBMET02542 0.162 0.024 DBMET02533 | DBMET02545 | |
| 0.073 | 0.004 | 0.103 | Cyclophilin A inhibitor | 0.103 0.004 DBMET02543 0.036 0.015 DBMET02545 | DBMET02543 | |
| 0.096 | 0.03 | 0.256 | Peroxisome proliferator-activated receptor gamma agonist | 0.171 0.009 DBMET02521 0.156 0.011 DBMET02535 0.09 0.034 DBMET02543 0.199 0.007 DBMET02530 0.164 0.01 DBMET02534 0.256 0.005 DBMET00764 0.132 0.017 DBMET02536 0.149 0.013 DBMET02537 0.073 0.047 DBMET02545 0.192 0.007 DBMET02531 0.251 0.005 DBMET02523 0.089 0.035 DBMET02529 0.099 0.028 DBMET02538 0.13 0.018 DBMET02541 0.128 0.018 DBMET02532 0.083 0.038 DBMET02525 0.074 0.045 DBMET02539 0.096 0.03 DBMET02542 0.095 0.031 DBMET02533 | DBMET00764 | |
| 0.147 | 0.082 | 0.451 | Interferon gamma antagonist | 0.163 0.063 DBMET02521 0.26 0.026 DBMET02535 0.175 0.053 DBMET02543 0.191 0.044 DBMET02530 0.184 0.048 DBMET02534 0.249 0.029 DBMET00764 0.342 0.015 DBMET02536 0.298 0.02 DBMET02537 0.327 0.016 DBMET02545 0.225 0.034 DBMET02531 0.288 0.022 DBMET02523 0.369 0.013 DBMET02529 0.451 0.008 DBMET02538 0.369 0.013 DBMET02541 0.165 0.061 DBMET02546 0.368 0.013 DBMET02532 0.399 0.011 DBMET02525 0.259 0.027 DBMET02539 0.19 0.045 DBMET02542 0.189 0.045 DBMET02533 | DBMET02538 | |
| 0.084 | 0.02 | 0.091 | Exportin-1 inhibitor | 0.082 0.022 DBMET02521 0.091 0.014 DBMET02535 0.069 0.047 DBMET02543 0.091 0.014 DBMET02530 0.075 0.033 DBMET02534 0.082 0.022 DBMET00764 0.083 0.021 DBMET02537 0.083 0.021 DBMET02531 0.075 0.033 DBMET02523 | DBMET02530 | |
| 0.177 | 0.113 | 0.177 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.14 DBMET02543 0.163 0.16 DBMET00764 0.172 0.128 DBMET02523 | ||
| 0.096 | 0.033 | 0.096 | Caspase 7 inhibitor | 0.075 0.073 DBMET02543 0.094 0.035 DBMET00764 0.078 0.065 DBMET02523 | ||
| 0.07 | 0.006 | 0.07 | Dihydrofolate reductase inhibitor | 0.041 0.036 DBMET02535 0.048 0.022 DBMET02543 0.058 0.011 DBMET00764 0.042 0.034 DBMET02523 | ||
| 0.072 | 0.009 | 0.108 | Immunoglobulin Fc receptor antagonist | 0.072 0.01 DBMET02521 0.1 0.004 DBMET02535 0.076 0.007 DBMET02543 0.087 0.005 DBMET02530 0.075 0.008 DBMET02534 0.067 0.014 DBMET00764 0.108 0.004 DBMET02537 0.092 0.004 DBMET02531 0.07 0.011 DBMET02523 | DBMET02537 | |
| 0.127 | 0.065 | 0.175 | Papain-like protease (SARS coronavirus) inhibitor | 0.137 0.049 DBMET02521 0.141 0.043 DBMET02535 0.162 0.024 DBMET02543 0.141 0.044 DBMET02530 0.168 0.021 DBMET02534 0.123 0.074 DBMET00764 0.174 0.018 DBMET02537 0.175 0.018 DBMET02531 0.159 0.027 DBMET02523 | DBMET02531 | |
| 0.096 | 0.033 | 0.481 | Histidine decarboxylase inhibitor | 0.192 0.014 DBMET02521 0.094 0.034 DBMET02535 0.243 0.009 DBMET02543 0.101 0.031 DBMET02530 0.336 0.005 DBMET02534 0.363 0.004 DBMET00764 0.196 0.013 DBMET02537 0.211 0.012 DBMET02531 0.481 0.003 DBMET02523 0.071 0.05 DBMET02525 | DBMET02523 | |
| 0.112 | 0.05 | 0.261 | Carbonic anhydrase III inhibitor | 0.091 0.073 DBMET02521 0.113 0.05 DBMET02535 0.186 0.019 DBMET02543 0.103 0.059 DBMET02530 0.133 0.036 DBMET02534 0.183 0.019 DBMET00764 0.088 0.077 DBMET02536 0.166 0.023 DBMET02537 0.101 0.061 DBMET02545 0.151 0.028 DBMET02531 0.261 0.008 DBMET02523 0.113 0.049 DBMET02529 0.09 0.075 DBMET02538 0.119 0.045 DBMET02541 0.154 0.027 DBMET02525 | DBMET02523 | |
| 0.118 | 0.056 | 0.246 | Mucolytic | 0.166 0.024 DBMET02521 0.164 0.025 DBMET02535 0.122 0.052 DBMET02543 0.168 0.023 DBMET02530 0.156 0.029 DBMET02534 0.246 0.007 DBMET00764 0.146 0.035 DBMET02536 0.154 0.03 DBMET02537 0.129 0.046 DBMET02545 0.158 0.028 DBMET02531 0.232 0.008 DBMET02523 0.233 0.008 DBMET02529 0.146 0.035 DBMET02538 0.135 0.042 DBMET02541 0.149 0.033 DBMET02546 0.15 0.032 DBMET02532 0.218 0.01 DBMET02525 0.167 0.024 DBMET02539 0.155 0.03 DBMET02542 0.171 0.022 DBMET02533 | DBMET00764 | |
| 0.191 | 0.129 | 0.497 | Interleukin agonist | 0.2 0.121 DBMET02521 0.304 0.046 DBMET02535 0.238 0.088 DBMET02543 0.27 0.065 DBMET02530 0.236 0.089 DBMET02534 0.375 0.023 DBMET00764 0.451 0.013 DBMET02536 0.338 0.032 DBMET02537 0.369 0.024 DBMET02545 0.303 0.047 DBMET02531 0.415 0.017 DBMET02523 0.466 0.011 DBMET02529 0.476 0.01 DBMET02538 0.483 0.01 DBMET02541 0.313 0.042 DBMET02546 0.433 0.014 DBMET02532 0.497 0.009 DBMET02525 0.41 0.017 DBMET02539 0.418 0.016 DBMET02542 0.368 0.024 DBMET02533 | DBMET02525 | |
| 0.08 | 0.02 | 0.08 | Phosphodiesterase 4A inhibitor | |||
| 0.144 | 0.086 | 0.345 | Hexokinase inhibitor | 0.172 0.056 DBMET02521 0.171 0.057 DBMET02535 0.185 0.045 DBMET02543 0.172 0.056 DBMET02530 0.197 0.037 DBMET02534 0.189 0.042 DBMET00764 0.233 0.021 DBMET02536 0.196 0.037 DBMET02537 0.339 0.007 DBMET02545 0.198 0.036 DBMET02531 0.216 0.027 DBMET02523 0.321 0.009 DBMET02529 0.34 0.007 DBMET02538 0.258 0.016 DBMET02541 0.185 0.045 DBMET02546 0.342 0.007 DBMET02532 0.345 0.007 DBMET02525 0.186 0.044 DBMET02539 0.14 0.092 DBMET02542 0.188 0.043 DBMET02533 | DBMET02525 | |
| 0.098 | 0.039 | 0.131 | Glutathione S-transferase inhibitor | 0.076 0.067 DBMET02535 0.112 0.027 DBMET02543 0.118 0.024 DBMET00764 0.085 0.054 DBMET02537 0.131 0.018 DBMET02523 0.087 0.052 DBMET02546 | DBMET02523 | |
| 0.138 | 0.08 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.135 0.095 DBMET02521 0.141 0.07 DBMET02535 0.154 0.034 DBMET02543 0.139 0.078 DBMET02530 0.146 0.052 DBMET02534 0.153 0.036 DBMET00764 0.14 0.072 DBMET02536 0.153 0.036 DBMET02537 0.149 0.044 DBMET02545 0.151 0.041 DBMET02531 0.166 0.017 DBMET02523 0.162 0.021 DBMET02529 0.145 0.056 DBMET02538 0.15 0.043 DBMET02541 0.143 0.063 DBMET02532 0.173 0.011 DBMET02525 | DBMET02525 | |
| 0.141 | 0.083 | 0.595 | Peroxidase inhibitor | 0.289 0.039 DBMET02521 0.335 0.031 DBMET02535 0.428 0.017 DBMET02543 0.341 0.03 DBMET02530 0.505 0.009 DBMET02534 0.407 0.019 DBMET00764 0.54 0.007 DBMET02537 0.544 0.006 DBMET02531 0.595 0.005 DBMET02523 | DBMET02523 | |
| 0.06 | 0.003 | 0.061 | Calcium-independent phospholipase A2 inhibitor | 0.04 0.01 DBMET02521 0.036 0.017 DBMET02535 0.061 0.003 DBMET02543 0.04 0.01 DBMET02534 0.033 0.026 DBMET00764 0.036 0.017 DBMET02537 0.044 0.006 DBMET02545 0.033 0.027 DBMET02523 0.04 0.01 DBMET02546 | DBMET02543 | |
| 0.088 | 0.033 | 0.145 | Leukotriene synthesis inhibitor | 0.071 0.043 DBMET02521 0.115 0.019 DBMET02535 0.102 0.025 DBMET02543 0.069 0.045 DBMET02530 0.076 0.04 DBMET02534 0.133 0.013 DBMET00764 0.122 0.016 DBMET02537 0.074 0.041 DBMET02531 0.145 0.01 DBMET02523 | DBMET02523 | |
| 0.173 | 0.118 | 0.173 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.169 0.122 DBMET02543 0.163 0.127 DBMET00764 0.156 0.135 DBMET02523 | ||
| 0.084 | 0.029 | 0.168 | HIV-1 integrase (Strand Transfer) inhibitor | 0.168 0.011 DBMET02543 0.084 0.029 DBMET02534 0.053 0.047 DBMET00764 0.095 0.025 DBMET02545 0.053 0.047 DBMET02531 0.104 0.021 DBMET02523 0.071 0.035 DBMET02546 | DBMET02543 | |
| 0.087 | 0.033 | 0.088 | Calcium channel L-type blocker | 0.088 0.032 DBMET02535 0.069 0.054 DBMET00764 | DBMET02535 | |
| 0.086 | 0.033 | 0.113 | Amidase inhibitor | 0.071 0.048 DBMET02535 0.079 0.038 DBMET02543 0.113 0.018 DBMET00764 0.071 0.048 DBMET02537 0.113 0.018 DBMET02523 | DBMET02523 | |
| 0.069 | 0.016 | 0.071 | Nicotinic receptor alpha3 subunit antagonist | 0.071 0.015 DBMET02543 | DBMET02543 | |
| 0.095 | 0.043 | 0.095 | Acetylcholine nicotinic antagonist | 0.088 0.047 DBMET02543 | ||
| 0.093 | 0.041 | 0.239 | Catalase inhibitor | 0.165 0.023 DBMET02521 0.135 0.03 DBMET02535 0.151 0.026 DBMET02543 0.121 0.033 DBMET02530 0.185 0.018 DBMET02534 0.22 0.012 DBMET00764 0.159 0.024 DBMET02537 0.148 0.027 DBMET02531 0.239 0.01 DBMET02523 | DBMET02523 | |
| 0.103 | 0.052 | 0.198 | Prolactin inhibitor | 0.109 0.047 DBMET02535 0.171 0.015 DBMET02543 0.09 0.067 DBMET02530 0.128 0.033 DBMET02534 0.132 0.031 DBMET00764 0.172 0.015 DBMET02537 0.148 0.023 DBMET02531 0.198 0.009 DBMET02523 | DBMET02523 | |
| 0.069 | 0.019 | 0.095 | Ryanodine receptor antagonist | 0.065 0.025 DBMET02521 0.07 0.017 DBMET02535 0.056 0.052 DBMET02543 0.07 0.017 DBMET02530 0.095 0.005 DBMET00764 0.056 0.052 DBMET02537 0.056 0.052 DBMET02531 0.072 0.015 DBMET02523 | DBMET00764 | |
| 0.058 | 0.007 | 0.061 | Heme oxygenase inhibitor | 0.051 0.012 DBMET02521 0.058 0.007 DBMET02535 0.058 0.007 DBMET02543 0.049 0.015 DBMET02530 0.053 0.01 DBMET02534 0.045 0.022 DBMET00764 0.061 0.005 DBMET02537 0.051 0.012 DBMET02531 0.047 0.018 DBMET02523 | DBMET02537 | |
| 0.095 | 0.044 | 0.178 | Transcription factor NF kappa B stimulant | 0.078 0.073 DBMET02521 0.078 0.074 DBMET02535 0.099 0.039 DBMET02543 0.079 0.071 DBMET02534 0.147 0.016 DBMET02536 0.079 0.072 DBMET02537 0.178 0.011 DBMET02545 0.078 0.075 DBMET02531 0.148 0.016 DBMET02529 0.153 0.015 DBMET02538 0.151 0.015 DBMET02541 0.146 0.017 DBMET02546 0.155 0.015 DBMET02532 0.153 0.015 DBMET02525 0.129 0.022 DBMET02539 0.127 0.022 DBMET02542 0.129 0.021 DBMET02533 | DBMET02545 | |
| 0.084 | 0.034 | 0.179 | GABA B receptor agonist | 0.089 0.026 DBMET02521 0.096 0.02 DBMET02535 0.102 0.015 DBMET02543 0.086 0.03 DBMET02530 0.1 0.016 DBMET02534 0.152 0.004 DBMET00764 0.108 0.012 DBMET02537 0.097 0.019 DBMET02531 0.179 0.004 DBMET02523 | DBMET02523 | |
| 0.125 | 0.075 | 0.209 | Cyclooxygenase 2 inhibitor | 0.12 0.08 DBMET02543 0.201 0.03 DBMET00764 0.209 0.028 DBMET02523 0.145 0.057 DBMET02529 0.145 0.057 DBMET02525 | DBMET02523 | |
| 0.083 | 0.034 | 0.162 | Phosphodiesterase 4B inhibitor | 0.162 0.011 DBMET00764 0.065 0.05 DBMET02523 | DBMET00764 | |
| 0.091 | 0.042 | 0.102 | Chymotrypsin inhibitor | 0.074 0.063 DBMET02521 0.102 0.035 DBMET02543 0.084 0.05 DBMET02534 0.077 0.058 DBMET02523 | DBMET02543 | |
| 0.056 | 0.008 | 0.056 | Melatonin agonist | 0.037 0.018 DBMET02535 0.041 0.014 DBMET00764 | ||
| 0.087 | 0.039 | 0.154 | Estrogen receptor alpha antagonist | 0.07 0.069 DBMET02521 0.081 0.047 DBMET02535 0.154 0.011 DBMET02543 0.071 0.066 DBMET02530 0.099 0.027 DBMET02534 0.092 0.033 DBMET00764 0.121 0.018 DBMET02537 0.101 0.026 DBMET02531 0.142 0.013 DBMET02523 | DBMET02543 | |
| 0.102 | 0.054 | 0.126 | Breast cancer-resistant protein inhibitor | 0.094 0.061 DBMET02535 0.085 0.073 DBMET02530 0.126 0.035 DBMET00764 0.083 0.075 DBMET02523 | DBMET00764 | |
| 0.056 | 0.009 | 0.056 | Melatonin 2 agonist | 0.042 0.014 DBMET02535 0.034 0.022 DBMET02530 0.042 0.014 DBMET00764 0.031 0.026 DBMET02536 | ||
| 0.073 | 0.026 | 0.073 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET02535 0.066 0.039 DBMET02543 0.063 0.047 DBMET02530 0.071 0.028 DBMET00764 0.066 0.037 DBMET02523 | ||
| 0.065 | 0.019 | 0.07 | Prolyl endopeptidase inhibitor | 0.07 0.015 DBMET02543 | DBMET02543 | |
| 0.069 | 0.023 | 0.137 | Sphingosine kinase 2 inhibitor | 0.088 0.012 DBMET02521 0.106 0.006 DBMET02535 0.098 0.008 DBMET02543 0.103 0.007 DBMET02530 0.113 0.005 DBMET02534 0.053 0.042 DBMET00764 0.137 0.004 DBMET02537 0.132 0.004 DBMET02531 0.072 0.02 DBMET02523 | DBMET02537 | |
| 0.157 | 0.11 | 0.252 | Psychostimulant | 0.218 0.071 DBMET02535 0.167 0.102 DBMET02543 0.158 0.11 DBMET02530 0.239 0.063 DBMET00764 0.17 0.1 DBMET02536 0.231 0.066 DBMET02537 0.173 0.098 DBMET02545 0.167 0.102 DBMET02531 0.252 0.058 DBMET02523 0.143 0.123 DBMET02529 0.224 0.068 DBMET02538 0.181 0.092 DBMET02541 0.162 0.106 DBMET02532 0.153 0.113 DBMET02525 | DBMET02523 | |
| 0.084 | 0.039 | 0.114 | Lipase inhibitor | 0.114 0.021 DBMET02543 0.086 0.037 DBMET02537 0.081 0.042 DBMET02545 0.08 0.043 DBMET02523 0.068 0.057 DBMET02538 0.068 0.056 DBMET02541 0.077 0.047 DBMET02546 0.078 0.046 DBMET02525 0.064 0.06 DBMET02539 0.065 0.06 DBMET02542 | DBMET02543 | |
| 0.136 | 0.091 | 0.175 | Heat shock protein 70 antagonist | 0.142 0.069 DBMET02535 0.147 0.054 DBMET02543 0.137 0.088 DBMET02530 0.133 0.103 DBMET02534 0.164 0.023 DBMET00764 0.138 0.083 DBMET02536 0.15 0.045 DBMET02537 0.151 0.044 DBMET02545 0.145 0.059 DBMET02531 0.175 0.015 DBMET02523 0.15 0.047 DBMET02529 0.154 0.037 DBMET02538 0.144 0.061 DBMET02541 0.149 0.048 DBMET02532 0.156 0.033 DBMET02525 | DBMET02523 | |
| 0.116 | 0.072 | 0.225 | DNA polymerase I inhibitor | 0.099 0.087 DBMET02521 0.14 0.055 DBMET02535 0.181 0.035 DBMET02543 0.094 0.093 DBMET02530 0.145 0.052 DBMET02534 0.12 0.068 DBMET00764 0.198 0.029 DBMET02536 0.187 0.033 DBMET02537 0.189 0.032 DBMET02545 0.143 0.053 DBMET02531 0.174 0.037 DBMET02523 0.187 0.032 DBMET02529 0.185 0.033 DBMET02538 0.225 0.022 DBMET02541 0.168 0.04 DBMET02546 0.157 0.045 DBMET02532 0.216 0.024 DBMET02525 0.164 0.042 DBMET02539 0.198 0.029 DBMET02542 0.141 0.055 DBMET02533 | DBMET02541 | |
| 0.134 | 0.091 | 0.134 | Cholinergic | |||
| 0.082 | 0.038 | 0.105 | Phosphodiesterase VI inhibitor | 0.105 0.017 DBMET02535 0.069 0.065 DBMET02543 0.069 0.063 DBMET02530 0.094 0.024 DBMET02536 0.089 0.029 DBMET02537 0.076 0.047 DBMET02545 0.101 0.019 DBMET02538 0.083 0.036 DBMET02541 0.069 0.065 DBMET02539 | DBMET02535 | |
| 0.052 | 0.008 | 0.107 | Free fatty acid receptor 1 antagonist | 0.032 0.025 DBMET02521 0.051 0.008 DBMET02535 0.042 0.014 DBMET02543 0.038 0.018 DBMET02530 0.107 0.003 DBMET00764 0.037 0.019 DBMET02537 0.079 0.004 DBMET02523 | DBMET00764 | |
| 0.087 | 0.043 | 0.209 | Phosphodiesterase 4D inhibitor | 0.209 0.01 DBMET00764 0.137 0.022 DBMET02523 | DBMET00764 | |
| 0.048 | 0.005 | 0.048 | Adenosine uptake inhibitor | 0.041 0.01 DBMET02543 0.037 0.018 DBMET02545 | ||
| 0.063 | 0.02 | 0.107 | Lysophosphatidic acid 3 receptor antagonist | 0.072 0.013 DBMET02521 0.086 0.007 DBMET02535 0.056 0.027 DBMET02543 0.078 0.01 DBMET02530 0.061 0.022 DBMET02534 0.107 0.004 DBMET00764 0.073 0.012 DBMET02537 0.066 0.017 DBMET02531 0.091 0.006 DBMET02523 | DBMET00764 | |
| 0.079 | 0.037 | 0.079 | Neuronal nicotinic receptor antagonist | 0.073 0.042 DBMET02543 | ||
| 0.101 | 0.06 | 0.428 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 DBMET02521 0.098 0.063 DBMET02535 0.19 0.019 DBMET02543 0.11 0.051 DBMET02530 0.286 0.011 DBMET02534 0.102 0.059 DBMET00764 0.19 0.019 DBMET02536 0.164 0.025 DBMET02537 0.394 0.006 DBMET02545 0.185 0.02 DBMET02531 0.17 0.023 DBMET02523 0.325 0.009 DBMET02529 0.34 0.008 DBMET02538 0.322 0.009 DBMET02541 0.142 0.032 DBMET02546 0.369 0.007 DBMET02532 0.428 0.005 DBMET02525 0.114 0.048 DBMET02539 0.107 0.054 DBMET02542 0.127 0.039 DBMET02533 | DBMET02525 | |
| 0.05 | 0.009 | 0.05 | Melatonin 1 agonist | 0.038 0.017 DBMET02535 0.031 0.027 DBMET02530 0.043 0.013 DBMET00764 | ||
| 0.061 | 0.02 | 0.061 | Potassium channel Kv1.3 blocker | 0.043 0.038 DBMET02543 0.049 0.03 DBMET00764 | ||
| 0.078 | 0.038 | 0.217 | Sphingosine 1-phosphate receptor 4 agonist | 0.126 0.015 DBMET02535 0.101 0.025 DBMET02543 0.09 0.03 DBMET02530 0.06 0.055 DBMET02534 0.202 0.004 DBMET00764 0.137 0.011 DBMET02537 0.103 0.023 DBMET02531 0.217 0.004 DBMET02523 | DBMET02523 | |
| 0.112 | 0.073 | 0.163 | Anesthetic local | 0.163 0.043 DBMET02535 0.1 0.083 DBMET02543 0.094 0.088 DBMET02530 0.153 0.047 DBMET02537 | DBMET02535 | |
| 0.052 | 0.013 | 0.052 | Diamine oxidase inhibitor | 0.034 0.031 DBMET02543 0.035 0.03 DBMET00764 | ||
| 0.102 | 0.064 | 0.102 | Gastric antisecretory | 0.095 0.072 DBMET02535 | ||
| 0.063 | 0.026 | 0.063 | 5 Hydroxytryptamine 7 agonist | 0.052 0.048 DBMET00764 | ||
| 0.062 | 0.025 | 0.097 | Leukotriene C antagonist | 0.061 0.026 DBMET02521 0.063 0.023 DBMET02535 0.07 0.014 DBMET02543 0.059 0.031 DBMET02530 0.067 0.018 DBMET02534 0.086 0.006 DBMET00764 0.069 0.015 DBMET02537 0.064 0.021 DBMET02531 0.097 0.004 DBMET02523 | DBMET02523 | |
| 0.06 | 0.024 | 0.106 | Glucose-6-phosphate translocase inhibitor | 0.048 0.042 DBMET02521 0.057 0.027 DBMET02543 0.051 0.037 DBMET00764 0.081 0.011 DBMET02536 0.106 0.005 DBMET02545 0.047 0.045 DBMET02523 0.091 0.008 DBMET02529 0.087 0.009 DBMET02538 0.079 0.012 DBMET02541 0.059 0.025 DBMET02546 0.083 0.01 DBMET02532 0.09 0.008 DBMET02525 0.048 0.044 DBMET02539 | DBMET02545 | |
| 0.062 | 0.028 | 0.062 | Elastase inhibitor | 0.054 0.036 DBMET02543 | ||
| 0.094 | 0.059 | 0.211 | Uric acid excretion stimulant | 0.162 0.02 DBMET02543 0.086 0.071 DBMET02534 0.138 0.028 DBMET00764 0.149 0.023 DBMET02536 0.195 0.014 DBMET02545 0.084 0.074 DBMET02531 0.211 0.012 DBMET02523 0.141 0.027 DBMET02529 0.124 0.035 DBMET02538 0.185 0.015 DBMET02541 0.086 0.072 DBMET02546 0.129 0.033 DBMET02532 0.176 0.017 DBMET02525 0.083 0.076 DBMET02542 | DBMET02523 | |
| 0.098 | 0.064 | 0.098 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET02543 | ||
| 0.051 | 0.017 | 0.076 | Plasmepsin II inhibitor | 0.055 0.015 DBMET02521 0.076 0.007 DBMET02535 0.059 0.012 DBMET02530 0.038 0.035 DBMET02534 0.061 0.011 DBMET00764 0.053 0.015 DBMET02537 0.041 0.029 DBMET02531 0.042 0.027 DBMET02523 | DBMET02535 | |
| 0.134 | 0.102 | 0.284 | Growth hormone agonist | 0.216 0.053 DBMET02535 0.201 0.058 DBMET02543 0.152 0.086 DBMET02530 0.157 0.082 DBMET02534 0.187 0.064 DBMET00764 0.284 0.035 DBMET02537 0.209 0.055 DBMET02531 0.262 0.04 DBMET02523 0.136 0.1 DBMET02539 0.145 0.091 DBMET02542 | DBMET02537 | |
| 0.053 | 0.02 | 0.053 | Histone deacetylase 8 inhibitor | 0.052 0.02 DBMET02543 | ||
| 0.036 | 0.004 | 0.036 | Melatonin receptor 1A antagonist | |||
| 0.046 | 0.016 | 0.079 | Squalene synthetase inhibitor | 0.068 0.01 DBMET02521 0.034 0.021 DBMET02535 0.053 0.014 DBMET02543 0.075 0.009 DBMET02534 0.034 0.021 DBMET00764 0.054 0.013 DBMET02536 0.037 0.019 DBMET02537 0.079 0.008 DBMET02545 0.038 0.019 DBMET02523 0.05 0.014 DBMET02529 0.064 0.011 DBMET02538 0.056 0.013 DBMET02541 0.051 0.014 DBMET02532 0.052 0.014 DBMET02525 | DBMET02545 | |
| 0.113 | 0.086 | 0.673 | Amylase inhibitor | 0.205 0.043 DBMET02521 0.332 0.015 DBMET02535 0.186 0.049 DBMET02543 0.25 0.028 DBMET02530 0.243 0.03 DBMET02534 0.301 0.018 DBMET00764 0.558 0.004 DBMET02536 0.383 0.01 DBMET02537 0.448 0.007 DBMET02545 0.29 0.02 DBMET02531 0.352 0.013 DBMET02523 0.525 0.005 DBMET02529 0.673 0.003 DBMET02538 0.596 0.004 DBMET02541 0.332 0.015 DBMET02546 0.563 0.004 DBMET02532 0.561 0.004 DBMET02525 0.55 0.005 DBMET02539 0.472 0.007 DBMET02542 0.433 0.008 DBMET02533 | DBMET02538 | |
| 0.052 | 0.025 | 0.07 | Cytokine production stimulant | 0.047 0.037 DBMET02535 0.052 0.025 DBMET02543 0.051 0.026 DBMET02536 0.049 0.032 DBMET02537 0.07 0.007 DBMET02545 0.057 0.016 DBMET02529 0.063 0.01 DBMET02538 0.053 0.022 DBMET02541 0.049 0.03 DBMET02532 0.059 0.014 DBMET02525 | DBMET02545 | |
| 0.053 | 0.026 | 0.053 | Cholesterol esterase inhibitor | 0.049 0.031 DBMET02535 0.049 0.031 DBMET02543 0.045 0.037 DBMET00764 0.049 0.032 DBMET02537 0.045 0.038 DBMET02523 | ||
| 0.035 | 0.008 | 0.035 | CYP24 inhibitor | 0.032 0.009 DBMET02535 0.033 0.009 DBMET02543 0.032 0.009 DBMET02537 | ||
| 0.034 | 0.007 | 0.042 | Hedgehog signaling activator | 0.033 0.008 DBMET02521 0.042 0.004 DBMET02535 0.03 0.012 DBMET02543 0.037 0.005 DBMET02530 0.029 0.015 DBMET02534 0.033 0.009 DBMET00764 0.036 0.006 DBMET02537 0.032 0.01 DBMET02531 0.028 0.016 DBMET02523 | DBMET02535 | |
| 0.056 | 0.03 | 0.273 | Heparanase inhibitor | 0.055 0.034 DBMET02521 0.056 0.03 DBMET02535 0.053 0.037 DBMET02543 0.054 0.035 DBMET02530 0.049 0.048 DBMET02534 0.103 0.004 DBMET00764 0.187 0.002 DBMET02536 0.051 0.044 DBMET02537 0.197 0.002 DBMET02545 0.092 0.004 DBMET02523 0.273 0.002 DBMET02529 0.161 0.003 DBMET02538 0.162 0.003 DBMET02541 0.107 0.004 DBMET02546 0.147 0.003 DBMET02532 0.243 0.002 DBMET02525 0.094 0.004 DBMET02539 0.095 0.004 DBMET02542 0.09 0.005 DBMET02533 | DBMET02529 | |
| 0.09 | 0.065 | 0.256 | ABCA1 expression enhancer | 0.099 0.051 DBMET02521 0.095 0.057 DBMET02535 0.098 0.053 DBMET02543 0.1 0.05 DBMET02530 0.102 0.048 DBMET02534 0.228 0.007 DBMET00764 0.097 0.054 DBMET02537 0.103 0.047 DBMET02531 0.256 0.006 DBMET02523 | DBMET02523 | |
| 0.057 | 0.033 | 0.185 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 DBMET02521 0.094 0.012 DBMET02535 0.125 0.007 DBMET02543 0.09 0.013 DBMET02530 0.129 0.006 DBMET02534 0.069 0.022 DBMET00764 0.185 0.004 DBMET02537 0.177 0.004 DBMET02531 0.132 0.006 DBMET02523 | DBMET02537 | |
| 0.044 | 0.021 | 0.049 | Histone deacetylase 7 inhibitor | 0.049 0.019 DBMET02543 | DBMET02543 | |
| 0.042 | 0.019 | 0.119 | Nicotinic acid receptor agonist | 0.119 0.004 DBMET02543 0.038 0.023 DBMET02534 0.039 0.022 DBMET00764 0.051 0.014 DBMET02537 0.093 0.005 DBMET02523 | DBMET02543 | |
| 0.039 | 0.017 | 0.062 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.038 0.019 DBMET02535 0.044 0.013 DBMET02543 0.059 0.006 DBMET00764 0.04 0.016 DBMET02537 0.062 0.005 DBMET02523 | DBMET02523 | |
| 0.052 | 0.03 | 0.099 | Topoisomerase II beta inhibitor | 0.051 0.031 DBMET02521 0.099 0.009 DBMET02543 0.089 0.011 DBMET02534 0.054 0.027 DBMET00764 0.048 0.037 DBMET02537 0.066 0.018 DBMET02545 0.069 0.017 DBMET02531 0.097 0.01 DBMET02523 0.051 0.032 DBMET02532 0.047 0.039 DBMET02525 | DBMET02543 | |
| 0.054 | 0.032 | 0.073 | Vanilloid 2 antagonist | 0.07 0.014 DBMET02535 0.057 0.027 DBMET02543 0.049 0.044 DBMET00764 0.073 0.012 DBMET02537 0.049 0.043 DBMET02523 | DBMET02537 | |
| 0.045 | 0.024 | 0.205 | Liver X receptor alpha agonist | 0.056 0.015 DBMET02535 0.058 0.014 DBMET02543 0.041 0.029 DBMET02530 0.037 0.035 DBMET02534 0.164 0.004 DBMET00764 0.063 0.011 DBMET02537 0.048 0.021 DBMET02531 0.205 0.004 DBMET02523 | DBMET02523 | |
| 0.06 | 0.039 | 0.145 | Sphingosine kinase inhibitor | 0.077 0.018 DBMET02521 0.101 0.007 DBMET02535 0.091 0.01 DBMET02543 0.094 0.009 DBMET02530 0.106 0.006 DBMET02534 0.145 0.004 DBMET02537 0.134 0.004 DBMET02531 0.069 0.026 DBMET02523 | DBMET02537 | |
| 0.081 | 0.06 | 0.081 | Inducible nitric-oxide synthase inhibitor | 0.077 0.068 DBMET02543 | ||
| 0.042 | 0.02 | 0.196 | Estrogen receptor alpha agonist | 0.196 0.005 DBMET02543 0.09 0.01 DBMET02534 0.104 0.008 DBMET02537 0.094 0.009 DBMET02531 0.097 0.009 DBMET02523 | DBMET02543 | |
| 0.065 | 0.044 | 0.093 | CDC25B inhibitor | 0.093 0.019 DBMET02543 0.061 0.05 DBMET00764 0.085 0.024 DBMET02523 0.069 0.039 DBMET02529 0.081 0.027 DBMET02525 | DBMET02543 | |
| 0.072 | 0.051 | 0.15 | Aminopeptidase I inhibitor | 0.087 0.036 DBMET02521 0.095 0.03 DBMET02535 0.13 0.017 DBMET02543 0.078 0.044 DBMET02530 0.138 0.015 DBMET02534 0.094 0.031 DBMET00764 0.15 0.013 DBMET02537 0.126 0.018 DBMET02531 0.148 0.013 DBMET02523 | DBMET02537 | |
| 0.079 | 0.058 | 0.213 | Carbonic anhydrase VI inhibitor | 0.132 0.025 DBMET02543 0.09 0.046 DBMET02534 0.137 0.024 DBMET00764 0.099 0.04 DBMET02537 0.094 0.044 DBMET02531 0.213 0.012 DBMET02523 0.078 0.06 DBMET02529 0.106 0.036 DBMET02525 | DBMET02523 | |
| 0.107 | 0.086 | 0.132 | Cholinergic antagonist | 0.132 0.064 DBMET02543 | DBMET02543 | |
| 0.088 | 0.068 | 0.088 | MAO B inhibitor | 0.088 0.068 DBMET02543 | ||
| 0.034 | 0.013 | 0.034 | Melatonin antagonist | |||
| 0.041 | 0.02 | 0.05 | Vanilloid 3 antagonist | 0.036 0.035 DBMET02521 0.043 0.015 DBMET02535 0.039 0.024 DBMET02530 0.05 0.008 DBMET00764 0.039 0.023 DBMET02523 | DBMET00764 | |
| 0.041 | 0.022 | 0.051 | Nicotinic receptor beta4 subunit antagonist | 0.051 0.015 DBMET02543 | DBMET02543 | |
| 0.06 | 0.04 | 0.08 | Beta tubulin antagonist | 0.08 0.029 DBMET00764 | DBMET00764 | |
| 0.086 | 0.066 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.048 | 0.029 | 0.064 | Carbonic anhydrase VII inhibitor | 0.047 0.032 DBMET02521 0.064 0.017 DBMET02543 0.06 0.019 DBMET02534 0.048 0.029 DBMET02531 0.043 0.036 DBMET02523 | DBMET02543 | |
| 0.066 | 0.047 | 0.066 | Phosphodiesterase III inhibitor | 0.057 0.055 DBMET02535 | ||
| 0.057 | 0.039 | 0.068 | Pregnane X receptor antagonist | 0.054 0.049 DBMET02535 0.056 0.041 DBMET02543 0.054 0.049 DBMET02530 0.068 0.017 DBMET00764 0.066 0.02 DBMET02523 | DBMET00764 | |
| 0.045 | 0.027 | 0.059 | Guanylate cyclase inhibitor | 0.055 0.016 DBMET02521 0.038 0.037 DBMET02535 0.043 0.029 DBMET02543 0.042 0.031 DBMET02530 0.048 0.023 DBMET02534 0.059 0.013 DBMET00764 0.056 0.015 DBMET02545 0.053 0.018 DBMET02523 0.053 0.018 DBMET02529 0.038 0.037 DBMET02538 0.042 0.03 DBMET02532 0.05 0.021 DBMET02525 | DBMET00764 | |
| 0.112 | 0.094 | 0.261 | Bone formation stimulant | 0.129 0.077 DBMET02521 0.204 0.035 DBMET02535 0.159 0.052 DBMET02543 0.146 0.062 DBMET02530 0.156 0.055 DBMET02534 0.177 0.043 DBMET00764 0.178 0.042 DBMET02536 0.261 0.023 DBMET02537 0.133 0.073 DBMET02545 0.178 0.043 DBMET02531 0.239 0.027 DBMET02523 0.144 0.064 DBMET02529 0.173 0.044 DBMET02538 0.206 0.034 DBMET02541 0.15 0.059 DBMET02546 0.14 0.068 DBMET02532 0.161 0.051 DBMET02525 0.187 0.039 DBMET02539 0.216 0.032 DBMET02542 0.155 0.055 DBMET02533 | DBMET02537 | |
| 0.064 | 0.047 | 0.064 | Histone deacetylase inhibitor | 0.064 0.048 DBMET02543 | ||
| 0.069 | 0.051 | 0.105 | Secretase beta inhibitor | 0.072 0.046 DBMET02521 0.105 0.016 DBMET02535 0.091 0.024 DBMET02530 0.067 0.055 DBMET02534 0.098 0.019 DBMET02537 0.086 0.029 DBMET02531 | DBMET02535 | |
| 0.094 | 0.078 | 0.241 | Adenylate kinase inhibitor | 0.127 0.038 DBMET02521 0.096 0.075 DBMET02535 0.137 0.032 DBMET02543 0.096 0.074 DBMET02530 0.173 0.02 DBMET02534 0.171 0.02 DBMET00764 0.125 0.04 DBMET02537 0.11 0.053 DBMET02545 0.126 0.039 DBMET02531 0.241 0.011 DBMET02523 0.093 0.081 DBMET02529 0.095 0.077 DBMET02538 0.095 0.076 DBMET02532 0.115 0.048 DBMET02525 | DBMET02523 | |
| 0.095 | 0.079 | 0.208 | Toll-Like receptor 4 antagonist | 0.112 0.052 DBMET02521 0.123 0.041 DBMET02535 0.107 0.059 DBMET02543 0.113 0.051 DBMET02530 0.117 0.046 DBMET02534 0.126 0.038 DBMET00764 0.196 0.007 DBMET02536 0.129 0.035 DBMET02537 0.172 0.012 DBMET02545 0.118 0.045 DBMET02531 0.133 0.032 DBMET02523 0.202 0.006 DBMET02529 0.176 0.011 DBMET02538 0.201 0.006 DBMET02541 0.153 0.019 DBMET02546 0.173 0.011 DBMET02532 0.208 0.005 DBMET02525 0.157 0.017 DBMET02539 0.181 0.009 DBMET02542 0.154 0.019 DBMET02533 | DBMET02525 | |
| 0.103 | 0.087 | 0.128 | Caspase 3 inhibitor | 0.12 0.06 DBMET02535 0.114 0.07 DBMET02543 0.124 0.054 DBMET00764 0.124 0.055 DBMET02537 0.128 0.049 DBMET02523 | DBMET02523 | |
| 0.02 | 0.004 | 0.028 | Calcium-dependent phospholipase A2 inhibitor | 0.028 0.004 DBMET02543 | DBMET02543 | |
| 0.093 | 0.077 | 0.493 | Expectorant | 0.148 0.036 DBMET02521 0.219 0.017 DBMET02535 0.096 0.073 DBMET02543 0.175 0.027 DBMET02530 0.134 0.043 DBMET02534 0.244 0.013 DBMET00764 0.321 0.007 DBMET02536 0.201 0.02 DBMET02537 0.298 0.009 DBMET02545 0.16 0.032 DBMET02531 0.225 0.016 DBMET02523 0.493 0.004 DBMET02529 0.492 0.004 DBMET02538 0.292 0.009 DBMET02541 0.217 0.017 DBMET02546 0.399 0.005 DBMET02532 0.454 0.004 DBMET02525 0.357 0.006 DBMET02539 0.212 0.018 DBMET02542 0.295 0.009 DBMET02533 | DBMET02529 | |
| 0.053 | 0.038 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.05 | 0.035 | 0.213 | Estrogen agonist | 0.213 0.007 DBMET02543 0.104 0.016 DBMET02534 0.043 0.04 DBMET02536 0.125 0.013 DBMET02537 0.094 0.019 DBMET02545 0.104 0.016 DBMET02531 0.157 0.011 DBMET02523 0.045 0.039 DBMET02529 0.065 0.028 DBMET02538 0.091 0.019 DBMET02541 0.054 0.033 DBMET02532 0.099 0.017 DBMET02525 | DBMET02543 | |
| 0.067 | 0.052 | 0.094 | Elastase 1 inhibitor | 0.069 0.049 DBMET02543 0.086 0.03 DBMET00764 0.064 0.055 DBMET02537 0.094 0.024 DBMET02523 | DBMET02523 | |
| 0.048 | 0.033 | 0.198 | Peroxisome proliferator-activated receptor alpha agonist | 0.075 0.02 DBMET02521 0.146 0.006 DBMET02535 0.109 0.01 DBMET02530 0.044 0.037 DBMET02534 0.198 0.004 DBMET00764 0.094 0.014 DBMET02536 0.102 0.012 DBMET02537 0.074 0.02 DBMET02531 0.142 0.007 DBMET02523 0.053 0.03 DBMET02538 0.074 0.02 DBMET02541 | DBMET00764 | |
| 0.151 | 0.136 | 0.514 | Hypolipemic | 0.261 0.063 DBMET02521 0.476 0.014 DBMET02535 0.191 0.101 DBMET02543 0.31 0.046 DBMET02530 0.287 0.053 DBMET02534 0.359 0.033 DBMET00764 0.456 0.017 DBMET02536 0.514 0.011 DBMET02537 0.352 0.035 DBMET02545 0.342 0.037 DBMET02531 0.396 0.026 DBMET02523 0.324 0.042 DBMET02529 0.513 0.011 DBMET02538 0.478 0.014 DBMET02541 0.278 0.056 DBMET02546 0.412 0.023 DBMET02532 0.346 0.036 DBMET02525 0.434 0.019 DBMET02539 0.406 0.024 DBMET02542 0.338 0.039 DBMET02533 | DBMET02537 | |
| 0.055 | 0.04 | 0.126 | Beta 1 adrenoreceptor antagonist | 0.086 0.014 DBMET02521 0.119 0.007 DBMET02535 0.069 0.027 DBMET02543 0.091 0.013 DBMET02530 0.091 0.013 DBMET02534 0.071 0.025 DBMET00764 0.126 0.006 DBMET02537 0.095 0.011 DBMET02531 0.075 0.022 DBMET02523 | DBMET02537 | |
| 0.019 | 0.004 | 0.019 | Melatonin 2 antagonist | |||
| 0.089 | 0.075 | 0.122 | Protease inhibitor | 0.118 0.049 DBMET02521 0.11 0.056 DBMET02535 0.095 0.07 DBMET02543 0.109 0.057 DBMET02530 0.122 0.046 DBMET02534 0.113 0.053 DBMET02537 0.112 0.055 DBMET02531 0.084 0.081 DBMET02538 0.101 0.064 DBMET02546 0.106 0.06 DBMET02539 0.088 0.077 DBMET02542 0.105 0.061 DBMET02533 | DBMET02534 | |
| 0.039 | 0.025 | 0.069 | Leukotriene C4 antagonist | 0.04 0.025 DBMET02535 0.046 0.014 DBMET02543 0.039 0.026 DBMET02534 0.059 0.006 DBMET00764 0.044 0.016 DBMET02537 0.038 0.031 DBMET02531 0.069 0.004 DBMET02523 | DBMET02523 | |
| 0.092 | 0.079 | 0.221 | Estrogen receptor beta antagonist | 0.089 0.085 DBMET02535 0.205 0.009 DBMET02543 0.139 0.019 DBMET02534 0.104 0.056 DBMET00764 0.156 0.014 DBMET02537 0.144 0.017 DBMET02531 0.221 0.008 DBMET02523 0.104 0.056 DBMET02525 | DBMET02523 | |
| 0.101 | 0.088 | 0.164 | Beta amyloid protein antagonist | 0.123 0.064 DBMET00764 0.164 0.031 DBMET02529 0.139 0.049 DBMET02525 | DBMET02529 | |
| 0.102 | 0.089 | 0.124 | Acetylcholine antagonist | 0.124 0.067 DBMET02543 | DBMET02543 | |
| 0.021 | 0.009 | 0.113 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET02521 0.037 0.004 DBMET02535 0.015 0.014 DBMET02543 0.023 0.007 DBMET02530 0.113 0.003 DBMET00764 0.022 0.008 DBMET02537 0.045 0.004 DBMET02523 | DBMET00764 | |
| 0.063 | 0.05 | 0.143 | Beta adrenoreceptor antagonist | 0.094 0.019 DBMET02521 0.133 0.008 DBMET02535 0.076 0.03 DBMET02543 0.106 0.014 DBMET02530 0.103 0.015 DBMET02534 0.083 0.025 DBMET00764 0.143 0.006 DBMET02537 0.116 0.011 DBMET02531 0.092 0.02 DBMET02523 | DBMET02537 | |
| 0.039 | 0.027 | 0.044 | Histone deacetylase 9 inhibitor | 0.044 0.02 DBMET02543 | DBMET02543 | |
| 0.021 | 0.009 | 0.041 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET02521 0.022 0.008 DBMET02535 0.023 0.007 DBMET02543 0.019 0.013 DBMET02530 0.02 0.011 DBMET02534 0.022 0.008 DBMET00764 0.035 0.003 DBMET02536 0.023 0.007 DBMET02537 0.037 0.003 DBMET02545 0.02 0.012 DBMET02531 0.022 0.007 DBMET02523 0.041 0.002 DBMET02529 0.034 0.003 DBMET02538 0.034 0.003 DBMET02541 0.03 0.004 DBMET02532 0.04 0.002 DBMET02525 | DBMET02529 | |
| 0.062 | 0.05 | 0.14 | Beta 3 adrenoreceptor antagonist | 0.08 0.023 DBMET02521 0.124 0.009 DBMET02535 0.075 0.027 DBMET02543 0.106 0.013 DBMET02530 0.095 0.016 DBMET02534 0.075 0.027 DBMET00764 0.14 0.007 DBMET02537 0.123 0.009 DBMET02531 0.087 0.019 DBMET02523 | DBMET02537 | |
| 0.038 | 0.026 | 0.08 | 5-Alpha-reductase inhibitor | 0.058 0.016 DBMET02543 0.055 0.017 DBMET00764 0.08 0.012 DBMET02523 | DBMET02523 | |
| 0.08 | 0.068 | 0.133 | D-Ala-D-Ala ligase inhibitor | 0.08 0.067 DBMET02521 0.081 0.066 DBMET02535 0.101 0.028 DBMET02543 0.085 0.055 DBMET02530 0.094 0.037 DBMET02534 0.112 0.018 DBMET00764 0.095 0.036 DBMET02537 0.099 0.03 DBMET02531 0.133 0.009 DBMET02523 | DBMET02523 | |
| 0.034 | 0.022 | 0.169 | Peroxisome proliferator-activated receptor delta agonist | 0.043 0.015 DBMET02521 0.098 0.006 DBMET02535 0.076 0.008 DBMET02530 0.169 0.004 DBMET00764 0.053 0.012 DBMET02537 0.041 0.017 DBMET02531 0.107 0.005 DBMET02523 | DBMET00764 | |
| 0.079 | 0.068 | 0.09 | Myeloperoxidase inhibitor | 0.09 0.048 DBMET02543 0.08 0.068 DBMET02537 0.082 0.064 DBMET02523 | DBMET02543 | |
| 0.079 | 0.068 | 0.111 | CC chemokine 5 receptor agonist | 0.111 0.013 DBMET02543 0.08 0.063 DBMET02534 0.102 0.02 DBMET02537 0.091 0.034 DBMET02531 0.097 0.025 DBMET02523 | DBMET02543 | |
| 0.049 | 0.038 | 0.061 | Factor III inhibitor | 0.054 0.026 DBMET02543 0.049 0.038 DBMET02534 0.049 0.038 DBMET00764 0.049 0.036 DBMET02536 0.061 0.017 DBMET02545 0.052 0.03 DBMET02523 0.053 0.027 DBMET02529 0.053 0.027 DBMET02538 0.051 0.033 DBMET02541 0.056 0.023 DBMET02546 0.053 0.027 DBMET02532 0.055 0.024 DBMET02525 0.05 0.034 DBMET02539 0.048 0.041 DBMET02542 0.05 0.035 DBMET02533 | DBMET02545 | |
| 0.067 | 0.057 | 0.179 | Cathepsin G inhibitor | 0.076 0.047 DBMET02535 0.082 0.042 DBMET02543 0.068 0.056 DBMET02534 0.149 0.021 DBMET00764 0.093 0.036 DBMET02537 0.074 0.049 DBMET02531 0.179 0.018 DBMET02523 | DBMET02523 | |
| 0.021 | 0.011 | 0.021 | Melatonin 1 antagonist | |||
| 0.055 | 0.046 | 0.089 | Sphingosine 1-phosphate receptor 3 antagonist | 0.071 0.025 DBMET02535 0.074 0.022 DBMET02543 0.053 0.051 DBMET02530 0.054 0.048 DBMET02534 0.067 0.029 DBMET00764 0.089 0.012 DBMET02537 0.069 0.027 DBMET02531 0.084 0.014 DBMET02523 | DBMET02537 | |
| 0.031 | 0.021 | 0.161 | Prostaglandin agonist | 0.044 0.012 DBMET02521 0.141 0.004 DBMET02535 0.041 0.013 DBMET02543 0.054 0.009 DBMET02530 0.052 0.009 DBMET02534 0.1 0.005 DBMET00764 0.031 0.022 DBMET02536 0.161 0.004 DBMET02537 0.07 0.008 DBMET02531 0.12 0.005 DBMET02523 0.049 0.01 DBMET02538 0.033 0.019 DBMET02541 | DBMET02537 | |
| 0.108 | 0.099 | 0.193 | Nav1.2 sodium channel blocker | 0.193 0.037 DBMET02535 0.13 0.073 DBMET02530 0.108 0.099 DBMET00764 0.179 0.043 DBMET02537 0.12 0.083 DBMET02531 | DBMET02535 | |
| 0.081 | 0.072 | 0.132 | Falcipain inhibitor | 0.083 0.07 DBMET02543 0.132 0.039 DBMET02545 0.081 0.072 DBMET02538 0.106 0.051 DBMET02546 | DBMET02545 | |
| 0.039 | 0.03 | 0.122 | Dopamine D5 agonist | 0.112 0.004 DBMET02543 0.068 0.009 DBMET02534 0.049 0.018 DBMET00764 0.086 0.005 DBMET02537 0.084 0.005 DBMET02531 0.122 0.003 DBMET02523 | DBMET02523 | |
| 0.091 | 0.082 | 0.11 | Glutamate (mGluR7) agonist | 0.11 0.042 DBMET00764 | DBMET00764 | |
| 0.026 | 0.018 | 0.156 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 DBMET02521 0.054 0.005 DBMET02535 0.03 0.013 DBMET02543 0.08 0.004 DBMET02530 0.04 0.009 DBMET02534 0.028 0.015 DBMET00764 0.126 0.002 DBMET02536 0.057 0.005 DBMET02537 0.121 0.002 DBMET02545 0.082 0.004 DBMET02531 0.029 0.014 DBMET02523 0.111 0.003 DBMET02529 0.131 0.002 DBMET02538 0.124 0.002 DBMET02541 0.048 0.007 DBMET02546 0.156 0.001 DBMET02532 0.109 0.003 DBMET02525 0.062 0.005 DBMET02539 0.051 0.006 DBMET02542 0.087 0.004 DBMET02533 | DBMET02532 | |
| 0.085 | 0.077 | 0.2 | Aminopeptidase B inhibitor | 0.108 0.059 DBMET02521 0.111 0.058 DBMET02535 0.168 0.031 DBMET02543 0.092 0.071 DBMET02530 0.174 0.029 DBMET02534 0.139 0.043 DBMET00764 0.176 0.028 DBMET02537 0.159 0.034 DBMET02531 0.2 0.021 DBMET02523 | DBMET02523 | |
| 0.042 | 0.035 | 0.047 | Dihydroorotase inhibitor | 0.047 0.028 DBMET02543 0.047 0.027 DBMET00764 0.047 0.028 DBMET02523 | DBMET02523 | |
| 0.046 | 0.039 | 0.048 | Cannabinoid CB2 receptor antagonist | 0.048 0.038 DBMET02543 | DBMET02543 | |
| 0.023 | 0.016 | 0.058 | Prostaglandin F2 alpha agonist | 0.023 0.016 DBMET02521 0.045 0.005 DBMET02535 0.032 0.008 DBMET02543 0.026 0.012 DBMET02530 0.028 0.01 DBMET02534 0.03 0.009 DBMET00764 0.058 0.004 DBMET02537 0.033 0.008 DBMET02531 0.04 0.005 DBMET02523 0.024 0.014 DBMET02538 0.021 0.018 DBMET02541 | DBMET02537 | |
| 0.025 | 0.018 | 0.216 | Sodium/glucose cotransporter inhibitor | 0.031 0.01 DBMET02521 0.049 0.005 DBMET02535 0.029 0.012 DBMET02543 0.069 0.004 DBMET02530 0.034 0.009 DBMET02534 0.026 0.017 DBMET00764 0.139 0.002 DBMET02536 0.054 0.005 DBMET02537 0.124 0.002 DBMET02545 0.075 0.004 DBMET02531 0.027 0.014 DBMET02523 0.097 0.003 DBMET02529 0.159 0.002 DBMET02538 0.141 0.002 DBMET02541 0.052 0.005 DBMET02546 0.216 0.001 DBMET02532 0.098 0.003 DBMET02525 0.071 0.004 DBMET02539 0.063 0.004 DBMET02542 0.091 0.003 DBMET02533 | DBMET02532 | |
| 0.078 | 0.072 | 0.129 | Falcipain 2 inhibitor | 0.08 0.07 DBMET02543 0.129 0.038 DBMET02545 0.101 0.051 DBMET02546 | DBMET02545 | |
| 0.138 | 0.133 | 0.287 | Phospholipase C inhibitor | 0.144 0.12 DBMET02521 0.167 0.077 DBMET02535 0.195 0.048 DBMET02543 0.146 0.115 DBMET02530 0.187 0.054 DBMET02534 0.192 0.05 DBMET00764 0.139 0.13 DBMET02536 0.223 0.032 DBMET02537 0.166 0.078 DBMET02545 0.19 0.051 DBMET02531 0.287 0.019 DBMET02523 0.144 0.118 DBMET02529 0.174 0.068 DBMET02538 0.175 0.066 DBMET02541 0.17 0.073 DBMET02546 0.152 0.102 DBMET02532 0.182 0.059 DBMET02525 0.178 0.063 DBMET02539 0.18 0.061 DBMET02542 0.156 0.095 DBMET02533 | DBMET02523 | |
| 0.025 | 0.02 | 0.025 | Acid ceramidase inhibitor | |||
| 0.054 | 0.049 | 0.087 | Acetylcholine M3 receptor antagonist | 0.087 0.023 DBMET02543 | DBMET02543 | |
| 0.036 | 0.031 | 0.036 | Histone deacetylase class I inhibitor | |||
| 0.028 | 0.024 | 0.032 | Thiazolidinedione | 0.031 0.017 DBMET02521 0.032 0.015 DBMET02530 0.029 0.022 DBMET00764 | DBMET02530 | |
| 0.098 | 0.094 | 0.232 | Microtubule formation inhibitor | 0.132 0.049 DBMET02521 0.133 0.048 DBMET02535 0.136 0.046 DBMET02530 0.12 0.06 DBMET02534 0.134 0.048 DBMET00764 0.175 0.027 DBMET02536 0.121 0.059 DBMET02537 0.127 0.054 DBMET02545 0.123 0.057 DBMET02531 0.122 0.058 DBMET02523 0.232 0.013 DBMET02529 0.153 0.036 DBMET02538 0.152 0.036 DBMET02541 0.156 0.034 DBMET02532 0.208 0.018 DBMET02525 | DBMET02529 | |
| 0.025 | 0.021 | 0.06 | Leukotriene B4 receptor 1 antagonist | 0.04 0.012 DBMET02535 0.035 0.015 DBMET02543 0.052 0.006 DBMET00764 0.032 0.017 DBMET02536 0.044 0.009 DBMET02537 0.03 0.018 DBMET02545 0.06 0.005 DBMET02523 0.03 0.018 DBMET02529 0.035 0.015 DBMET02538 0.035 0.015 DBMET02541 0.033 0.016 DBMET02525 | DBMET02523 | |
| 0.029 | 0.026 | 0.052 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.052 0.01 DBMET02543 0.032 0.023 DBMET02534 0.033 0.021 DBMET02537 0.03 0.025 DBMET02531 0.039 0.016 DBMET02523 | DBMET02543 | |
| 0.03 | 0.026 | 0.117 | ATP citrate lysase inhibitor | 0.035 0.017 DBMET02521 0.046 0.009 DBMET02535 0.062 0.005 DBMET02543 0.034 0.018 DBMET02530 0.066 0.005 DBMET02534 0.054 0.007 DBMET00764 0.094 0.004 DBMET02537 0.063 0.005 DBMET02531 0.117 0.003 DBMET02523 | DBMET02523 | |
| 0.063 | 0.06 | 0.122 | HIV-1 integrase inhibitor | 0.122 0.015 DBMET02543 0.083 0.036 DBMET02534 0.071 0.046 DBMET00764 0.12 0.015 DBMET02523 | DBMET02543 | |
| 0.031 | 0.028 | 0.092 | Fumarate hydratase inhibitor | 0.071 0.008 DBMET02521 0.037 0.021 DBMET02535 0.047 0.015 DBMET02543 0.045 0.016 DBMET02530 0.092 0.006 DBMET02534 0.05 0.013 DBMET00764 0.046 0.015 DBMET02537 0.033 0.025 DBMET02545 0.056 0.011 DBMET02531 0.063 0.009 DBMET02523 0.035 0.023 DBMET02532 | DBMET02534 | |
| 0.116 | 0.114 | 0.151 | Acetylcholine M1 receptor antagonist | 0.151 0.073 DBMET02543 | DBMET02543 | |
| 0.088 | 0.086 | 0.257 | Ferrochelatase inhibitor | 0.087 0.086 DBMET02535 0.167 0.031 DBMET02543 0.092 0.08 DBMET02534 0.166 0.032 DBMET00764 0.144 0.04 DBMET02537 0.101 0.07 DBMET02531 0.257 0.012 DBMET02523 | DBMET02523 | |
| 0.029 | 0.027 | 0.034 | Sirtuin 2 inhibitor | 0.033 0.023 DBMET02543 0.034 0.022 DBMET02523 | DBMET02523 | |
| 0.051 | 0.049 | 0.051 | Cathepsin L inhibitor | |||
| 0.038 | 0.036 | 0.1 | Sphingosine kinase 1 inhibitor | 0.04 0.03 DBMET02521 0.067 0.007 DBMET02535 0.055 0.012 DBMET02543 0.05 0.016 DBMET02530 0.053 0.014 DBMET02534 0.1 0.004 DBMET02537 0.066 0.007 DBMET02531 0.039 0.033 DBMET02523 | DBMET02537 | |
| 0.16 | 0.158 | 0.357 | DNA damaging | 0.179 0.135 DBMET02521 0.201 0.115 DBMET02535 0.164 0.153 DBMET02543 0.184 0.13 DBMET02534 0.241 0.085 DBMET00764 0.238 0.087 DBMET02536 0.207 0.11 DBMET02537 0.185 0.129 DBMET02545 0.248 0.082 DBMET02523 0.356 0.039 DBMET02529 0.233 0.091 DBMET02538 0.239 0.086 DBMET02541 0.192 0.122 DBMET02546 0.357 0.039 DBMET02525 0.241 0.085 DBMET02539 0.248 0.081 DBMET02542 | DBMET02525 | |
| 0.033 | 0.033 | 0.06 | Tryptophan 5 hydroxylase inhibitor | 0.035 0.029 DBMET02521 0.06 0.004 DBMET00764 0.056 0.004 DBMET02523 | DBMET00764 | |
| 0.065 | 0.064 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.05 | 0.05 | 0.06 | Epithelial sodium channel blocker | 0.055 0.036 DBMET02535 0.051 0.047 DBMET02543 0.05 0.048 DBMET00764 0.06 0.029 DBMET02537 0.054 0.039 DBMET02523 | DBMET02537 | |
| 0.048 | 0.048 | 0.049 | Phosphodiesterase 4C inhibitor | 0.049 0.047 DBMET00764 | DBMET00764 | |
| 0.027 | 0.028 | 0.052 | Prostaglandin D2 agonist | 0.048 0.008 DBMET02535 0.032 0.02 DBMET02543 0.041 0.012 DBMET00764 0.052 0.007 DBMET02537 0.045 0.01 DBMET02523 0.035 0.017 DBMET02538 | DBMET02537 | |
| 0.264 | 0.265 | 0.284 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.267 0.261 DBMET00764 0.284 0.235 DBMET02523 | DBMET02523 | |
| 0.106 | 0.108 | 0.228 | DNA repair enzyme inhibitor | 0.13 0.055 DBMET00764 0.166 0.019 DBMET02536 0.194 0.01 DBMET02545 0.126 0.061 DBMET02523 0.228 0.006 DBMET02529 0.175 0.015 DBMET02538 0.164 0.021 DBMET02541 0.116 0.082 DBMET02546 0.172 0.017 DBMET02532 0.223 0.007 DBMET02525 | DBMET02529 | |
| 0.099 | 0.101 | 0.247 | Estrogen antagonist | 0.102 0.093 DBMET02535 0.207 0.012 DBMET02543 0.148 0.024 DBMET02534 0.12 0.055 DBMET00764 0.174 0.017 DBMET02537 0.16 0.02 DBMET02531 0.247 0.009 DBMET02523 0.119 0.057 DBMET02541 0.133 0.035 DBMET02525 | DBMET02523 | |
| 0.045 | 0.047 | 0.064 | Squalene epoxidase inhibitor | 0.054 0.027 DBMET02535 0.05 0.035 DBMET02543 0.064 0.017 DBMET02537 0.049 0.036 DBMET02531 0.051 0.032 DBMET02523 0.053 0.029 DBMET02541 | DBMET02537 | |
| 0.133 | 0.135 | 0.304 | ATPase inhibitor | 0.166 0.076 DBMET02521 0.174 0.065 DBMET02535 0.145 0.11 DBMET02543 0.175 0.063 DBMET02530 0.175 0.064 DBMET02534 0.235 0.018 DBMET00764 0.266 0.01 DBMET02536 0.183 0.054 DBMET02537 0.267 0.01 DBMET02545 0.184 0.053 DBMET02531 0.246 0.014 DBMET02523 0.275 0.009 DBMET02529 0.302 0.006 DBMET02538 0.269 0.01 DBMET02541 0.19 0.046 DBMET02546 0.304 0.005 DBMET02532 0.278 0.008 DBMET02525 0.222 0.023 DBMET02539 0.193 0.044 DBMET02542 0.224 0.022 DBMET02533 | DBMET02532 | |
| 0.045 | 0.048 | 0.05 | Human rhinovirus A protease inhibitor | 0.05 0.043 DBMET02543 0.048 0.045 DBMET02534 | DBMET02543 | |
| 0.048 | 0.051 | 0.066 | Matrix metalloproteinase (membrane-type) inhibitor | 0.06 0.032 DBMET02535 0.066 0.027 DBMET00764 0.05 0.046 DBMET02537 0.054 0.039 DBMET02523 | DBMET00764 | |
| 0.029 | 0.033 | 0.137 | Retinoid X alpha receptor agonist | 0.033 0.027 DBMET02535 0.042 0.018 DBMET02543 0.127 0.004 DBMET00764 0.039 0.021 DBMET02537 0.031 0.029 DBMET02531 0.137 0.003 DBMET02523 | DBMET02523 | |
| 0.061 | 0.065 | 0.098 | Glutamate (mGluR6) antagonist | 0.063 0.057 DBMET02535 0.07 0.039 DBMET02543 0.091 0.015 DBMET00764 0.067 0.045 DBMET02537 0.062 0.061 DBMET02531 0.098 0.011 DBMET02523 | DBMET02523 | |
| 0.045 | 0.049 | 0.218 | CD45 antagonist | 0.049 0.037 DBMET02521 0.054 0.027 DBMET02535 0.057 0.024 DBMET02543 0.059 0.022 DBMET02530 0.06 0.021 DBMET02534 0.129 0.007 DBMET00764 0.069 0.015 DBMET02537 0.08 0.012 DBMET02531 0.218 0.004 DBMET02523 | DBMET02523 | |
| 0.094 | 0.098 | 0.121 | Acetylcholine muscarinic antagonist | 0.121 0.066 DBMET02543 | DBMET02543 | |
| 0.031 | 0.036 | 0.077 | Glutamate (mGluR3) antagonist | 0.043 0.017 DBMET02535 0.037 0.025 DBMET02543 0.075 0.005 DBMET00764 0.044 0.017 DBMET02537 0.077 0.005 DBMET02523 | DBMET02523 | |
| 0.018 | 0.023 | 0.055 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.016 DBMET02521 0.03 0.007 DBMET02535 0.026 0.009 DBMET02530 0.055 0.004 DBMET00764 0.031 0.006 DBMET02523 | DBMET00764 | |
| 0.041 | 0.046 | 0.196 | Carbonic anhydrase XIV inhibitor | 0.07 0.02 DBMET02535 0.05 0.033 DBMET02543 0.045 0.038 DBMET02530 0.073 0.019 DBMET00764 0.16 0.005 DBMET02536 0.084 0.015 DBMET02537 0.084 0.015 DBMET02545 0.053 0.03 DBMET02531 0.087 0.015 DBMET02523 0.134 0.005 DBMET02529 0.118 0.007 DBMET02538 0.196 0.004 DBMET02541 0.087 0.014 DBMET02532 0.154 0.005 DBMET02525 0.062 0.024 DBMET02539 0.096 0.012 DBMET02542 | DBMET02541 | |
| 0.078 | 0.083 | 0.13 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET02521 0.105 0.033 DBMET02535 0.105 0.033 DBMET02530 0.096 0.046 DBMET02534 0.091 0.054 DBMET00764 0.111 0.027 DBMET02536 0.095 0.047 DBMET02537 0.123 0.018 DBMET02545 0.095 0.047 DBMET02531 0.111 0.027 DBMET02529 0.13 0.014 DBMET02538 0.104 0.035 DBMET02541 0.116 0.022 DBMET02546 0.13 0.014 DBMET02532 0.103 0.036 DBMET02525 0.123 0.018 DBMET02539 0.099 0.041 DBMET02542 0.123 0.018 DBMET02533 | DBMET02532 | |
| 0.022 | 0.028 | 0.053 | Vanilloid 2 agonist | 0.032 0.007 DBMET02543 0.029 0.011 DBMET02536 0.03 0.009 DBMET02537 0.053 0.003 DBMET02545 0.025 0.018 DBMET02531 0.031 0.009 DBMET02523 0.029 0.011 DBMET02529 0.049 0.003 DBMET02538 0.041 0.004 DBMET02541 0.03 0.01 DBMET02546 0.04 0.004 DBMET02532 0.041 0.004 DBMET02525 0.028 0.013 DBMET02539 | DBMET02545 | |
| 0.061 | 0.067 | 0.383 | Glutamate decarboxylase inhibitor | 0.087 0.038 DBMET02521 0.079 0.045 DBMET02535 0.151 0.013 DBMET02543 0.074 0.05 DBMET02530 0.178 0.009 DBMET02534 0.182 0.009 DBMET00764 0.162 0.011 DBMET02537 0.153 0.012 DBMET02531 0.383 0.003 DBMET02523 0.07 0.055 DBMET02525 | DBMET02523 | |
| 0.021 | 0.027 | 0.035 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 DBMET02521 0.034 0.008 DBMET02535 0.028 0.013 DBMET02530 0.035 0.007 DBMET00764 0.033 0.009 DBMET02537 0.027 0.015 DBMET02531 0.034 0.008 DBMET02523 | DBMET00764 | |
| 0.058 | 0.064 | 0.159 | Carbonic anhydrase VA inhibitor | 0.066 0.051 DBMET02535 0.075 0.041 DBMET02543 0.133 0.015 DBMET00764 0.085 0.033 DBMET02537 0.062 0.057 DBMET02531 0.159 0.009 DBMET02523 | DBMET02523 | |
| 0.029 | 0.035 | 0.216 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.017 DBMET02521 0.041 0.014 DBMET02535 0.054 0.009 DBMET02530 0.037 0.018 DBMET02534 0.205 0.004 DBMET00764 0.054 0.009 DBMET02536 0.04 0.014 DBMET02537 0.054 0.009 DBMET02531 0.216 0.004 DBMET02523 0.057 0.008 DBMET02541 0.031 0.028 DBMET02532 0.046 0.011 DBMET02542 | DBMET02523 | |
| 0.069 | 0.076 | 0.098 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 DBMET02535 0.085 0.036 DBMET02543 0.081 0.044 DBMET00764 0.085 0.036 DBMET02537 0.098 0.023 DBMET02523 | DBMET02523 | |
| 0.051 | 0.058 | 0.055 | Acetylcholine M5 receptor antagonist | 0.055 0.05 DBMET02543 | DBMET02543 | |
| 0.044 | 0.051 | 0.117 | Aconitate hydratase inhibitor | 0.064 0.023 DBMET02521 0.058 0.028 DBMET02535 0.063 0.023 DBMET02543 0.054 0.032 DBMET02530 0.079 0.014 DBMET02534 0.093 0.01 DBMET00764 0.071 0.018 DBMET02537 0.067 0.02 DBMET02531 0.117 0.006 DBMET02523 | DBMET02523 | |
| 0.036 | 0.044 | 0.077 | Kainate receptor agonist | 0.038 0.037 DBMET02535 0.042 0.028 DBMET02543 0.073 0.004 DBMET00764 0.04 0.032 DBMET02537 0.038 0.036 DBMET02531 0.077 0.004 DBMET02523 | DBMET02523 | |
| 0.121 | 0.128 | 0.137 | Pregnane X receptor agonist | 0.133 0.092 DBMET02543 0.124 0.118 DBMET00764 0.123 0.12 DBMET02537 0.137 0.082 DBMET02523 | DBMET02523 | |
| 0.115 | 0.123 | 0.163 | Heat shock protein 90 antagonist | 0.163 0.061 DBMET02543 | DBMET02543 | |
| 0.039 | 0.047 | 0.053 | Metalloproteinase-3 inhibitor | 0.046 0.038 DBMET02535 0.053 0.03 DBMET00764 | DBMET00764 | |
| 0.021 | 0.031 | 0.038 | Nicotinic acid receptor 2 antagonist | 0.033 0.01 DBMET02543 0.029 0.014 DBMET00764 0.027 0.018 DBMET02537 0.038 0.005 DBMET02523 | DBMET02523 | |
| 0.038 | 0.048 | 0.059 | Adenylate cyclase 1 inhibitor | 0.05 0.026 DBMET02535 0.043 0.037 DBMET02543 0.053 0.024 DBMET02530 0.05 0.026 DBMET00764 0.056 0.02 DBMET02537 0.059 0.018 DBMET02531 0.056 0.02 DBMET02523 | DBMET02531 | |
| 0.063 | 0.073 | 0.092 | Metalloproteinase-9 inhibitor | 0.092 0.036 DBMET02535 0.068 0.06 DBMET02530 0.09 0.037 DBMET00764 0.079 0.045 DBMET02537 0.077 0.046 DBMET02523 | DBMET02535 | |
| 0.075 | 0.086 | 0.282 | Triose-phosphate isomerase inhibitor | 0.113 0.037 DBMET02521 0.1 0.048 DBMET02535 0.122 0.031 DBMET02543 0.098 0.049 DBMET02530 0.166 0.016 DBMET02534 0.134 0.025 DBMET00764 0.146 0.021 DBMET02536 0.145 0.021 DBMET02537 0.243 0.007 DBMET02545 0.143 0.022 DBMET02531 0.203 0.01 DBMET02523 0.192 0.012 DBMET02529 0.266 0.006 DBMET02538 0.21 0.01 DBMET02541 0.114 0.036 DBMET02546 0.262 0.006 DBMET02532 0.282 0.005 DBMET02525 0.122 0.031 DBMET02539 0.101 0.047 DBMET02542 0.121 0.032 DBMET02533 | DBMET02525 | |
| 0.09 | 0.101 | 0.355 | Alkylator | 0.134 0.056 DBMET02535 0.111 0.076 DBMET02543 0.11 0.078 DBMET02530 0.126 0.063 DBMET00764 0.189 0.03 DBMET02536 0.152 0.046 DBMET02537 0.221 0.021 DBMET02545 0.125 0.063 DBMET02531 0.142 0.051 DBMET02523 0.332 0.011 DBMET02529 0.278 0.014 DBMET02538 0.202 0.026 DBMET02541 0.182 0.032 DBMET02546 0.231 0.019 DBMET02532 0.355 0.009 DBMET02525 0.222 0.021 DBMET02539 0.165 0.039 DBMET02542 0.191 0.029 DBMET02533 | DBMET02525 | |
| 0.016 | 0.028 | 0.12 | Prostaglandin E2 agonist | 0.025 0.015 DBMET02521 0.095 0.004 DBMET02535 0.023 0.016 DBMET02543 0.035 0.009 DBMET02530 0.029 0.011 DBMET02534 0.066 0.005 DBMET00764 0.12 0.004 DBMET02537 0.043 0.007 DBMET02531 0.088 0.004 DBMET02523 0.03 0.01 DBMET02538 0.021 0.02 DBMET02541 | DBMET02537 | |
| 0.012 | 0.023 | 0.016 | Endothelin B receptor antagonist | 0.016 0.015 DBMET00764 | DBMET00764 | |
| 0.047 | 0.059 | 0.133 | DNA helicase inhibitor | 0.053 0.042 DBMET02521 0.052 0.044 DBMET02535 0.053 0.041 DBMET02543 0.055 0.036 DBMET02530 0.052 0.043 DBMET02534 0.125 0.004 DBMET00764 0.051 0.046 DBMET02537 0.055 0.037 DBMET02531 0.133 0.003 DBMET02523 0.07 0.017 DBMET02529 0.05 0.049 DBMET02546 0.07 0.017 DBMET02525 0.051 0.047 DBMET02542 0.05 0.049 DBMET02533 | DBMET02523 | |
| 0.02 | 0.033 | 0.13 | Liver X receptor beta antagonist | 0.039 0.013 DBMET02543 0.086 0.004 DBMET00764 0.029 0.019 DBMET02537 0.13 0.003 DBMET02523 | DBMET02523 | |
| 0.05 | 0.063 | 0.114 | Purinergic P2X1 antagonist | 0.061 0.042 DBMET02535 0.083 0.024 DBMET02543 0.068 0.034 DBMET02534 0.077 0.027 DBMET00764 0.091 0.02 DBMET02537 0.077 0.027 DBMET02531 0.114 0.013 DBMET02523 0.058 0.047 DBMET02525 | DBMET02523 | |
| 0.079 | 0.091 | 0.117 | Urease inhibitor | 0.102 0.065 DBMET02543 0.103 0.064 DBMET00764 0.086 0.083 DBMET02537 0.117 0.048 DBMET02523 | DBMET02523 | |
| 0.03 | 0.043 | 0.083 | Estradiol 17 beta-dehydrogenase inhibitor | 0.073 0.015 DBMET02543 0.059 0.02 DBMET02534 0.044 0.028 DBMET00764 0.052 0.023 DBMET02537 0.061 0.019 DBMET02531 0.083 0.013 DBMET02523 | DBMET02523 | |
| 0.024 | 0.037 | 0.064 | Cholesterol ester transfer protein antagonist | 0.044 0.01 DBMET02521 0.059 0.005 DBMET02535 0.064 0.004 DBMET02530 0.029 0.025 DBMET02534 0.045 0.01 DBMET00764 0.043 0.01 DBMET02537 0.048 0.008 DBMET02531 0.03 0.024 DBMET02523 | DBMET02530 | |
| 0.035 | 0.049 | 0.057 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.05 0.015 DBMET02543 0.044 0.023 DBMET00764 0.044 0.024 DBMET02537 0.04 0.033 DBMET02531 0.057 0.009 DBMET02523 | DBMET02523 | |
| 0.024 | 0.037 | 0.116 | Retinoid X receptor agonist | 0.042 0.021 DBMET02535 0.04 0.022 DBMET02543 0.046 0.019 DBMET02530 0.035 0.025 DBMET02534 0.108 0.004 DBMET00764 0.052 0.017 DBMET02537 0.056 0.015 DBMET02531 0.116 0.004 DBMET02523 | DBMET02523 | |
| 0.035 | 0.049 | 0.058 | Geranyltranstransferase inhibitor | 0.048 0.025 DBMET02535 0.051 0.022 DBMET02543 0.045 0.029 DBMET00764 0.058 0.015 DBMET02537 0.047 0.027 DBMET02531 0.056 0.017 DBMET02523 | DBMET02537 | |
| 0.01 | 0.024 | 0.126 | Peroxisome proliferator-activated receptor alpha antagonist | 0.042 0.009 DBMET02535 0.039 0.009 DBMET02530 0.126 0.004 DBMET00764 0.027 0.013 DBMET02537 0.026 0.013 DBMET02531 0.1 0.004 DBMET02523 | DBMET00764 | |
| 0.051 | 0.065 | 0.072 | Lipocortins synthesis agonist | 0.058 0.04 DBMET02543 0.056 0.045 DBMET02534 0.064 0.028 DBMET02536 0.072 0.019 DBMET02545 0.057 0.042 DBMET02523 0.069 0.023 DBMET02529 0.067 0.025 DBMET02538 0.066 0.026 DBMET02541 0.058 0.039 DBMET02546 0.067 0.025 DBMET02532 0.071 0.02 DBMET02525 | DBMET02545 | |
| 0.025 | 0.039 | 0.124 | Liver X receptor beta agonist | 0.034 0.021 DBMET02535 0.032 0.025 DBMET02543 0.102 0.005 DBMET00764 0.04 0.015 DBMET02537 0.124 0.004 DBMET02523 | DBMET02523 | |
| 0.033 | 0.047 | 0.087 | Sphingosine 1-phosphate receptor 1 agonist | 0.045 0.026 DBMET02521 0.087 0.005 DBMET02535 0.068 0.009 DBMET02530 0.044 0.027 DBMET02534 0.073 0.008 DBMET00764 0.085 0.005 DBMET02537 0.067 0.009 DBMET02531 0.072 0.008 DBMET02523 | DBMET02535 | |
| 0.048 | 0.062 | 0.058 | 5 Hydroxytryptamine 2A agonist | 0.058 0.049 DBMET00764 | DBMET00764 | |
| 0.085 | 0.1 | 0.191 | Chelator | 0.191 0.026 DBMET02543 0.099 0.078 DBMET02534 0.093 0.088 DBMET02537 0.152 0.035 DBMET02523 0.148 0.036 DBMET02546 0.108 0.067 DBMET02539 0.151 0.035 DBMET02542 0.103 0.074 DBMET02533 | DBMET02543 | |
| 0.041 | 0.055 | 0.111 | Carbonic anhydrase VB inhibitor | 0.057 0.037 DBMET02535 0.075 0.025 DBMET02543 0.052 0.043 DBMET02534 0.066 0.03 DBMET00764 0.094 0.018 DBMET02537 0.061 0.034 DBMET02531 0.111 0.014 DBMET02523 | DBMET02523 | |
| 0.02 | 0.036 | 0.109 | Thyroid hormone agonist | 0.037 0.008 DBMET02543 0.024 0.022 DBMET02534 0.061 0.004 DBMET00764 0.034 0.009 DBMET02537 0.027 0.016 DBMET02531 0.109 0.002 DBMET02523 | DBMET02523 | |
| 0.014 | 0.03 | 0.026 | Estrogen-related receptor gamma agonist | 0.026 0.005 DBMET02543 0.017 0.016 DBMET02534 0.021 0.009 DBMET02537 0.019 0.012 DBMET02531 0.026 0.005 DBMET02523 | DBMET02523 | |
| 0.042 | 0.059 | 0.106 | Argininosuccinate synthase inhibitor | 0.087 0.023 DBMET02543 0.07 0.03 DBMET02534 0.061 0.036 DBMET00764 0.056 0.04 DBMET02545 0.106 0.018 DBMET02523 | DBMET02523 | |
| 0.009 | 0.026 | 0.031 | Calcium-sensing receptor antagonist | 0.017 0.009 DBMET02521 0.029 0.006 DBMET02535 0.027 0.007 DBMET02530 0.017 0.009 DBMET02534 0.014 0.011 DBMET00764 0.031 0.006 DBMET02537 0.03 0.006 DBMET02531 0.014 0.011 DBMET02523 | DBMET02537 | |
| 0.05 | 0.068 | 0.174 | Carbonic anhydrase V inhibitor | 0.058 0.056 DBMET02535 0.071 0.042 DBMET02543 0.142 0.016 DBMET00764 0.079 0.036 DBMET02537 0.174 0.01 DBMET02523 | DBMET02523 | |
| 0.032 | 0.05 | 0.038 | Leukocyte elastase inhibitor | 0.038 0.036 DBMET00764 | DBMET00764 | |
| 0.016 | 0.035 | 0.036 | Leukotriene D4 antagonist | 0.031 0.015 DBMET00764 0.036 0.013 DBMET02523 | DBMET02523 | |
| 0.093 | 0.112 | 0.478 | Alpha-N-acetylglucosaminidase inhibitor | 0.192 0.037 DBMET02521 0.181 0.04 DBMET02535 0.186 0.038 DBMET02543 0.206 0.032 DBMET02530 0.312 0.015 DBMET02534 0.258 0.022 DBMET00764 0.246 0.024 DBMET02536 0.296 0.017 DBMET02537 0.322 0.014 DBMET02545 0.333 0.013 DBMET02531 0.406 0.009 DBMET02523 0.327 0.014 DBMET02529 0.432 0.007 DBMET02538 0.352 0.012 DBMET02541 0.183 0.04 DBMET02546 0.478 0.006 DBMET02532 0.455 0.007 DBMET02525 0.255 0.022 DBMET02539 0.202 0.034 DBMET02542 0.288 0.017 DBMET02533 | DBMET02532 | |
| 0.016 | 0.036 | 0.026 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET00764 0.026 0.006 DBMET02523 | DBMET02523 | |
| 0.062 | 0.082 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.068 0.065 DBMET00764 0.072 0.054 DBMET02523 | DBMET02523 | |
| 0.009 | 0.029 | 0.085 | Free fatty acid receptor 1 agonist | 0.02 0.01 DBMET02535 0.085 0.004 DBMET00764 0.016 0.014 DBMET02537 0.074 0.004 DBMET02523 | DBMET00764 | |
| 0.015 | 0.035 | 0.046 | Leukotriene B4 receptor 2 antagonist | 0.027 0.01 DBMET02535 0.036 0.006 DBMET00764 0.027 0.011 DBMET02536 0.034 0.007 DBMET02537 0.023 0.014 DBMET02545 0.046 0.005 DBMET02523 0.027 0.011 DBMET02529 0.031 0.008 DBMET02538 0.03 0.009 DBMET02541 0.02 0.018 DBMET02532 0.03 0.008 DBMET02525 | DBMET02523 | |
| 0.037 | 0.057 | 0.102 | Beta 2 adrenoreceptor antagonist | 0.062 0.022 DBMET02521 0.079 0.012 DBMET02535 0.059 0.025 DBMET02543 0.073 0.015 DBMET02530 0.077 0.013 DBMET02534 0.06 0.024 DBMET00764 0.102 0.008 DBMET02537 0.09 0.009 DBMET02531 0.075 0.014 DBMET02523 | DBMET02537 | |
| 0.075 | 0.095 | 0.311 | Creatine kinase inhibitor | 0.22 0.008 DBMET02543 0.181 0.014 DBMET02534 0.137 0.03 DBMET00764 0.202 0.01 DBMET02537 0.201 0.01 DBMET02531 0.311 0.004 DBMET02523 0.095 0.065 DBMET02525 | DBMET02523 | |
| 0.064 | 0.085 | 0.148 | Interferon agonist | 0.098 0.03 DBMET02535 0.075 0.061 DBMET02543 0.078 0.056 DBMET02530 0.095 0.033 DBMET00764 0.143 0.011 DBMET02536 0.105 0.025 DBMET02537 0.101 0.028 DBMET02545 0.084 0.046 DBMET02531 0.102 0.027 DBMET02523 0.106 0.024 DBMET02529 0.137 0.012 DBMET02538 0.148 0.01 DBMET02541 0.075 0.06 DBMET02546 0.105 0.025 DBMET02532 0.108 0.023 DBMET02525 0.1 0.029 DBMET02539 0.105 0.025 DBMET02542 0.079 0.054 DBMET02533 | DBMET02541 | |
| 0.038 | 0.059 | 0.09 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 DBMET02521 0.049 0.031 DBMET02535 0.054 0.024 DBMET02543 0.048 0.034 DBMET02530 0.067 0.014 DBMET02534 0.061 0.018 DBMET00764 0.059 0.02 DBMET02536 0.063 0.016 DBMET02537 0.079 0.009 DBMET02545 0.061 0.018 DBMET02531 0.078 0.009 DBMET02523 0.072 0.012 DBMET02529 0.084 0.007 DBMET02538 0.073 0.011 DBMET02541 0.053 0.025 DBMET02546 0.082 0.008 DBMET02532 0.09 0.006 DBMET02525 0.057 0.021 DBMET02539 0.049 0.031 DBMET02542 0.055 0.023 DBMET02533 | DBMET02525 | |
| 0.033 | 0.054 | 0.097 | Sphingosine 1-phosphate receptor agonist | 0.042 0.033 DBMET02521 0.097 0.006 DBMET02535 0.071 0.011 DBMET02530 0.092 0.006 DBMET00764 0.089 0.007 DBMET02537 0.065 0.013 DBMET02531 0.085 0.008 DBMET02523 | DBMET02535 | |
| 0.021 | 0.043 | 0.04 | Toll-Like receptor 4 agonist | 0.04 0.005 DBMET02536 0.034 0.008 DBMET02545 0.036 0.006 DBMET02529 0.035 0.007 DBMET02538 0.039 0.005 DBMET02541 0.026 0.018 DBMET02546 0.034 0.007 DBMET02532 0.035 0.007 DBMET02525 0.027 0.016 DBMET02539 0.03 0.011 DBMET02542 0.027 0.018 DBMET02533 | DBMET02536 | |
| 0.071 | 0.094 | 0.08 | Thioredoxin reductase inhibitor | 0.08 0.062 DBMET02535 0.079 0.065 DBMET02537 | DBMET02535 | |
| 0.046 | 0.069 | 0.079 | Sphingosine 1-phosphate receptor 1 antagonist | 0.055 0.039 DBMET02535 0.059 0.031 DBMET02543 0.061 0.028 DBMET00764 0.068 0.02 DBMET02537 0.054 0.042 DBMET02531 0.079 0.014 DBMET02523 | DBMET02523 | |
| 0.09 | 0.113 | 0.333 | Cyclooxygenase 1 inhibitor | 0.113 0.087 DBMET02543 0.138 0.065 DBMET02530 0.289 0.015 DBMET00764 0.156 0.053 DBMET02531 0.333 0.011 DBMET02523 0.202 0.033 DBMET02529 0.115 0.085 DBMET02532 0.212 0.03 DBMET02525 | DBMET02523 | |
| 0.007 | 0.03 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 DBMET02535 | DBMET02535 | |
| 0.165 | 0.188 | 0.226 | Transcription factor STAT3 inhibitor | 0.216 0.115 DBMET02535 0.175 0.172 DBMET02543 0.195 0.14 DBMET02530 0.187 0.153 DBMET00764 0.184 0.157 DBMET02536 0.226 0.105 DBMET02537 0.204 0.129 DBMET02531 0.195 0.141 DBMET02523 0.189 0.15 DBMET02541 | DBMET02537 | |
| 0.055 | 0.078 | 0.088 | Beta 2 adrenoreceptor agonist | 0.071 0.018 DBMET02535 0.07 0.02 DBMET02543 0.063 0.038 DBMET02530 0.07 0.019 DBMET02534 0.062 0.04 DBMET00764 0.088 0.005 DBMET02537 0.076 0.012 DBMET02531 0.075 0.012 DBMET02523 | DBMET02537 | |
| 0.05 | 0.074 | 0.419 | Phenylalanine 4-hydroxylase inhibitor | 0.084 0.034 DBMET02521 0.147 0.012 DBMET02535 0.194 0.007 DBMET02543 0.126 0.016 DBMET02530 0.26 0.005 DBMET02534 0.139 0.014 DBMET00764 0.419 0.003 DBMET02537 0.371 0.003 DBMET02531 0.401 0.003 DBMET02523 0.06 0.058 DBMET02538 0.071 0.046 DBMET02541 0.066 0.05 DBMET02525 | DBMET02537 | |
| 0.014 | 0.038 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.015 DBMET02523 | DBMET02523 | |
| 0.057 | 0.081 | 0.136 | Glutamate dehydrogenase inhibitor | 0.083 0.042 DBMET02521 0.106 0.028 DBMET02543 0.136 0.018 DBMET02534 0.083 0.042 DBMET00764 0.099 0.031 DBMET02537 0.072 0.054 DBMET02545 0.093 0.035 DBMET02531 0.136 0.018 DBMET02523 0.068 0.059 DBMET02525 | DBMET02523 | |
| 0.065 | 0.089 | 0.109 | Histamine N-methyltransferase inhibitor | 0.105 0.041 DBMET02543 0.088 0.058 DBMET02537 0.109 0.038 DBMET02523 | DBMET02523 | |
| 0.034 | 0.058 | 0.052 | GABA B receptor antagonist | 0.04 0.035 DBMET02543 0.043 0.029 DBMET00764 0.052 0.018 DBMET02523 | DBMET02523 | |
| 0.005 | 0.03 | 0.012 | Thromboxane agonist | 0.012 0.006 DBMET02537 0.01 0.009 DBMET02523 | DBMET02537 | |
| 0.021 | 0.046 | 0.055 | Lysophosphatidic acid 2 receptor antagonist | 0.032 0.019 DBMET02535 0.055 0.008 DBMET00764 0.029 0.023 DBMET02537 0.049 0.009 DBMET02523 | DBMET00764 | |
| 0.099 | 0.125 | 0.139 | Nav1.6 sodium channel blocker | 0.139 0.068 DBMET02535 0.126 0.088 DBMET02530 0.116 0.102 DBMET00764 0.126 0.086 DBMET02537 0.112 0.109 DBMET02531 | DBMET02535 | |
| 0.059 | 0.085 | 0.096 | Glycine receptor agonist | 0.07 0.055 DBMET02543 0.086 0.032 DBMET00764 0.068 0.059 DBMET02537 0.096 0.023 DBMET02523 0.072 0.05 DBMET02529 0.077 0.042 DBMET02525 | DBMET02523 | |
| 0.043 | 0.07 | 0.13 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.08 0.025 DBMET02535 0.079 0.025 DBMET02543 0.065 0.034 DBMET02530 0.071 0.03 DBMET02534 0.076 0.027 DBMET00764 0.07 0.031 DBMET02536 0.13 0.01 DBMET02537 0.075 0.027 DBMET02545 0.109 0.014 DBMET02531 0.125 0.011 DBMET02523 0.058 0.041 DBMET02529 0.119 0.012 DBMET02538 0.11 0.014 DBMET02541 0.099 0.017 DBMET02532 0.091 0.02 DBMET02525 | DBMET02537 | |
| 0.01 | 0.037 | 0.035 | Nicotinic acid receptor 1 antagonist | 0.032 0.004 DBMET02543 0.017 0.012 DBMET02534 0.027 0.005 DBMET02537 0.02 0.009 DBMET02531 0.035 0.004 DBMET02523 | DBMET02523 | |
| 0.008 | 0.035 | 0.047 | Ileal bile acid transport inhibitor | 0.018 0.011 DBMET02535 0.017 0.012 DBMET00764 0.028 0.005 DBMET02536 0.02 0.009 DBMET02537 0.033 0.005 DBMET02545 0.019 0.01 DBMET02523 0.028 0.005 DBMET02529 0.047 0.004 DBMET02538 0.027 0.005 DBMET02541 0.023 0.007 DBMET02546 0.036 0.004 DBMET02532 0.027 0.005 DBMET02525 0.033 0.005 DBMET02539 0.019 0.01 DBMET02542 0.025 0.006 DBMET02533 | DBMET02538 | |
| 0.024 | 0.051 | 0.087 | Carnitine palmitoyltransferase inhibitor | 0.087 0.004 DBMET00764 0.05 0.008 DBMET02523 | DBMET00764 | |
| 0.028 | 0.055 | 0.054 | GABA uptake inhibitor | 0.036 0.032 DBMET02543 0.048 0.017 DBMET00764 0.039 0.027 DBMET02537 0.054 0.013 DBMET02523 | DBMET02523 | |
| 0.076 | 0.104 | 0.277 | Xanthine oxidase inhibitor | 0.092 0.068 DBMET02521 0.131 0.042 DBMET02535 0.113 0.051 DBMET02543 0.121 0.047 DBMET02530 0.135 0.041 DBMET02534 0.17 0.027 DBMET00764 0.226 0.015 DBMET02536 0.181 0.024 DBMET02537 0.188 0.022 DBMET02545 0.171 0.027 DBMET02531 0.223 0.015 DBMET02523 0.212 0.017 DBMET02529 0.267 0.01 DBMET02538 0.277 0.009 DBMET02541 0.255 0.012 DBMET02532 0.264 0.011 DBMET02525 0.124 0.045 DBMET02539 0.132 0.042 DBMET02542 0.114 0.051 DBMET02533 | DBMET02541 | |
| 0.045 | 0.073 | 0.077 | Matrix metalloproteinase inhibitor | 0.075 0.041 DBMET02535 0.077 0.039 DBMET00764 0.06 0.054 DBMET02537 0.062 0.051 DBMET02523 | DBMET00764 | |
| 0.028 | 0.056 | 0.066 | Retinoid X receptor antagonist | 0.035 0.033 DBMET02543 0.062 0.005 DBMET00764 0.066 0.004 DBMET02523 | DBMET02523 | |
| 0.077 | 0.106 | 0.192 | GABA C receptor rho-1 antagonist | 0.096 0.067 DBMET02535 0.106 0.055 DBMET02543 0.096 0.068 DBMET02530 0.11 0.05 DBMET02534 0.152 0.02 DBMET00764 0.124 0.037 DBMET02537 0.123 0.037 DBMET02531 0.192 0.009 DBMET02523 | DBMET02523 | |
| 0.047 | 0.076 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.044 DBMET02545 | DBMET02545 | |
| 0.032 | 0.061 | 0.052 | Fructose-1,6-bisphosphatase inhibitor | 0.052 0.023 DBMET00764 0.049 0.026 DBMET02523 | DBMET00764 | |
| 0.008 | 0.037 | 0.015 | KiSS-1 receptor antagonist | 0.015 0.014 DBMET02543 0.015 0.014 DBMET02534 | DBMET02534 | |
| 0.018 | 0.047 | 0.04 | Calcium-sensing receptor agonist | 0.04 0.007 DBMET00764 0.026 0.019 DBMET02523 | DBMET00764 | |
| 0.096 | 0.126 | 0.296 | Interleukin 4 antagonist | 0.127 0.076 DBMET02535 0.164 0.039 DBMET02543 0.146 0.053 DBMET02534 0.201 0.022 DBMET00764 0.158 0.043 DBMET02536 0.174 0.033 DBMET02537 0.151 0.048 DBMET02545 0.148 0.051 DBMET02531 0.296 0.009 DBMET02523 0.206 0.021 DBMET02529 0.154 0.046 DBMET02538 0.182 0.029 DBMET02541 0.121 0.084 DBMET02546 0.138 0.062 DBMET02532 0.251 0.013 DBMET02525 0.124 0.079 DBMET02539 0.147 0.053 DBMET02542 0.109 0.103 DBMET02533 | DBMET02523 | |
| 0.013 | 0.043 | 0.019 | Caspase 8 inhibitor | 0.019 0.016 DBMET02523 | DBMET02523 | |
| 0.012 | 0.041 | 0.046 | Prostaglandin H2 antagonist | 0.024 0.019 DBMET02535 0.045 0.004 DBMET00764 0.026 0.017 DBMET02537 0.046 0.004 DBMET02523 | DBMET02523 | |
| 0.025 | 0.056 | 0.055 | Retinoid X alpha receptor antagonist | 0.052 0.005 DBMET00764 0.055 0.005 DBMET02523 | DBMET02523 | |
| 0.019 | 0.051 | 0.09 | Liver X receptor alpha antagonist | 0.027 0.025 DBMET02543 0.06 0.005 DBMET00764 0.09 0.004 DBMET02523 | DBMET02523 | |
| 0.023 | 0.055 | 0.085 | Carnitine palmitoyltransferase 1 inhibitor | 0.085 0.004 DBMET00764 0.048 0.009 DBMET02523 | DBMET00764 | |
| 0.021 | 0.053 | 0.046 | Catechol O-methyltransferase inhibitor | 0.046 0.01 DBMET02543 0.041 0.013 DBMET02523 | DBMET02543 | |
| 0.011 | 0.043 | 0.04 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.032 0.011 DBMET02543 0.022 0.016 DBMET02537 0.021 0.017 DBMET02531 0.04 0.009 DBMET02523 | DBMET02523 | |
| 0.043 | 0.076 | 0.121 | Sphingosine 1-phosphate receptor 5 agonist | 0.068 0.018 DBMET02535 0.055 0.034 DBMET02530 0.111 0.007 DBMET00764 0.071 0.016 DBMET02537 0.056 0.032 DBMET02531 0.121 0.006 DBMET02523 0.051 0.045 DBMET02542 | DBMET02523 | |
| 0.093 | 0.126 | 0.25 | NADPH oxidase inhibitor | 0.234 0.024 DBMET00764 0.25 0.021 DBMET02523 0.195 0.036 DBMET02529 0.198 0.035 DBMET02525 | DBMET02523 | |
| 0.025 | 0.059 | 0.039 | Dihydropteroate synthase inhibitor | 0.037 0.031 DBMET00764 0.039 0.028 DBMET02523 | DBMET02523 | |
| 0.021 | 0.054 | 0.052 | Phosphoglycerate kinase inhibitor | 0.031 0.03 DBMET02521 0.05 0.014 DBMET02535 0.036 0.023 DBMET02530 0.032 0.028 DBMET02534 0.052 0.013 DBMET02537 0.037 0.022 DBMET02531 0.031 0.03 DBMET02523 | DBMET02537 | |
| 0.004 | 0.037 | 0.063 | Thyroid hormone beta agonist | 0.02 0.004 DBMET00764 0.063 0.002 DBMET02523 | DBMET02523 | |
| 0.011 | 0.045 | 0.158 | Estrogen receptor beta agonist | 0.158 0.007 DBMET02543 0.089 0.013 DBMET02534 0.093 0.013 DBMET02537 0.042 0.021 DBMET02545 0.099 0.012 DBMET02531 0.118 0.009 DBMET02523 0.047 0.02 DBMET02541 0.074 0.015 DBMET02525 | DBMET02543 | |
| 0.069 | 0.103 | 0.35 | NADH dehydrogenase inhibitor | 0.098 0.046 DBMET02521 0.101 0.043 DBMET02535 0.094 0.051 DBMET02543 0.107 0.037 DBMET02530 0.122 0.028 DBMET02534 0.129 0.024 DBMET00764 0.194 0.011 DBMET02536 0.126 0.026 DBMET02537 0.162 0.015 DBMET02545 0.134 0.022 DBMET02531 0.162 0.015 DBMET02523 0.278 0.007 DBMET02529 0.201 0.01 DBMET02538 0.238 0.008 DBMET02541 0.108 0.037 DBMET02546 0.216 0.009 DBMET02532 0.35 0.005 DBMET02525 0.13 0.024 DBMET02539 0.149 0.018 DBMET02542 0.138 0.021 DBMET02533 | DBMET02525 | |
| 0.005 | 0.039 | 0.093 | Prostaglandin EP4 agonist | 0.013 0.012 DBMET02521 0.059 0.005 DBMET02535 0.032 0.007 DBMET02530 0.019 0.009 DBMET02534 0.073 0.004 DBMET00764 0.08 0.004 DBMET02537 0.045 0.005 DBMET02531 0.093 0.004 DBMET02523 0.015 0.01 DBMET02541 | DBMET02523 | |
| 0.014 | 0.049 | 0.043 | Beta 1 adrenoreceptor agonist | 0.021 0.019 DBMET02521 0.029 0.008 DBMET02535 0.022 0.017 DBMET02543 0.028 0.009 DBMET02530 0.029 0.009 DBMET02534 0.023 0.015 DBMET00764 0.043 0.004 DBMET02537 0.04 0.005 DBMET02531 0.032 0.007 DBMET02523 | DBMET02537 | |
| 0.014 | 0.049 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 DBMET02543 0.025 0.021 DBMET02523 | DBMET02523 | |
| 0.024 | 0.059 | 0.051 | Estrogen-related receptor beta antagonist | 0.048 0.006 DBMET02543 0.041 0.01 DBMET02534 0.046 0.007 DBMET02537 0.046 0.007 DBMET02531 0.051 0.005 DBMET02523 | DBMET02523 | |
| 0.042 | 0.078 | 0.081 | Neutrophil collagenase inhibitor | 0.081 0.031 DBMET00764 0.077 0.034 DBMET02523 | DBMET00764 | |
| 0.01 | 0.046 | 0.083 | Prostaglandin EP2 agonist | 0.02 0.017 DBMET02521 0.066 0.004 DBMET02535 0.039 0.009 DBMET02530 0.032 0.012 DBMET02534 0.044 0.007 DBMET00764 0.019 0.018 DBMET02536 0.083 0.004 DBMET02537 0.048 0.006 DBMET02531 0.054 0.005 DBMET02523 0.042 0.008 DBMET02538 0.027 0.013 DBMET02541 0.025 0.014 DBMET02525 0.019 0.018 DBMET02539 | DBMET02537 | |
| 0.025 | 0.061 | 0.084 | Macrophage elastase inhibitor | 0.082 0.012 DBMET02535 0.061 0.018 DBMET00764 0.084 0.011 DBMET02537 0.061 0.018 DBMET02523 0.039 0.035 DBMET02538 0.044 0.03 DBMET02539 0.042 0.031 DBMET02542 | DBMET02537 | |
| 0.026 | 0.063 | 0.07 | Glycine transporter 2 inhibitor | 0.049 0.031 DBMET00764 0.041 0.037 DBMET02537 0.07 0.021 DBMET02523 | DBMET02523 | |
| 0.056 | 0.093 | 0.163 | GABA aminotransferase inhibitor | 0.092 0.034 DBMET02543 0.085 0.04 DBMET02534 0.114 0.019 DBMET00764 0.083 0.042 DBMET02536 0.097 0.029 DBMET02537 0.079 0.048 DBMET02545 0.093 0.032 DBMET02531 0.163 0.006 DBMET02523 0.113 0.019 DBMET02529 0.085 0.04 DBMET02538 0.114 0.019 DBMET02541 0.082 0.044 DBMET02532 0.153 0.007 DBMET02525 | DBMET02523 | |
| 0.01 | 0.048 | 0.019 | Vitamin D receptor agonist | 0.015 0.014 DBMET02535 0.019 0.008 DBMET02537 0.017 0.01 DBMET02523 0.015 0.014 DBMET02538 0.016 0.013 DBMET02541 0.016 0.013 DBMET02525 0.016 0.012 DBMET02539 0.016 0.012 DBMET02542 | DBMET02537 | |
| 0.014 | 0.053 | 0.029 | Endothelin receptor antagonist | 0.029 0.018 DBMET00764 | DBMET00764 | |
| 0.036 | 0.075 | 0.064 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 DBMET02543 0.047 0.037 DBMET00764 0.054 0.023 DBMET02537 0.046 0.04 DBMET02531 0.064 0.011 DBMET02523 | DBMET02523 | |
| 0.035 | 0.074 | 0.445 | Alcohol oxidase inhibitor | 0.071 0.028 DBMET02521 0.075 0.026 DBMET02535 0.123 0.014 DBMET02543 0.079 0.024 DBMET02530 0.213 0.006 DBMET02534 0.124 0.013 DBMET00764 0.226 0.005 DBMET02537 0.24 0.005 DBMET02531 0.445 0.004 DBMET02523 0.049 0.046 DBMET02525 | DBMET02523 | |
| 0.044 | 0.083 | 0.066 | Cathepsin E inhibitor | 0.056 0.047 DBMET02521 0.066 0.033 DBMET02535 0.062 0.037 DBMET02530 0.063 0.036 DBMET02537 0.059 0.041 DBMET02531 | DBMET02535 | |
| 0.06 | 0.1 | 0.131 | Glycine receptor antagonist | 0.082 0.053 DBMET02543 0.087 0.046 DBMET02536 0.074 0.067 DBMET02537 0.131 0.013 DBMET02545 0.092 0.04 DBMET02523 0.098 0.034 DBMET02529 0.12 0.018 DBMET02538 0.104 0.029 DBMET02541 0.114 0.022 DBMET02546 0.107 0.026 DBMET02532 0.115 0.021 DBMET02525 0.103 0.03 DBMET02539 0.087 0.046 DBMET02542 0.091 0.042 DBMET02533 | DBMET02545 | |
| 0.016 | 0.057 | 0.022 | Vitamin D receptor antagonist | 0.021 0.018 DBMET02535 0.022 0.015 DBMET02537 0.021 0.018 DBMET02538 | DBMET02537 | |
| 0.041 | 0.082 | 0.088 | Collagenase 3 inhibitor | 0.071 0.031 DBMET02535 0.088 0.02 DBMET00764 0.053 0.052 DBMET02523 | DBMET00764 | |
| 0.014 | 0.055 | 0.032 | Neuraminidase (Influenza B) inhibitor | 0.026 0.007 DBMET02535 0.032 0.004 DBMET02537 0.024 0.009 DBMET02531 0.02 0.018 DBMET02538 0.025 0.008 DBMET02541 | DBMET02537 | |
| 0.037 | 0.079 | 0.085 | Beta adrenoreceptor agonist | 0.043 0.041 DBMET02521 0.058 0.009 DBMET02535 0.049 0.02 DBMET02543 0.048 0.021 DBMET02530 0.053 0.013 DBMET02534 0.047 0.025 DBMET00764 0.085 0.004 DBMET02537 0.063 0.007 DBMET02531 0.06 0.008 DBMET02523 | DBMET02537 | |
| 0.041 | 0.084 | 0.244 | Phosphofructokinase-1 inhibitor | 0.078 0.043 DBMET02521 0.07 0.047 DBMET02535 0.1 0.032 DBMET02543 0.065 0.051 DBMET02530 0.14 0.02 DBMET02534 0.107 0.029 DBMET00764 0.13 0.023 DBMET02536 0.13 0.022 DBMET02537 0.195 0.012 DBMET02545 0.123 0.024 DBMET02531 0.177 0.014 DBMET02523 0.169 0.015 DBMET02529 0.212 0.01 DBMET02538 0.196 0.011 DBMET02541 0.091 0.035 DBMET02546 0.204 0.011 DBMET02532 0.244 0.008 DBMET02525 0.104 0.03 DBMET02539 0.092 0.035 DBMET02542 0.098 0.033 DBMET02533 | DBMET02525 | |
| 0.057 | 0.1 | 0.084 | MDM2 inhibitor | 0.066 0.051 DBMET02535 0.081 0.019 DBMET00764 0.068 0.043 DBMET02537 0.084 0.015 DBMET02523 | DBMET02523 | |
| 0.021 | 0.065 | 0.073 | HMG CoA reductase inhibitor | 0.035 0.022 DBMET02521 0.064 0.004 DBMET02535 0.036 0.02 DBMET02530 0.039 0.015 DBMET02534 0.044 0.011 DBMET02536 0.073 0.004 DBMET02537 0.041 0.014 DBMET02531 0.034 0.025 DBMET02523 0.052 0.006 DBMET02538 0.047 0.009 DBMET02541 0.035 0.023 DBMET02532 0.046 0.009 DBMET02539 0.042 0.013 DBMET02542 0.032 0.029 DBMET02533 | DBMET02537 | |
| 0.027 | 0.071 | 0.056 | Glutamate (mGluR8) agonist | 0.05 0.012 DBMET00764 0.056 0.008 DBMET02523 | DBMET02523 | |
| 0.014 | 0.059 | 0.079 | Prostacyclin antagonist | 0.034 0.022 DBMET02535 0.038 0.019 DBMET02530 0.079 0.005 DBMET00764 0.072 0.007 DBMET02523 | DBMET00764 | |
| 0.015 | 0.059 | 0.023 | Retinoic acid gamma receptor agonist | 0.021 0.02 DBMET02534 0.023 0.015 DBMET02523 | DBMET02523 | |
| 0.01 | 0.056 | 0.062 | Retinoid X beta receptor agonist | 0.053 0.005 DBMET00764 0.062 0.004 DBMET02523 | DBMET02523 | |
| 0.023 | 0.068 | 0.045 | Glutamate (mGluR group II) antagonist | 0.045 0.02 DBMET00764 0.038 0.027 DBMET02523 | DBMET00764 | |
| 0.014 | 0.06 | 0.067 | Prostaglandin EP4 antagonist | 0.024 0.02 DBMET02521 0.055 0.008 DBMET02535 0.034 0.013 DBMET02530 0.023 0.022 DBMET02534 0.067 0.006 DBMET00764 0.05 0.008 DBMET02537 0.031 0.015 DBMET02531 0.062 0.007 DBMET02523 | DBMET00764 | |
| 0.092 | 0.138 | 0.151 | Sphingosine 1-phosphate receptor 2 agonist | 0.142 0.031 DBMET02535 0.126 0.046 DBMET02530 0.108 0.079 DBMET00764 0.151 0.025 DBMET02537 0.133 0.038 DBMET02531 0.113 0.067 DBMET02523 | DBMET02537 | |
| 0.151 | 0.198 | 0.234 | RNA-directed DNA polymerase inhibitor | 0.201 0.099 DBMET02535 0.193 0.11 DBMET02543 0.195 0.107 DBMET02530 0.186 0.122 DBMET02534 0.197 0.104 DBMET00764 0.167 0.16 DBMET02536 0.234 0.061 DBMET02537 0.228 0.066 DBMET02531 0.23 0.064 DBMET02523 0.167 0.159 DBMET02529 0.185 0.124 DBMET02538 0.196 0.105 DBMET02541 0.179 0.134 DBMET02532 0.196 0.105 DBMET02525 | DBMET02537 | |
| 0.031 | 0.079 | 0.041 | VCAM antagonist | 0.041 0.022 DBMET00764 0.041 0.021 DBMET02523 | DBMET02523 | |
| 0.053 | 0.102 | 0.097 | Metalloproteinase-2 inhibitor | 0.076 0.057 DBMET02535 0.097 0.04 DBMET00764 0.073 0.06 DBMET02537 0.093 0.042 DBMET02523 | DBMET00764 | |
| 0.014 | 0.063 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.017 DBMET02537 | DBMET02537 | |
| 0.006 | 0.056 | 0.022 | Prostacyclin agonist | 0.019 0.009 DBMET02535 0.019 0.009 DBMET02536 0.022 0.008 DBMET02537 0.02 0.008 DBMET02541 0.018 0.01 DBMET02542 | DBMET02537 | |
| 0.029 | 0.079 | 0.063 | AICAR transformylase inhibitor | 0.045 0.029 DBMET02543 0.045 0.029 DBMET00764 0.042 0.034 DBMET02537 0.063 0.013 DBMET02523 | DBMET02523 | |
| 0.006 | 0.056 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET02545 | DBMET02545 | |
| 0.011 | 0.062 | 0.052 | Kynurenine 3 monooxygenase inhibitor | 0.052 0.006 DBMET00764 0.033 0.013 DBMET02523 | DBMET00764 | |
| 0.031 | 0.082 | 0.041 | VCAM-1 antagonist | 0.041 0.022 DBMET00764 0.041 0.021 DBMET02523 | DBMET02523 | |
| 0.024 | 0.076 | 0.087 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET02535 0.045 0.035 DBMET02543 0.056 0.025 DBMET02530 0.05 0.03 DBMET02534 0.047 0.033 DBMET00764 0.056 0.025 DBMET02536 0.087 0.008 DBMET02537 0.041 0.04 DBMET02545 0.067 0.015 DBMET02531 0.061 0.02 DBMET02523 0.042 0.038 DBMET02529 0.077 0.01 DBMET02538 0.064 0.018 DBMET02541 0.057 0.023 DBMET02532 0.054 0.026 DBMET02525 0.066 0.016 DBMET02539 0.05 0.031 DBMET02542 | DBMET02537 | |
| 0.007 | 0.059 | 0.046 | Integrin beta7 antagonist | 0.046 0.007 DBMET00764 0.032 0.009 DBMET02523 | DBMET00764 | |
| 0.009 | 0.062 | 0.041 | Thyroid hormone alpha agonist | 0.029 0.004 DBMET00764 0.041 0.003 DBMET02523 | DBMET02523 | |
| 0.114 | 0.167 | 0.198 | Aryl hydrocarbon receptor agonist | 0.198 0.103 DBMET00764 0.17 0.121 DBMET02523 | DBMET00764 | |
| 0.019 | 0.072 | 0.03 | Estrogen-related receptor gamma antagonist | 0.029 0.018 DBMET02543 0.028 0.021 DBMET02537 0.03 0.017 DBMET02523 | DBMET02523 | |
| 0.013 | 0.066 | 0.028 | Urotensin II agonist | 0.028 0.017 DBMET02523 | DBMET02523 | |
| 0.076 | 0.131 | 0.204 | Multidrug resistance-associated protein 1 inhibitor | 0.124 0.044 DBMET00764 0.129 0.039 DBMET02536 0.098 0.082 DBMET02545 0.112 0.059 DBMET02523 0.204 0.009 DBMET02529 0.104 0.072 DBMET02538 0.123 0.045 DBMET02541 0.095 0.087 DBMET02532 0.203 0.01 DBMET02525 | DBMET02529 | |
| 0.068 | 0.123 | 0.078 | 3C-Like protease (SARS coronavirus) inhibitor | 0.078 0.075 DBMET02534 | DBMET02534 | |
| 0.021 | 0.076 | 0.029 | Elastase 2B inhibitor | 0.029 0.025 DBMET00764 | DBMET00764 | |
| 0.021 | 0.076 | 0.029 | Elastase 3B inhibitor | 0.029 0.025 DBMET00764 | DBMET00764 | |
| 0.021 | 0.076 | 0.029 | Elastase 3A inhibitor | 0.029 0.025 DBMET00764 | DBMET00764 | |
| 0.067 | 0.123 | 0.493 | GABA C receptor agonist | 0.143 0.037 DBMET02543 0.103 0.063 DBMET02534 0.303 0.009 DBMET00764 0.116 0.052 DBMET02537 0.112 0.056 DBMET02531 0.493 0.004 DBMET02523 | DBMET02523 | |
| 0.045 | 0.104 | 0.058 | Caspase 9 inhibitor | 0.058 0.053 DBMET02523 | DBMET02523 | |
| 0.004 | 0.063 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET02523 | DBMET02523 | |
| 0.004 | 0.064 | 0.025 | Beta 3 adrenoreceptor agonist | 0.011 0.009 DBMET02535 0.025 0.004 DBMET02537 0.015 0.005 DBMET02531 0.015 0.006 DBMET02523 | DBMET02537 | |
| 0.085 | 0.145 | 0.155 | Alkaline phosphatase inhibitor | 0.15 0.06 DBMET00764 0.128 0.077 DBMET02536 0.155 0.056 DBMET02523 0.138 0.069 DBMET02529 0.127 0.078 DBMET02541 0.136 0.07 DBMET02525 | DBMET02523 | |
| 0.093 | 0.154 | 0.294 | Anticoagulant | 0.121 0.111 DBMET00764 0.189 0.058 DBMET02536 0.294 0.029 DBMET02545 0.144 0.086 DBMET02523 0.232 0.043 DBMET02529 0.201 0.053 DBMET02538 0.211 0.049 DBMET02541 0.261 0.036 DBMET02546 0.226 0.045 DBMET02532 0.26 0.036 DBMET02525 0.182 0.06 DBMET02539 0.19 0.057 DBMET02542 0.201 0.053 DBMET02533 | DBMET02545 | |
| 0.034 | 0.094 | 0.111 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.049 DBMET02521 0.066 0.038 DBMET02543 0.085 0.026 DBMET02534 0.073 0.032 DBMET00764 0.079 0.029 DBMET02537 0.073 0.032 DBMET02531 0.111 0.018 DBMET02523 | DBMET02523 | |
| 0.124 | 0.185 | 0.283 | Catenin beta inhibitor | 0.18 0.051 DBMET02521 0.152 0.101 DBMET02535 0.156 0.092 DBMET02543 0.2 0.032 DBMET02530 0.203 0.03 DBMET02534 0.242 0.013 DBMET00764 0.173 0.061 DBMET02537 0.226 0.017 DBMET02531 0.283 0.007 DBMET02523 | DBMET02523 | |
| 0.076 | 0.139 | 0.122 | Folate antagonist | 0.092 0.081 DBMET02535 0.122 0.037 DBMET00764 0.115 0.044 DBMET02523 0.094 0.077 DBMET02529 0.093 0.08 DBMET02538 0.103 0.06 DBMET02546 0.09 0.087 DBMET02525 0.108 0.052 DBMET02539 0.1 0.064 DBMET02542 0.102 0.061 DBMET02533 | DBMET00764 | |
| 0.01 | 0.072 | 0.059 | Sphingosine 1-phosphate receptor 3 agonist | 0.051 0.015 DBMET02535 0.059 0.012 DBMET02537 0.038 0.022 DBMET02531 0.038 0.023 DBMET02523 | DBMET02537 | |
| 0.029 | 0.091 | 0.073 | Acyl-CoA dehydrogenase inhibitor | 0.051 0.042 DBMET02543 0.07 0.027 DBMET02534 0.066 0.029 DBMET02537 0.063 0.031 DBMET02531 0.073 0.025 DBMET02523 | DBMET02523 | |
| 0.014 | 0.077 | 0.035 | Plasmepsin I inhibitor | 0.035 0.016 DBMET02535 0.029 0.023 DBMET02530 0.034 0.017 DBMET02537 0.027 0.024 DBMET02531 | DBMET02535 | |
| 0.01 | 0.074 | 0.033 | Uridine phosphorylase inhibitor | 0.033 0.016 DBMET02536 0.026 0.021 DBMET02538 0.028 0.019 DBMET02541 0.027 0.02 DBMET02532 | DBMET02536 | |
| 0.026 | 0.09 | 0.098 | Xanthine dehydrogenase inhibitor | 0.051 0.045 DBMET02543 0.051 0.045 DBMET02530 0.049 0.047 DBMET02534 0.075 0.028 DBMET00764 0.068 0.033 DBMET02537 0.075 0.027 DBMET02531 0.098 0.016 DBMET02523 0.061 0.038 DBMET02541 0.06 0.038 DBMET02525 | DBMET02523 | |
| 0.008 | 0.072 | 0.017 | Retinoic acid receptor antagonist | 0.017 0.015 DBMET02523 | DBMET02523 | |
| 0.014 | 0.078 | 0.093 | Liver X receptor antagonist | 0.061 0.008 DBMET00764 0.093 0.005 DBMET02523 | DBMET02523 | |
| 0.028 | 0.093 | 0.11 | Plasminogen activator inhibitor antagonist | 0.049 0.034 DBMET02521 0.054 0.028 DBMET02530 0.052 0.03 DBMET02534 0.096 0.011 DBMET00764 0.059 0.025 DBMET02531 0.11 0.009 DBMET02523 | DBMET02523 | |
| 0.072 | 0.137 | 0.216 | GABA C receptor antagonist | 0.128 0.045 DBMET02543 0.121 0.051 DBMET02534 0.142 0.035 DBMET00764 0.143 0.034 DBMET02537 0.139 0.037 DBMET02531 0.216 0.01 DBMET02523 | DBMET02523 | |
| 0.038 | 0.103 | 0.288 | Antineoplastic antibiotic | 0.076 0.06 DBMET02521 0.082 0.056 DBMET02535 0.136 0.034 DBMET02530 0.093 0.049 DBMET02534 0.204 0.02 DBMET02536 0.102 0.045 DBMET02537 0.209 0.019 DBMET02545 0.171 0.026 DBMET02531 0.198 0.021 DBMET02529 0.238 0.016 DBMET02538 0.223 0.017 DBMET02541 0.126 0.037 DBMET02546 0.288 0.01 DBMET02532 0.219 0.018 DBMET02525 0.151 0.031 DBMET02539 0.139 0.033 DBMET02542 0.19 0.023 DBMET02533 | DBMET02532 | |
| 0.007 | 0.073 | 0.153 | Thyroid hormone alpha antagonist | 0.083 0.004 DBMET00764 0.153 0.003 DBMET02523 | DBMET02523 | |
| 0.092 | 0.158 | 0.299 | Diuretic | 0.137 0.088 DBMET02543 0.143 0.083 DBMET02534 0.147 0.08 DBMET00764 0.299 0.023 DBMET02545 0.133 0.091 DBMET02531 0.194 0.046 DBMET02523 0.121 0.104 DBMET02529 0.224 0.036 DBMET02538 0.146 0.08 DBMET02541 0.162 0.067 DBMET02546 0.283 0.025 DBMET02532 0.169 0.061 DBMET02525 0.118 0.107 DBMET02539 0.152 0.076 DBMET02533 | DBMET02545 | |
| 0.03 | 0.098 | 0.066 | Glutamate (mGluR group III) antagonist | 0.066 0.011 DBMET00764 0.062 0.012 DBMET02523 | DBMET00764 | |
| 0.12 | 0.188 | 0.639 | Immunostimulant | 0.274 0.087 DBMET02535 0.218 0.11 DBMET02543 0.234 0.103 DBMET02530 0.232 0.104 DBMET02534 0.198 0.121 DBMET00764 0.563 0.021 DBMET02536 0.363 0.061 DBMET02537 0.509 0.028 DBMET02545 0.329 0.07 DBMET02531 0.289 0.082 DBMET02523 0.52 0.027 DBMET02529 0.59 0.018 DBMET02538 0.607 0.016 DBMET02541 0.55 0.023 DBMET02546 0.566 0.021 DBMET02532 0.574 0.02 DBMET02525 0.619 0.014 DBMET02539 0.639 0.013 DBMET02542 0.599 0.017 DBMET02533 | DBMET02542 | |
| 0.008 | 0.076 | 0.021 | Complement factor D inhibitor | 0.021 0.008 DBMET00764 0.018 0.013 DBMET02523 | DBMET00764 | |
| 0.008 | 0.077 | 0.021 | Retinoic acid alpha receptor antagonist | 0.018 0.017 DBMET00764 0.021 0.013 DBMET02523 | DBMET02523 | |
| 0.005 | 0.074 | 0.021 | Aminopeptidase A inhibitor | 0.021 0.01 DBMET02523 | DBMET02523 | |
| 0.032 | 0.102 | 0.122 | Biliverdin reductase inhibitor | 0.055 0.046 DBMET02535 0.063 0.037 DBMET02543 0.068 0.034 DBMET02534 0.072 0.03 DBMET00764 0.094 0.02 DBMET02537 0.074 0.029 DBMET02531 0.122 0.013 DBMET02523 0.056 0.045 DBMET02538 | DBMET02523 | |
| 0.084 | 0.154 | 0.137 | Calcium channel blocker | 0.137 0.071 DBMET02535 | DBMET02535 | |
| 0.021 | 0.092 | 0.064 | Ribonucleoside-diphosphate reductase inhibitor | 0.064 0.032 DBMET02543 0.047 0.043 DBMET02534 0.064 0.032 DBMET02537 0.048 0.042 DBMET02531 0.054 0.038 DBMET02523 | DBMET02537 | |
| 0.061 | 0.132 | 0.107 | MAP kinase kinase 7 inhibitor | 0.092 0.021 DBMET02543 0.089 0.025 DBMET02534 0.078 0.052 DBMET00764 0.096 0.017 DBMET02537 0.099 0.013 DBMET02531 0.107 0.008 DBMET02523 | DBMET02523 | |
| 0.042 | 0.113 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.061 0.041 DBMET02543 0.056 0.054 DBMET02523 | DBMET02543 | |
| 0.094 | 0.165 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET02521 0.125 0.092 DBMET02535 0.137 0.077 DBMET02530 0.123 0.096 DBMET02534 0.167 0.051 DBMET00764 0.131 0.084 DBMET02536 0.126 0.091 DBMET02537 0.139 0.075 DBMET02531 0.168 0.05 DBMET02523 0.185 0.039 DBMET02529 0.132 0.083 DBMET02538 0.127 0.09 DBMET02541 0.145 0.069 DBMET02532 0.179 0.043 DBMET02525 | DBMET02529 | |
| 0.033 | 0.105 | 0.059 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET00764 0.047 0.039 DBMET02537 0.059 0.024 DBMET02523 | DBMET02523 | |
| 0.033 | 0.106 | 0.069 | Androgen agonist | 0.062 0.038 DBMET02543 0.069 0.031 DBMET02523 | DBMET02523 | |
| 0.055 | 0.129 | 0.283 | Topoisomerase I inhibitor | 0.102 0.068 DBMET02543 0.182 0.031 DBMET02536 0.233 0.019 DBMET02545 0.09 0.079 DBMET02531 0.1 0.07 DBMET02523 0.251 0.017 DBMET02529 0.217 0.023 DBMET02538 0.208 0.025 DBMET02541 0.152 0.04 DBMET02546 0.225 0.021 DBMET02532 0.283 0.013 DBMET02525 0.14 0.045 DBMET02539 0.132 0.049 DBMET02542 0.145 0.043 DBMET02533 | DBMET02525 | |
| 0.04 | 0.113 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.068 0.062 DBMET02543 0.082 0.048 DBMET02534 0.091 0.04 DBMET02536 0.081 0.049 DBMET02537 0.106 0.026 DBMET02545 0.088 0.043 DBMET02531 0.085 0.046 DBMET02523 0.1 0.032 DBMET02529 0.108 0.025 DBMET02538 0.104 0.028 DBMET02541 0.072 0.058 DBMET02546 0.112 0.022 DBMET02532 0.111 0.023 DBMET02525 0.076 0.054 DBMET02539 0.067 0.063 DBMET02542 0.084 0.047 DBMET02533 | DBMET02532 | |
| 0.02 | 0.094 | 0.051 | Angiotensin AT1 receptor antagonist | 0.042 0.029 DBMET00764 0.051 0.017 DBMET02523 | DBMET02523 | |
| 0.02 | 0.094 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.033 0.031 DBMET02523 0.034 0.028 DBMET02525 | DBMET02525 | |
| 0.018 | 0.093 | 0.04 | Angiotensin II receptor antagonist | 0.031 0.029 DBMET00764 0.04 0.015 DBMET02523 | DBMET02523 | |
| 0.035 | 0.11 | 0.087 | Thromboxane synthase inhibitor | 0.075 0.014 DBMET00764 0.052 0.043 DBMET02537 0.087 0.009 DBMET02523 | DBMET02523 | |
| 0.044 | 0.119 | 0.103 | Interferon inducer | 0.068 0.038 DBMET02535 0.065 0.044 DBMET00764 0.095 0.014 DBMET02536 0.077 0.026 DBMET02537 0.069 0.036 DBMET02545 0.062 0.05 DBMET02531 0.074 0.03 DBMET02523 0.073 0.031 DBMET02529 0.097 0.014 DBMET02538 0.103 0.011 DBMET02541 0.076 0.027 DBMET02532 0.079 0.025 DBMET02525 0.072 0.033 DBMET02539 0.076 0.027 DBMET02542 | DBMET02541 | |
| 0.04 | 0.115 | 0.059 | Heat shock protein 90 beta antagonist | 0.055 0.048 DBMET02543 0.059 0.041 DBMET02537 0.056 0.047 DBMET02531 | DBMET02537 | |
| 0.063 | 0.138 | 0.252 | Topoisomerase II inhibitor | 0.122 0.065 DBMET02543 0.096 0.09 DBMET02534 0.201 0.033 DBMET02536 0.12 0.067 DBMET02537 0.252 0.024 DBMET02545 0.119 0.067 DBMET02523 0.192 0.035 DBMET02529 0.244 0.025 DBMET02538 0.243 0.025 DBMET02541 0.158 0.046 DBMET02546 0.209 0.031 DBMET02532 0.238 0.026 DBMET02525 0.154 0.048 DBMET02539 0.153 0.048 DBMET02542 0.131 0.059 DBMET02533 | DBMET02545 | |
| 0.143 | 0.219 | 0.443 | DNA synthesis inhibitor | 0.21 0.109 DBMET02521 0.199 0.125 DBMET02535 0.207 0.112 DBMET02543 0.252 0.065 DBMET02530 0.252 0.065 DBMET02534 0.217 0.099 DBMET00764 0.357 0.029 DBMET02536 0.238 0.075 DBMET02537 0.354 0.029 DBMET02545 0.31 0.04 DBMET02531 0.262 0.059 DBMET02523 0.323 0.036 DBMET02529 0.371 0.026 DBMET02538 0.396 0.022 DBMET02541 0.286 0.049 DBMET02546 0.443 0.018 DBMET02532 0.368 0.027 DBMET02525 0.305 0.042 DBMET02539 0.336 0.033 DBMET02542 0.376 0.025 DBMET02533 | DBMET02532 | |
| 0.02 | 0.095 | 0.066 | Ribonucleotide reductase inhibitor | 0.065 0.034 DBMET02543 0.046 0.045 DBMET02534 0.066 0.033 DBMET02537 0.048 0.044 DBMET02531 0.055 0.039 DBMET02523 | DBMET02537 | |
| 0.008 | 0.084 | 0.02 | Telomerase stimulant | 0.018 0.011 DBMET02545 0.016 0.014 DBMET02538 0.016 0.015 DBMET02541 0.017 0.012 DBMET02532 0.02 0.008 DBMET02525 | DBMET02525 | |
| 0.036 | 0.112 | 0.117 | HIV-1 integrase (3'-Processing) inhibitor | 0.075 0.036 DBMET02543 0.085 0.032 DBMET02534 0.059 0.048 DBMET00764 0.067 0.041 DBMET02531 0.117 0.02 DBMET02523 0.058 0.049 DBMET02525 | DBMET02523 | |
| 0.025 | 0.102 | 0.257 | Prostaglandin EP2 antagonist | 0.179 0.008 DBMET02521 0.237 0.005 DBMET02535 0.221 0.005 DBMET02530 0.192 0.007 DBMET02534 0.189 0.007 DBMET00764 0.131 0.012 DBMET02536 0.257 0.005 DBMET02537 0.054 0.047 DBMET02545 0.238 0.005 DBMET02531 0.205 0.006 DBMET02523 0.077 0.028 DBMET02529 0.181 0.008 DBMET02538 0.132 0.012 DBMET02541 0.167 0.008 DBMET02532 0.075 0.029 DBMET02525 0.142 0.01 DBMET02539 0.108 0.017 DBMET02542 0.133 0.012 DBMET02533 | DBMET02537 | |
| 0.009 | 0.086 | 0.054 | Retinoid X gamma receptor agonist | 0.044 0.006 DBMET00764 0.054 0.005 DBMET02523 | DBMET02523 | |
| 0.009 | 0.087 | 0.056 | Prostaglandin EP3 antagonist | 0.034 0.018 DBMET02521 0.053 0.009 DBMET02535 0.043 0.013 DBMET02530 0.034 0.018 DBMET02534 0.041 0.013 DBMET00764 0.056 0.009 DBMET02537 0.044 0.012 DBMET02531 0.042 0.013 DBMET02523 | DBMET02537 | |
| 0.006 | 0.084 | 0.015 | Thromboxane A2 agonist | 0.015 0.011 DBMET02523 | DBMET02523 | |
| 0.048 | 0.127 | 0.223 | Adrenaline agonist | 0.153 0.014 DBMET02535 0.094 0.041 DBMET02543 0.103 0.035 DBMET02530 0.115 0.028 DBMET02534 0.09 0.045 DBMET00764 0.223 0.005 DBMET02537 0.159 0.013 DBMET02531 0.143 0.016 DBMET02523 | DBMET02537 | |
| 0.009 | 0.088 | 0.033 | 5-Alpha-reductase 2 inhibitor | 0.021 0.012 DBMET00764 0.033 0.009 DBMET02523 | DBMET02523 | |
| 0.004 | 0.084 | 0.015 | Integrin alpha4beta1 antagonist | 0.015 0.011 DBMET00764 | DBMET00764 | |
| 0.013 | 0.094 | 0.03 | NMDA 2D receptor antagonist | 0.025 0.022 DBMET00764 0.03 0.015 DBMET02523 | DBMET02523 | |
| 0.063 | 0.144 | 0.09 | 5 Hydroxytryptamine 3A agonist | 0.09 0.088 DBMET02523 | DBMET02523 | |
| 0.015 | 0.096 | 0.047 | Farnesoid X receptor agonist | 0.037 0.027 DBMET02535 0.047 0.016 DBMET00764 0.041 0.023 DBMET02523 | DBMET00764 | |
| 0.02 | 0.102 | 0.042 | Glutamate (mGluR3) agonist | 0.035 0.017 DBMET00764 0.042 0.008 DBMET02523 | DBMET02523 | |
| 0.005 | 0.087 | 0.064 | VLA-4 antagonist | 0.061 0.011 DBMET00764 0.064 0.01 DBMET02523 | DBMET02523 | |
| 0.009 | 0.092 | 0.041 | Glucagon receptor antagonist | 0.031 0.019 DBMET00764 0.026 0.025 DBMET02537 0.041 0.013 DBMET02523 | DBMET02523 | |
| 0.022 | 0.105 | 0.082 | Liver X receptor agonist | 0.068 0.014 DBMET00764 0.082 0.01 DBMET02523 | DBMET02523 | |
| 0.018 | 0.103 | 0.138 | NMDA 2A receptor antagonist | 0.071 0.024 DBMET02543 0.053 0.035 DBMET00764 0.077 0.021 DBMET02537 0.052 0.035 DBMET02531 0.138 0.008 DBMET02523 | DBMET02523 | |
| 0.039 | 0.124 | 0.051 | Kallikrein 1 inhibitor | 0.051 0.049 DBMET02531 | DBMET02531 | |
| 0.035 | 0.121 | 0.059 | Dihydroorotate oxidase inhibitor | 0.055 0.038 DBMET02543 0.059 0.03 DBMET02523 | DBMET02523 | |
| 0.002 | 0.087 | 0.015 | Antibiotic Macrolide-like | 0.014 0.01 DBMET02529 0.014 0.01 DBMET02532 0.015 0.009 DBMET02525 | DBMET02525 | |
| 0.039 | 0.124 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.047 DBMET02543 | DBMET02543 | |
| 0.005 | 0.09 | 0.042 | Integrin alpha4beta7 antagonist | 0.042 0.006 DBMET00764 0.033 0.008 DBMET02523 | DBMET00764 | |
| 0.032 | 0.12 | 0.065 | Carbonic anhydrase stimulant | 0.056 0.045 DBMET00764 0.065 0.036 DBMET02523 | DBMET02523 | |
| 0.011 | 0.102 | 0.059 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.048 0.017 DBMET02543 0.044 0.019 DBMET02534 0.041 0.02 DBMET02537 0.052 0.015 DBMET02531 0.059 0.011 DBMET02523 | DBMET02523 | |
| 0.014 | 0.105 | 0.029 | Retinoid X gamma receptor antagonist | 0.027 0.018 DBMET00764 0.029 0.015 DBMET02523 | DBMET02523 | |
| 0.019 | 0.114 | 0.103 | Thromboxane A2 antagonist | 0.049 0.037 DBMET02535 0.088 0.011 DBMET00764 0.067 0.023 DBMET02537 0.103 0.007 DBMET02523 | DBMET02523 | |
| 0.017 | 0.114 | 0.07 | Carbonic anhydrase II inhibitor | 0.05 0.044 DBMET02529 0.07 0.03 DBMET02525 | DBMET02525 | |
| 0.013 | 0.111 | 0.039 | Nicotinic acid receptor 2 agonist | 0.039 0.021 DBMET02523 | DBMET02523 | |
| 0.013 | 0.112 | 0.113 | Urate transporter 1 inhibitor | 0.081 0.008 DBMET00764 0.113 0.005 DBMET02523 | DBMET02523 | |
| 0.022 | 0.121 | 0.043 | Nerve growth factor antagonist | 0.043 0.029 DBMET02523 | DBMET02523 | |
| 0.056 | 0.155 | 0.139 | DNA intercalator | 0.139 0.048 DBMET02545 0.093 0.081 DBMET02529 0.089 0.087 DBMET02538 0.1 0.074 DBMET02525 | DBMET02545 | |
| 0.01 | 0.11 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.014 DBMET00764 0.017 0.013 DBMET02523 | DBMET02523 | |
| 0.026 | 0.127 | 0.064 | Aminopeptidase microsomal inhibitor | 0.064 0.036 DBMET02523 | DBMET02523 | |
| 0.021 | 0.121 | 0.1 | Carbonic anhydrase inhibitor | 0.07 0.04 DBMET02529 0.1 0.027 DBMET02525 | DBMET02525 | |
| 0.021 | 0.122 | 0.115 | Thromboxane antagonist | 0.052 0.04 DBMET02535 0.097 0.012 DBMET00764 0.072 0.025 DBMET02537 0.115 0.007 DBMET02523 | DBMET02523 | |
| 0.012 | 0.113 | 0.102 | Carbonic anhydrase XII inhibitor | 0.045 0.042 DBMET02545 0.067 0.03 DBMET02529 0.102 0.019 DBMET02525 | DBMET02525 | |
| 0.014 | 0.115 | 0.241 | NMDA receptor subunit 3A antagonist | 0.044 0.023 DBMET02543 0.086 0.01 DBMET00764 0.241 0.004 DBMET02523 | DBMET02523 | |
| 0.02 | 0.122 | 0.28 | NMDA receptor subunit 3B antagonist | 0.048 0.026 DBMET02543 0.116 0.009 DBMET00764 0.043 0.031 DBMET02537 0.28 0.004 DBMET02523 | DBMET02523 | |
| 0.038 | 0.14 | 0.18 | Topoisomerase II alpha inhibitor | 0.067 0.065 DBMET02543 0.113 0.032 DBMET02536 0.152 0.023 DBMET02545 0.096 0.042 DBMET02523 0.142 0.025 DBMET02529 0.142 0.025 DBMET02538 0.142 0.025 DBMET02541 0.098 0.041 DBMET02546 0.135 0.026 DBMET02532 0.18 0.018 DBMET02525 0.095 0.043 DBMET02539 0.094 0.043 DBMET02542 0.091 0.046 DBMET02533 | DBMET02525 | |
| 0.029 | 0.131 | 0.106 | Factor IXa inhibitor | 0.073 0.019 DBMET02536 0.106 0.009 DBMET02545 0.094 0.011 DBMET02529 0.09 0.013 DBMET02538 0.081 0.016 DBMET02541 0.047 0.042 DBMET02546 0.094 0.011 DBMET02532 0.102 0.009 DBMET02525 | DBMET02545 | |
| 0.001 | 0.103 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET02534 | DBMET02534 | |
| 0.005 | 0.108 | 0.017 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 DBMET02523 | DBMET02523 | |
| 0.028 | 0.131 | 0.06 | Cathepsin D inhibitor | 0.048 0.044 DBMET02521 0.06 0.034 DBMET02535 0.051 0.04 DBMET02530 0.047 0.046 DBMET02534 0.06 0.034 DBMET02537 0.05 0.041 DBMET02531 | DBMET02537 | |
| 0.081 | 0.185 | 0.125 | Transcription factor STAT6 inhibitor | 0.113 0.073 DBMET02543 0.125 0.051 DBMET02523 | DBMET02523 | |
| 0.05 | 0.154 | 0.219 | Protein-tyrosine phosphatase 1B inhibitor | 0.114 0.067 DBMET02521 0.116 0.066 DBMET02535 0.091 0.088 DBMET02543 0.128 0.057 DBMET02530 0.147 0.047 DBMET02534 0.169 0.039 DBMET00764 0.139 0.05 DBMET02536 0.151 0.045 DBMET02537 0.128 0.057 DBMET02545 0.169 0.038 DBMET02531 0.219 0.024 DBMET02523 0.17 0.038 DBMET02529 0.162 0.041 DBMET02538 0.164 0.04 DBMET02541 0.174 0.037 DBMET02532 0.199 0.029 DBMET02525 | DBMET02523 | |
| 0.026 | 0.129 | 0.162 | NMDA 2 receptor antagonist | 0.107 0.028 DBMET02543 0.066 0.056 DBMET02537 0.063 0.059 DBMET02531 0.162 0.014 DBMET02523 | DBMET02523 | |
| 0.119 | 0.224 | 0.324 | Cardiotonic | 0.324 0.047 DBMET02535 0.165 0.158 DBMET00764 0.307 0.053 DBMET02537 0.191 0.128 DBMET02538 0.18 0.14 DBMET02546 0.284 0.063 DBMET02539 0.242 0.088 DBMET02542 | DBMET02535 | |
| 0.145 | 0.25 | 0.297 | Transcription factor STAT inhibitor | 0.253 0.084 DBMET02535 0.297 0.057 DBMET02537 0.19 0.153 DBMET02531 0.191 0.151 DBMET02523 | DBMET02537 | |
| 0.018 | 0.123 | 0.044 | Aminopeptidase N inhibitor | 0.044 0.037 DBMET02523 | DBMET02523 | |
| 0.043 | 0.148 | 0.286 | NMDA receptor antagonist | 0.079 0.067 DBMET02535 0.127 0.032 DBMET02543 0.076 0.071 DBMET02534 0.114 0.038 DBMET00764 0.201 0.014 DBMET02537 0.082 0.063 DBMET02531 0.286 0.007 DBMET02523 | DBMET02523 | |
| 0.062 | 0.169 | 0.485 | AMP-activated protein kinase stimulant | 0.125 0.044 DBMET02535 0.115 0.054 DBMET02530 0.109 0.06 DBMET02534 0.169 0.018 DBMET00764 0.433 0.004 DBMET02536 0.153 0.027 DBMET02537 0.264 0.006 DBMET02545 0.144 0.032 DBMET02531 0.205 0.01 DBMET02523 0.354 0.004 DBMET02529 0.414 0.004 DBMET02538 0.485 0.003 DBMET02541 0.103 0.067 DBMET02546 0.385 0.004 DBMET02532 0.414 0.004 DBMET02525 0.158 0.023 DBMET02539 0.187 0.013 DBMET02542 0.15 0.029 DBMET02533 | DBMET02541 | |
| 0.025 | 0.133 | 0.123 | Carnitine palmitoyltransferase 1B inhibitor | 0.123 0.004 DBMET00764 0.097 0.005 DBMET02523 | DBMET00764 | |
| 0.015 | 0.125 | 0.038 | Oxytocin agonist | 0.038 0.033 DBMET02543 0.038 0.034 DBMET02523 | DBMET02523 | |
| 0.079 | 0.19 | 0.154 | Mcl-1 antagonist | 0.138 0.103 DBMET02543 0.154 0.086 DBMET02523 | DBMET02523 | |
| 0.006 | 0.12 | 0.039 | NMDA receptor glycine site antagonist | 0.039 0.008 DBMET02523 | DBMET02523 | |
| 0.003 | 0.118 | 0.012 | Thrombopoietin agonist | 0.012 0.008 DBMET02523 | DBMET02523 | |
| 0.013 | 0.128 | 0.035 | Calcitonin receptor agonist | 0.035 0.023 DBMET02537 0.034 0.024 DBMET02531 0.031 0.026 DBMET02523 | DBMET02537 | |
| 0.023 | 0.138 | 0.155 | Neuraminidase inhibitor | 0.065 0.038 DBMET02535 0.054 0.051 DBMET02543 0.079 0.026 DBMET02530 0.065 0.037 DBMET02534 0.135 0.008 DBMET02536 0.094 0.018 DBMET02537 0.099 0.016 DBMET02545 0.111 0.012 DBMET02531 0.058 0.046 DBMET02529 0.115 0.011 DBMET02538 0.155 0.005 DBMET02541 0.062 0.041 DBMET02546 0.128 0.009 DBMET02532 0.076 0.029 DBMET02525 0.076 0.028 DBMET02539 0.107 0.013 DBMET02542 0.083 0.023 DBMET02533 | DBMET02541 | |
| 0.043 | 0.158 | 0.06 | Heme oxygenase stimulant | 0.06 0.045 DBMET02523 | DBMET02523 | |
| 0.162 | 0.279 | 0.672 | Antibacterial | 0.281 0.15 DBMET02521 0.234 0.192 DBMET02535 0.275 0.155 DBMET02543 0.308 0.129 DBMET02530 0.371 0.091 DBMET02534 0.58 0.022 DBMET02536 0.324 0.118 DBMET02537 0.638 0.014 DBMET02545 0.398 0.078 DBMET02531 0.286 0.146 DBMET02523 0.632 0.015 DBMET02529 0.644 0.014 DBMET02538 0.61 0.018 DBMET02541 0.571 0.024 DBMET02546 0.672 0.011 DBMET02532 0.659 0.012 DBMET02525 0.578 0.023 DBMET02539 0.537 0.031 DBMET02542 0.611 0.018 DBMET02533 | DBMET02532 | |
| 0.018 | 0.135 | 0.156 | Mannosidase inhibitor | 0.045 0.032 DBMET02535 0.041 0.038 DBMET02530 0.04 0.039 DBMET00764 0.079 0.009 DBMET02536 0.053 0.022 DBMET02537 0.081 0.008 DBMET02545 0.049 0.026 DBMET02531 0.048 0.027 DBMET02523 0.082 0.008 DBMET02529 0.136 0.004 DBMET02538 0.086 0.008 DBMET02541 0.089 0.007 DBMET02546 0.12 0.005 DBMET02532 0.089 0.007 DBMET02525 0.156 0.004 DBMET02539 0.095 0.006 DBMET02542 0.138 0.004 DBMET02533 | DBMET02539 | |
| 0.038 | 0.156 | 0.121 | Androgen antagonist | 0.079 0.067 DBMET02535 0.074 0.073 DBMET02543 0.121 0.033 DBMET02537 0.083 0.061 DBMET02531 | DBMET02537 | |
| 0.024 | 0.147 | 0.149 | Alpha-mannosidase inhibitor | 0.054 0.036 DBMET02535 0.054 0.036 DBMET02530 0.052 0.039 DBMET00764 0.079 0.011 DBMET02536 0.061 0.026 DBMET02537 0.08 0.011 DBMET02545 0.06 0.026 DBMET02531 0.059 0.028 DBMET02523 0.085 0.009 DBMET02529 0.114 0.005 DBMET02538 0.083 0.01 DBMET02541 0.094 0.007 DBMET02546 0.113 0.005 DBMET02532 0.089 0.008 DBMET02525 0.149 0.004 DBMET02539 0.099 0.007 DBMET02542 0.148 0.004 DBMET02533 | DBMET02539 | |
| 0.025 | 0.147 | 0.042 | Purinergic P2X4 antagonist | 0.042 0.041 DBMET02523 | DBMET02523 | |
| 0.018 | 0.143 | 0.044 | Retinoic acid alpha receptor agonist | 0.038 0.028 DBMET00764 0.044 0.02 DBMET02523 | DBMET02523 | |
| 0.07 | 0.195 | 0.364 | Cell adhesion inhibitor | 0.251 0.015 DBMET00764 0.222 0.019 DBMET02536 0.268 0.013 DBMET02545 0.239 0.016 DBMET02523 0.361 0.007 DBMET02529 0.253 0.014 DBMET02538 0.217 0.02 DBMET02541 0.264 0.013 DBMET02546 0.255 0.014 DBMET02532 0.364 0.006 DBMET02525 0.251 0.015 DBMET02539 0.221 0.02 DBMET02542 0.253 0.014 DBMET02533 | DBMET02525 | |
| 0.012 | 0.137 | 0.027 | ICAM 1 antagonist | 0.022 0.018 DBMET00764 0.027 0.01 DBMET02523 | DBMET02523 | |
| 0.005 | 0.131 | 0.067 | Arginase inhibitor | 0.054 0.013 DBMET02545 0.055 0.012 DBMET02523 0.04 0.023 DBMET02529 0.057 0.011 DBMET02538 0.054 0.013 DBMET02541 0.038 0.024 DBMET02546 0.05 0.015 DBMET02532 0.067 0.008 DBMET02525 0.041 0.021 DBMET02539 0.037 0.024 DBMET02542 0.033 0.028 DBMET02533 | DBMET02525 | |
| 0.01 | 0.136 | 0.094 | Kainate receptor antagonist | 0.053 0.019 DBMET00764 0.094 0.008 DBMET02523 | DBMET02523 | |
| 0.009 | 0.135 | 0.061 | Kainate receptor 2 antagonist | 0.043 0.02 DBMET00764 0.061 0.011 DBMET02523 | DBMET02523 | |
| 0.116 | 0.243 | 0.883 | Hypoglycemic | 0.364 0.034 DBMET02521 0.419 0.025 DBMET02535 0.791 0.004 DBMET02530 0.406 0.027 DBMET02534 0.398 0.028 DBMET00764 0.635 0.006 DBMET02536 0.467 0.019 DBMET02537 0.612 0.007 DBMET02545 0.84 0.004 DBMET02531 0.454 0.02 DBMET02523 0.592 0.009 DBMET02529 0.717 0.005 DBMET02538 0.664 0.005 DBMET02541 0.477 0.017 DBMET02546 0.883 0.004 DBMET02532 0.619 0.007 DBMET02525 0.586 0.009 DBMET02539 0.538 0.012 DBMET02542 0.77 0.004 DBMET02533 | DBMET02532 | |
| 0.032 | 0.159 | 0.051 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET02537 0.051 0.045 DBMET02523 | DBMET02523 | |
| 0.008 | 0.136 | 0.045 | HCV NS5B polymerase inhibitor | 0.032 0.021 DBMET00764 0.045 0.012 DBMET02523 | DBMET02523 | |
| 0.028 | 0.157 | 0.089 | Adrenaline uptake inhibitor | 0.084 0.025 DBMET02521 0.089 0.022 DBMET02534 | DBMET02534 | |
| 0.014 | 0.144 | 0.055 | HIV-1 protease inhibitor | 0.043 0.031 DBMET02521 0.045 0.027 DBMET02535 0.045 0.027 DBMET02530 0.052 0.019 DBMET02534 0.055 0.016 DBMET02537 0.055 0.016 DBMET02531 | DBMET02531 | |
| 0.019 | 0.15 | 0.086 | Opioid delta receptor antagonist | 0.077 0.037 DBMET02543 0.056 0.049 DBMET02537 0.086 0.034 DBMET02523 | DBMET02523 | |
| 0.056 | 0.188 | 0.114 | Protein kinase C gamma inhibitor | 0.114 0.058 DBMET02537 0.097 0.083 DBMET02523 | DBMET02537 | |
| 0.007 | 0.139 | 0.023 | Corticosteroid-like | 0.021 0.015 DBMET02529 0.02 0.017 DBMET02541 0.023 0.013 DBMET02525 | DBMET02525 | |
| 0.084 | 0.217 | 0.124 | Heat shock protein 90 alpha antagonist | 0.124 0.121 DBMET02543 | DBMET02543 | |
| 0.007 | 0.141 | 0.027 | Glutamate (mGluR1a) agonist | 0.027 0.01 DBMET02523 | DBMET02523 | |
| 0.016 | 0.152 | 0.044 | Growth hormone release inhibitor | 0.044 0.026 DBMET02537 0.042 0.029 DBMET02531 | DBMET02537 | |
| 0.044 | 0.18 | 0.089 | Opioid kappa receptor antagonist | 0.086 0.05 DBMET02543 0.089 0.046 DBMET02523 | DBMET02523 | |
| 0.009 | 0.145 | 0.038 | Complement C3a chemotactic receptor antagonist | 0.038 0.034 DBMET02523 | DBMET02523 | |
| 0.016 | 0.153 | 0.157 | NMDA 2C receptor antagonist | 0.055 0.052 DBMET02543 0.083 0.023 DBMET00764 0.056 0.052 DBMET02537 0.157 0.006 DBMET02523 | DBMET02523 | |
| 0.006 | 0.142 | 0.054 | Renin inhibitor | 0.053 0.016 DBMET02530 0.054 0.015 DBMET02531 | DBMET02531 | |
| 0.054 | 0.191 | 0.249 | Adenylate cyclase inhibitor | 0.098 0.086 DBMET02535 0.099 0.085 DBMET02543 0.13 0.059 DBMET02530 0.15 0.045 DBMET02534 0.129 0.06 DBMET00764 0.157 0.041 DBMET02537 0.186 0.028 DBMET02531 0.185 0.029 DBMET02523 0.148 0.046 DBMET02546 0.11 0.076 DBMET02532 0.097 0.087 DBMET02525 0.195 0.026 DBMET02539 0.21 0.024 DBMET02542 0.249 0.019 DBMET02533 | DBMET02533 | |
| 0.084 | 0.222 | 0.505 | Insulin secretagoues | 0.14 0.085 DBMET02521 0.384 0.007 DBMET02535 0.195 0.039 DBMET02530 0.146 0.079 DBMET02534 0.292 0.013 DBMET00764 0.269 0.016 DBMET02536 0.437 0.005 DBMET02537 0.266 0.017 DBMET02545 0.206 0.033 DBMET02531 0.322 0.01 DBMET02523 0.293 0.013 DBMET02529 0.505 0.005 DBMET02538 0.287 0.014 DBMET02541 0.196 0.038 DBMET02546 0.349 0.008 DBMET02532 0.313 0.011 DBMET02525 0.366 0.008 DBMET02539 0.208 0.032 DBMET02542 0.25 0.019 DBMET02533 | DBMET02538 | |
| 0.004 | 0.144 | 0.049 | Integrin alpha4 antagonist | 0.048 0.012 DBMET00764 0.049 0.011 DBMET02523 | DBMET02523 | |
| 0.008 | 0.148 | 0.071 | Carbonic anhydrase IX inhibitor | 0.047 0.045 DBMET02529 0.071 0.032 DBMET02525 | DBMET02525 | |
| 0.013 | 0.154 | 0.045 | Opioid mu receptor agonist | 0.041 0.039 DBMET02543 0.045 0.033 DBMET02523 | DBMET02523 | |
| 0.04 | 0.183 | 0.104 | Opioid antagonist | 0.101 0.047 DBMET02543 0.085 0.062 DBMET02537 0.085 0.063 DBMET02531 0.104 0.045 DBMET02523 | DBMET02523 | |
| 0.015 | 0.158 | 0.05 | RNA-directed RNA polymerase inhibitor | 0.033 0.026 DBMET00764 0.05 0.013 DBMET02523 | DBMET02523 | |
| 0.023 | 0.166 | 0.083 | Prostaglandin-E synthase inhibitor | 0.063 0.059 DBMET00764 0.083 0.037 DBMET02523 | DBMET02523 | |
| 0.003 | 0.148 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET02523 | DBMET02523 | |
| 0.031 | 0.177 | 0.077 | Phospholipase D inhibitor | 0.077 0.039 DBMET02523 | DBMET02523 | |
| 0.069 | 0.215 | 0.276 | Protein-tyrosine phosphatase inhibitor | 0.139 0.091 DBMET02521 0.143 0.086 DBMET02535 0.122 0.111 DBMET02543 0.15 0.078 DBMET02530 0.173 0.06 DBMET02534 0.216 0.041 DBMET00764 0.151 0.077 DBMET02536 0.18 0.056 DBMET02537 0.139 0.091 DBMET02545 0.191 0.05 DBMET02531 0.276 0.024 DBMET02523 0.202 0.046 DBMET02529 0.167 0.064 DBMET02538 0.172 0.061 DBMET02541 0.174 0.06 DBMET02532 0.237 0.034 DBMET02525 | DBMET02523 | |
| 0.044 | 0.191 | 0.081 | Antineoplastic alkaloid | 0.081 0.064 DBMET02523 | DBMET02523 | |
| 0.047 | 0.195 | 0.071 | Vanilloid 4 agonist | 0.071 0.061 DBMET02537 | DBMET02537 | |
| 0.033 | 0.183 | 0.075 | Analgesic, opioid | 0.075 0.054 DBMET02543 0.075 0.054 DBMET02523 | DBMET02523 | |
| 0.051 | 0.202 | 0.091 | Protein kinase C zeta inhibitor | 0.091 0.063 DBMET02523 | DBMET02523 | |
| 0.023 | 0.174 | 0.058 | Glutamate (mGluR4) antagonist | 0.047 0.025 DBMET00764 0.058 0.015 DBMET02523 | DBMET02523 | |
| 0.003 | 0.155 | 0.041 | Egl nine homolog 1 inhibitor | 0.021 0.005 DBMET00764 0.041 0.004 DBMET02523 | DBMET02523 | |
| 0.133 | 0.285 | 0.533 | Alpha-glucosidase inhibitor | 0.454 0.094 DBMET02536 0.217 0.208 DBMET02537 0.404 0.113 DBMET02545 0.509 0.078 DBMET02529 0.48 0.086 DBMET02538 0.481 0.086 DBMET02541 0.309 0.155 DBMET02532 0.533 0.071 DBMET02525 | DBMET02525 | |
| 0.082 | 0.234 | 0.278 | Antimitotic | 0.163 0.11 DBMET02535 0.278 0.05 DBMET02530 0.175 0.1 DBMET02531 | DBMET02530 | |
| 0.153 | 0.306 | 0.261 | Analgesic | 0.261 0.173 DBMET02543 | DBMET02543 | |
| 0.007 | 0.161 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.016 DBMET02523 | DBMET02523 | |
| 0.08 | 0.233 | 0.362 | NOS3 expression enhancer | 0.165 0.06 DBMET02543 0.132 0.094 DBMET02534 0.268 0.023 DBMET02536 0.195 0.043 DBMET02537 0.316 0.015 DBMET02545 0.163 0.061 DBMET02531 0.225 0.032 DBMET02523 0.289 0.019 DBMET02529 0.332 0.013 DBMET02538 0.338 0.013 DBMET02541 0.22 0.034 DBMET02546 0.316 0.015 DBMET02532 0.362 0.01 DBMET02525 0.239 0.029 DBMET02539 0.245 0.028 DBMET02542 0.22 0.034 DBMET02533 | DBMET02525 | |
| 0.016 | 0.172 | 0.044 | Integrin alpha2 antagonist | 0.044 0.016 DBMET00764 0.041 0.019 DBMET02523 | DBMET00764 | |
| 0.052 | 0.209 | 0.12 | Interleukin 5 antagonist | 0.101 0.04 DBMET00764 0.12 0.024 DBMET02523 0.08 0.074 DBMET02538 0.086 0.061 DBMET02525 | DBMET02523 | |
| 0.055 | 0.212 | 0.166 | Nav1.1 sodium channel blocker | 0.144 0.035 DBMET02535 0.112 0.054 DBMET02530 0.166 0.027 DBMET02537 0.129 0.042 DBMET02531 | DBMET02537 | |
| 0.034 | 0.193 | 0.113 | CDC25A inhibitor | 0.083 0.04 DBMET00764 0.113 0.022 DBMET02523 | DBMET02523 | |
| 0.108 | 0.267 | 0.193 | Growth factor agonist | 0.178 0.09 DBMET02530 0.193 0.07 DBMET02531 | DBMET02531 | |
| 0.022 | 0.181 | 0.065 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.057 0.038 DBMET02534 0.057 0.038 DBMET02537 0.064 0.03 DBMET02531 0.064 0.031 DBMET02523 0.058 0.037 DBMET02538 0.065 0.03 DBMET02532 0.063 0.032 DBMET02525 | DBMET02532 | |
| 0.002 | 0.161 | 0.008 | Integrin alpha5beta6 antagonist | 0.008 0.004 DBMET02523 | DBMET02523 | |
| 0.02 | 0.18 | 0.043 | Glutamate (mGluR8) antagonist | 0.039 0.018 DBMET00764 0.043 0.013 DBMET02523 | DBMET02523 | |
| 0.027 | 0.187 | 0.058 | Fatty acid synthase inhibitor | 0.058 0.039 DBMET02523 | DBMET02523 | |
| 0.012 | 0.173 | 0.057 | Ornithine carbamoyltransferase inhibitor | 0.057 0.033 DBMET02523 | DBMET02523 | |
| 0.022 | 0.185 | 0.065 | Farnesyltransferase inhibitor | 0.056 0.023 DBMET02521 0.065 0.017 DBMET02534 | DBMET02534 | |
| 0.087 | 0.251 | 0.434 | Platelet antagonist | 0.169 0.127 DBMET02535 0.396 0.028 DBMET00764 0.409 0.025 DBMET02536 0.175 0.121 DBMET02537 0.326 0.044 DBMET02545 0.427 0.023 DBMET02523 0.407 0.026 DBMET02529 0.348 0.039 DBMET02538 0.429 0.022 DBMET02541 0.35 0.038 DBMET02546 0.283 0.059 DBMET02532 0.429 0.022 DBMET02525 0.368 0.034 DBMET02539 0.434 0.021 DBMET02542 0.316 0.048 DBMET02533 | DBMET02542 | |
| 0.032 | 0.199 | 0.28 | Potassium channel (Ca-activated) activator | 0.213 0.012 DBMET00764 0.28 0.006 DBMET02523 0.079 0.077 DBMET02525 | DBMET02523 | |
| 0.018 | 0.186 | 0.115 | Protein 50S ribosomal subunit inhibitor | 0.107 0.012 DBMET02536 0.1 0.013 DBMET02545 0.113 0.01 DBMET02529 0.104 0.012 DBMET02538 0.109 0.011 DBMET02541 0.082 0.019 DBMET02546 0.104 0.012 DBMET02532 0.115 0.01 DBMET02525 0.085 0.018 DBMET02539 0.088 0.016 DBMET02542 0.084 0.018 DBMET02533 | DBMET02525 | |
| 0.008 | 0.178 | 0.024 | Motilin receptor agonist | 0.022 0.017 DBMET02545 0.024 0.014 DBMET02538 0.022 0.018 DBMET02532 | DBMET02538 | |
| 0.018 | 0.189 | 0.093 | NMDA receptor glycine site agonist | 0.081 0.028 DBMET00764 0.093 0.02 DBMET02523 | DBMET02523 | |
| 0.017 | 0.188 | 0.086 | Opioid mu receptor antagonist | 0.071 0.045 DBMET02543 0.06 0.053 DBMET02537 0.059 0.054 DBMET02531 0.086 0.037 DBMET02523 | DBMET02523 | |
| 0.026 | 0.198 | 0.071 | Botulinum neurotoxin type A inhibitor | 0.056 0.043 DBMET02537 0.071 0.024 DBMET02523 | DBMET02523 | |
| 0.014 | 0.188 | 0.254 | Aldose reductase inhibitor | 0.178 0.008 DBMET00764 0.06 0.032 DBMET02545 0.254 0.005 DBMET02523 0.094 0.019 DBMET02529 0.052 0.037 DBMET02538 0.057 0.034 DBMET02541 0.065 0.03 DBMET02546 0.06 0.032 DBMET02532 0.123 0.014 DBMET02525 0.057 0.034 DBMET02539 0.062 0.031 DBMET02542 0.064 0.03 DBMET02533 | DBMET02523 | |
| 0.007 | 0.181 | 0.044 | Carnitine palmitoyltransferase 1A inhibitor | 0.044 0.009 DBMET00764 0.032 0.016 DBMET02523 | DBMET00764 | |
| 0.011 | 0.185 | 0.029 | Integrin alpha2beta1 antagonist | 0.028 0.015 DBMET00764 0.029 0.013 DBMET02523 | DBMET02523 | |
| 0.033 | 0.218 | 0.105 | Adenine nucleotide translocase inhibitor | 0.052 0.049 DBMET00764 0.091 0.005 DBMET02536 0.066 0.019 DBMET02545 0.064 0.022 DBMET02523 0.096 0.005 DBMET02529 0.066 0.019 DBMET02538 0.099 0.005 DBMET02541 0.058 0.032 DBMET02546 0.067 0.018 DBMET02532 0.105 0.004 DBMET02525 0.059 0.031 DBMET02539 0.084 0.007 DBMET02542 0.059 0.031 DBMET02533 | DBMET02525 | |
| 0.028 | 0.214 | 0.051 | Glucosylceramidase inhibitor | 0.051 0.047 DBMET02537 0.05 0.048 DBMET02531 | DBMET02537 | |
| 0.058 | 0.246 | 0.722 | Angiogenesis stimulant | 0.192 0.099 DBMET02535 0.199 0.095 DBMET00764 0.629 0.005 DBMET02536 0.247 0.071 DBMET02537 0.683 0.005 DBMET02545 0.137 0.131 DBMET02531 0.26 0.065 DBMET02523 0.66 0.005 DBMET02529 0.72 0.004 DBMET02538 0.684 0.005 DBMET02541 0.449 0.015 DBMET02546 0.677 0.005 DBMET02532 0.722 0.004 DBMET02525 0.481 0.013 DBMET02539 0.453 0.015 DBMET02542 0.445 0.016 DBMET02533 | DBMET02525 | |
| 0.042 | 0.23 | 0.239 | Cell adhesion molecule inhibitor | 0.164 0.013 DBMET00764 0.128 0.021 DBMET02536 0.13 0.02 DBMET02545 0.144 0.016 DBMET02523 0.239 0.007 DBMET02529 0.131 0.02 DBMET02538 0.12 0.024 DBMET02541 0.092 0.041 DBMET02546 0.12 0.024 DBMET02532 0.234 0.007 DBMET02525 0.093 0.039 DBMET02539 0.086 0.046 DBMET02542 0.085 0.047 DBMET02533 | DBMET02529 | |
| 0.012 | 0.201 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.031 DBMET02542 | DBMET02542 | |
| 0.026 | 0.216 | 0.132 | NMDA receptor agonist | 0.092 0.022 DBMET00764 0.132 0.011 DBMET02523 | DBMET02523 | |
| 0.046 | 0.236 | 0.109 | Nav1.3 sodium channel blocker | 0.109 0.086 DBMET02535 | DBMET02535 | |
| 0.048 | 0.239 | 0.138 | Electrolyte absorption antagonist | 0.096 0.063 DBMET02534 0.107 0.048 DBMET00764 0.087 0.081 DBMET02537 0.109 0.047 DBMET02531 0.138 0.025 DBMET02523 | DBMET02523 | |
| 0.032 | 0.228 | 0.113 | Somatostatin 1 agonist | 0.069 0.066 DBMET02535 0.074 0.058 DBMET02543 0.089 0.042 DBMET02534 0.113 0.027 DBMET02537 0.112 0.027 DBMET02531 0.082 0.049 DBMET02523 | DBMET02537 | |
| 0.008 | 0.206 | 0.081 | Protocollagen prolyl hydroxylase inhibitor | 0.027 0.02 DBMET00764 0.039 0.008 DBMET02523 0.081 0.005 DBMET02546 0.052 0.005 DBMET02539 0.054 0.005 DBMET02542 0.053 0.005 DBMET02533 | DBMET02546 | |
| 0.015 | 0.215 | 0.059 | Plasminogen activator inhibitor | 0.059 0.04 DBMET02523 | DBMET02523 | |
| 0.016 | 0.218 | 0.087 | Maillard reaction inhibitor | 0.087 0.022 DBMET02523 | DBMET02523 | |
| 0.019 | 0.225 | 0.048 | NMDA 2B receptor antagonist | 0.048 0.047 DBMET02543 | DBMET02543 | |
| 0.017 | 0.223 | 0.069 | Glucagon-like peptide 1 agonist | 0.054 0.052 DBMET02535 0.069 0.042 DBMET02537 0.062 0.047 DBMET02531 0.064 0.045 DBMET02523 | DBMET02537 | |
| 0.014 | 0.222 | 0.056 | p53 inhibitor | 0.054 0.012 DBMET00764 0.056 0.011 DBMET02523 | DBMET02523 | |
| 0.003 | 0.213 | 0.036 | Kainate receptor 1 antagonist | 0.036 0.008 DBMET02523 | DBMET02523 | |
| 0.017 | 0.228 | 0.096 | Neuropeptide agonist | 0.06 0.038 DBMET02535 0.057 0.039 DBMET02530 0.096 0.028 DBMET02537 0.094 0.028 DBMET02531 | DBMET02537 | |
| 0.062 | 0.273 | 0.143 | MAP3K9 inhibitor | 0.14 0.075 DBMET02535 0.141 0.074 DBMET02530 0.142 0.073 DBMET02537 0.143 0.072 DBMET02531 | DBMET02531 | |
| 0.027 | 0.239 | 0.119 | Adrenaline antagonist | 0.119 0.044 DBMET02535 0.103 0.052 DBMET02537 | DBMET02535 | |
| 0.028 | 0.241 | 0.122 | Antiadrenergic | 0.122 0.044 DBMET02535 0.106 0.052 DBMET02537 | DBMET02535 | |
| 0.071 | 0.291 | 0.249 | Interleukin 6 antagonist | 0.135 0.115 DBMET02521 0.149 0.09 DBMET02535 0.158 0.078 DBMET02530 0.147 0.093 DBMET02534 0.207 0.037 DBMET00764 0.15 0.089 DBMET02536 0.164 0.071 DBMET02537 0.2 0.041 DBMET02545 0.174 0.06 DBMET02531 0.237 0.026 DBMET02523 0.179 0.056 DBMET02529 0.237 0.026 DBMET02538 0.155 0.081 DBMET02541 0.195 0.043 DBMET02546 0.249 0.023 DBMET02532 0.188 0.048 DBMET02525 0.225 0.029 DBMET02539 0.159 0.076 DBMET02542 0.233 0.027 DBMET02533 | DBMET02532 | |
| 0.071 | 0.291 | 0.477 | Hemostatic | 0.147 0.071 DBMET00764 0.442 0.005 DBMET02536 0.12 0.114 DBMET02537 0.345 0.012 DBMET02545 0.174 0.046 DBMET02523 0.326 0.014 DBMET02529 0.41 0.007 DBMET02538 0.477 0.005 DBMET02541 0.182 0.041 DBMET02546 0.376 0.009 DBMET02532 0.371 0.01 DBMET02525 0.252 0.022 DBMET02539 0.349 0.012 DBMET02542 0.206 0.03 DBMET02533 | DBMET02541 | |
| 0.004 | 0.225 | 0.434 | Prostaglandin D2 antagonist | 0.409 0.003 DBMET00764 0.434 0.003 DBMET02523 | DBMET02523 | |
| 0.019 | 0.243 | 0.087 | Nitric oxide donor | 0.058 0.053 DBMET02535 0.073 0.029 DBMET02536 0.06 0.049 DBMET02545 0.086 0.017 DBMET02529 0.083 0.02 DBMET02538 0.074 0.028 DBMET02541 0.063 0.043 DBMET02546 0.073 0.029 DBMET02532 0.087 0.016 DBMET02525 0.082 0.02 DBMET02539 0.074 0.028 DBMET02542 0.074 0.028 DBMET02533 | DBMET02525 | |
| 0.007 | 0.235 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.019 DBMET02545 0.03 0.014 DBMET02538 0.03 0.015 DBMET02541 0.029 0.019 DBMET02532 0.03 0.016 DBMET02525 0.027 0.022 DBMET02539 0.027 0.023 DBMET02542 | DBMET02525 | |
| 0.003 | 0.232 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET02523 | DBMET02523 | |
| 0.016 | 0.246 | 0.467 | Selectin antagonist | 0.19 0.012 DBMET02530 0.077 0.038 DBMET00764 0.341 0.004 DBMET02536 0.066 0.045 DBMET02537 0.357 0.004 DBMET02545 0.254 0.008 DBMET02531 0.117 0.023 DBMET02523 0.361 0.004 DBMET02529 0.371 0.004 DBMET02538 0.361 0.004 DBMET02541 0.325 0.005 DBMET02546 0.467 0.003 DBMET02532 0.388 0.003 DBMET02525 0.338 0.004 DBMET02539 0.33 0.004 DBMET02542 0.392 0.003 DBMET02533 | DBMET02532 | |
| 0.01 | 0.24 | 0.065 | Prostaglandin E2 antagonist | 0.065 0.026 DBMET02535 0.045 0.04 DBMET02530 0.047 0.038 DBMET00764 0.063 0.027 DBMET02537 0.045 0.041 DBMET02523 | DBMET02535 | |
| 0.087 | 0.319 | 0.153 | MAP kinase kinase 4 inhibitor | 0.135 0.099 DBMET02543 0.139 0.088 DBMET02534 0.153 0.056 DBMET02537 0.153 0.055 DBMET02531 0.143 0.078 DBMET02523 | DBMET02531 | |
| 0.006 | 0.238 | 0.022 | Dopamine D1 agonist | 0.022 0.016 DBMET02545 0.022 0.017 DBMET02538 0.022 0.018 DBMET02532 | DBMET02532 | |
| 0.008 | 0.24 | 0.192 | Phosphorylase inhibitor | 0.073 0.019 DBMET02536 0.057 0.026 DBMET02545 0.066 0.022 DBMET02523 0.067 0.022 DBMET02529 0.102 0.013 DBMET02538 0.118 0.01 DBMET02541 0.106 0.012 DBMET02546 0.1 0.013 DBMET02532 0.108 0.012 DBMET02525 0.169 0.006 DBMET02539 0.192 0.005 DBMET02542 0.166 0.006 DBMET02533 | DBMET02542 | |
| 0.01 | 0.244 | 0.066 | Thymidylate synthase inhibitor | 0.041 0.04 DBMET00764 0.066 0.014 DBMET02523 | DBMET02523 | |
| 0.015 | 0.254 | 0.075 | Diacylglycerol O-acyltransferase inhibitor | 0.072 0.018 DBMET00764 0.075 0.016 DBMET02523 | DBMET02523 | |
| 0.139 | 0.383 | 0.915 | Cyclophilin D inhibitor | 0.333 0.135 DBMET02521 0.478 0.057 DBMET02535 0.233 0.232 DBMET02543 0.809 0.006 DBMET02530 0.39 0.096 DBMET02534 0.562 0.035 DBMET00764 0.744 0.01 DBMET02536 0.548 0.038 DBMET02537 0.762 0.009 DBMET02545 0.853 0.005 DBMET02531 0.634 0.022 DBMET02523 0.738 0.01 DBMET02529 0.825 0.005 DBMET02538 0.776 0.008 DBMET02541 0.663 0.018 DBMET02546 0.915 0.004 DBMET02532 0.774 0.008 DBMET02525 0.734 0.011 DBMET02539 0.682 0.016 DBMET02542 0.856 0.005 DBMET02533 | DBMET02532 | |
| 0.013 | 0.262 | 0.105 | AMPA 4 receptor antagonist | 0.038 0.031 DBMET00764 0.105 0.005 DBMET02523 | DBMET02523 | |
| 0.018 | 0.268 | 0.18 | Neuraminidase (influenza) inhibitor | 0.064 0.045 DBMET02535 0.084 0.023 DBMET02530 0.069 0.036 DBMET02534 0.146 0.008 DBMET02536 0.091 0.019 DBMET02537 0.089 0.02 DBMET02545 0.132 0.009 DBMET02531 0.069 0.036 DBMET02529 0.129 0.01 DBMET02538 0.18 0.005 DBMET02541 0.059 0.056 DBMET02546 0.156 0.007 DBMET02532 0.088 0.021 DBMET02525 0.075 0.029 DBMET02539 0.109 0.014 DBMET02542 0.089 0.02 DBMET02533 | DBMET02541 | |
| 0.006 | 0.26 | 0.016 | Adenosine A2b receptor agonist | 0.016 0.008 DBMET02546 0.016 0.008 DBMET02539 0.016 0.008 DBMET02542 0.016 0.008 DBMET02533 | DBMET02533 | |
| 0.049 | 0.305 | 0.237 | Dual specificity phosphatase 3 inhibitor | 0.2 0.061 DBMET00764 0.142 0.104 DBMET02537 0.237 0.044 DBMET02523 | DBMET02523 | |
| 0.01 | 0.266 | 0.531 | Prostaglandin antagonist | 0.057 0.034 DBMET02535 0.495 0.004 DBMET00764 0.051 0.039 DBMET02537 0.531 0.004 DBMET02523 | DBMET02523 | |
| 0.006 | 0.263 | 0.02 | Integrin beta5 antagonist | 0.02 0.015 DBMET00764 0.02 0.016 DBMET02523 | DBMET02523 | |
| 0.022 | 0.28 | 0.176 | Prostaglandin F2 alpha antagonist | 0.142 0.005 DBMET02535 0.057 0.052 DBMET02530 0.057 0.051 DBMET02534 0.069 0.034 DBMET00764 0.091 0.015 DBMET02536 0.176 0.004 DBMET02537 0.073 0.029 DBMET02531 0.087 0.017 DBMET02523 0.111 0.008 DBMET02538 0.099 0.012 DBMET02541 0.094 0.014 DBMET02539 0.083 0.02 DBMET02542 | DBMET02537 | |
| 0.024 | 0.285 | 0.139 | M18 aspartyl aminopeptidase inhibitor | 0.139 0.058 DBMET02523 | DBMET02523 | |
| 0.021 | 0.284 | 0.037 | Integrin alpha1beta1 antagonist | 0.037 0.032 DBMET00764 | DBMET00764 | |
| 0.009 | 0.281 | 0.028 | Glutamate (mGluR1) agonist | 0.028 0.011 DBMET02523 | DBMET02523 | |
| 0.029 | 0.302 | 0.141 | M17 leucyl aminopeptidase inhibitor | 0.141 0.062 DBMET00764 0.14 0.062 DBMET02523 | DBMET00764 | |
| 0.005 | 0.282 | 0.102 | Integrin antagonist | 0.077 0.02 DBMET00764 0.102 0.016 DBMET02523 | DBMET02523 | |
| 0.028 | 0.31 | 0.186 | Potassium channel large-conductance Ca-activated activator | 0.126 0.015 DBMET00764 0.186 0.007 DBMET02523 | DBMET02523 | |
| 0.012 | 0.3 | 0.045 | Erythropoietin receptor agonist | 0.045 0.025 DBMET02523 | DBMET02523 | |
| 0.059 | 0.353 | 0.149 | Antipruritic | 0.138 0.109 DBMET02537 0.149 0.095 DBMET02523 | DBMET02523 | |
| 0.045 | 0.343 | 0.297 | Cell wall synthesis inhibitor | 0.186 0.037 DBMET02536 0.113 0.11 DBMET02537 0.244 0.017 DBMET02545 0.16 0.056 DBMET02523 0.236 0.019 DBMET02529 0.254 0.015 DBMET02538 0.246 0.017 DBMET02541 0.129 0.087 DBMET02546 0.248 0.016 DBMET02532 0.297 0.01 DBMET02525 0.14 0.075 DBMET02539 0.132 0.084 DBMET02542 0.134 0.082 DBMET02533 | DBMET02525 | |
| 0.013 | 0.312 | 0.075 | Neuraminidase (Influenza A) inhibitor | 0.045 0.032 DBMET02535 0.068 0.008 DBMET02536 0.054 0.019 DBMET02537 0.051 0.022 DBMET02545 0.044 0.035 DBMET02531 0.048 0.028 DBMET02529 0.066 0.009 DBMET02538 0.075 0.005 DBMET02541 0.061 0.012 DBMET02532 0.054 0.019 DBMET02525 0.048 0.026 DBMET02539 0.056 0.016 DBMET02542 0.043 0.037 DBMET02533 | DBMET02541 | |
| 0.044 | 0.346 | 0.215 | Dual specificity phosphatase inhibitor | 0.177 0.069 DBMET00764 0.133 0.116 DBMET02537 0.215 0.048 DBMET02523 | DBMET02523 | |
| 0.079 | 0.384 | 0.346 | Angiogenesis inhibitor | 0.243 0.129 DBMET02530 0.286 0.1 DBMET02536 0.192 0.179 DBMET02545 0.198 0.172 DBMET02531 0.324 0.081 DBMET02529 0.195 0.175 DBMET02538 0.259 0.116 DBMET02541 0.346 0.073 DBMET02532 0.295 0.095 DBMET02525 0.189 0.182 DBMET02533 | DBMET02532 | |
| 0.049 | 0.355 | 0.143 | Amyloid beta precursor protein antagonist | 0.137 0.116 DBMET00764 0.143 0.109 DBMET02523 | DBMET02523 | |
| 0.005 | 0.313 | 0.053 | AMPA 3 receptor antagonist | 0.053 0.008 DBMET02523 | DBMET02523 | |
| 0.012 | 0.329 | 0.031 | Purinergic P2Y2 antagonist | 0.031 0.028 DBMET02523 | DBMET02523 | |
| 0.004 | 0.323 | 0.056 | GP IIb/IIIa receptor antagonist | 0.046 0.036 DBMET00764 0.056 0.029 DBMET02523 | DBMET02523 | |
| 0.015 | 0.335 | 0.076 | Antibiotic Aminoglycoside-like | 0.068 0.006 DBMET02536 0.073 0.005 DBMET02545 0.067 0.007 DBMET02529 0.076 0.005 DBMET02538 0.071 0.006 DBMET02541 0.063 0.008 DBMET02546 0.076 0.005 DBMET02532 0.07 0.006 DBMET02525 0.065 0.007 DBMET02539 0.062 0.008 DBMET02542 0.066 0.007 DBMET02533 | DBMET02532 | |
| 0.019 | 0.348 | 0.056 | CXC chemokine 1 receptor antagonist | 0.056 0.027 DBMET02523 | DBMET02523 | |
| 0.046 | 0.381 | 0.138 | Interleukin 12 antagonist | 0.104 0.047 DBMET02535 0.126 0.024 DBMET02537 0.099 0.056 DBMET02545 0.104 0.048 DBMET02523 0.138 0.017 DBMET02538 0.101 0.052 DBMET02532 0.095 0.063 DBMET02525 0.117 0.032 DBMET02539 | DBMET02538 | |
| 0.004 | 0.351 | 0.024 | Vitronectin receptor antagonist | 0.024 0.013 DBMET02523 | DBMET02523 | |
| 0.002 | 0.361 | 0.046 | AMPA 1 receptor antagonist | 0.046 0.012 DBMET02523 | DBMET02523 | |
| 0.008 | 0.374 | 0.039 | Integrin alpha5beta1 antagonist | 0.037 0.035 DBMET00764 0.039 0.031 DBMET02523 | DBMET02523 | |
| 0.102 | 0.469 | 0.532 | Interleukin 2 agonist | 0.203 0.184 DBMET02535 0.228 0.145 DBMET02543 0.269 0.099 DBMET02534 0.376 0.035 DBMET00764 0.445 0.016 DBMET02536 0.285 0.085 DBMET02537 0.419 0.022 DBMET02545 0.279 0.09 DBMET02531 0.449 0.016 DBMET02523 0.497 0.008 DBMET02529 0.429 0.02 DBMET02538 0.478 0.011 DBMET02541 0.395 0.029 DBMET02546 0.429 0.02 DBMET02532 0.532 0.005 DBMET02525 0.404 0.026 DBMET02539 0.448 0.016 DBMET02542 0.403 0.027 DBMET02533 | DBMET02525 | |
| 0.004 | 0.375 | 0.073 | AMPA receptor antagonist | 0.073 0.019 DBMET02523 | DBMET02523 | |
| 0.01 | 0.389 | 0.105 | Protein kinase (CK2) alpha inhibitor | 0.105 0.073 DBMET02523 | DBMET02523 | |
| 0.005 | 0.409 | 0.018 | Integrin alphaVbeta1 antagonist | 0.018 0.015 DBMET02523 | DBMET02523 | |
| 0.008 | 0.416 | 0.053 | Microtubule stabilization | 0.042 0.038 DBMET02536 0.051 0.027 DBMET02529 0.048 0.03 DBMET02538 0.045 0.035 DBMET02541 0.048 0.03 DBMET02532 0.053 0.024 DBMET02525 | DBMET02525 | |
| 0.059 | 0.493 | 0.306 | Antiobesity | 0.261 0.146 DBMET00764 0.227 0.179 DBMET02536 0.218 0.189 DBMET02545 0.306 0.112 DBMET02523 0.292 0.122 DBMET02538 0.255 0.152 DBMET02541 0.247 0.159 DBMET02532 0.208 0.199 DBMET02539 | DBMET02523 | |
| 0.01 | 0.454 | 0.051 | Protein kinase C eta inhibitor | 0.051 0.042 DBMET02541 | DBMET02541 | |
| 0.005 | 0.476 | 0.057 | Protein 30S ribosomal subunit inhibitor | 0.037 0.01 DBMET02536 0.047 0.009 DBMET02545 0.045 0.009 DBMET02529 0.051 0.008 DBMET02538 0.049 0.008 DBMET02541 0.031 0.012 DBMET02546 0.052 0.008 DBMET02532 0.057 0.007 DBMET02525 0.035 0.011 DBMET02539 0.033 0.012 DBMET02542 0.035 0.011 DBMET02533 | DBMET02525 | |
| 0.008 | 0.499 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.023 DBMET02541 0.032 0.029 DBMET02525 | DBMET02541 | |
| 0.077 | 0.576 | 0.147 | CC chemokine 6 receptor antagonist | 0.133 0.058 DBMET02536 0.14 0.039 DBMET02545 0.141 0.038 DBMET02529 0.138 0.046 DBMET02538 0.139 0.043 DBMET02541 0.139 0.043 DBMET02532 0.147 0.027 DBMET02525 | DBMET02525 | |
| 0.005 | 0.512 | 0.016 | Integrin beta6 antagonist | 0.016 0.006 DBMET02523 | DBMET02523 | |
| 0.011 | 0.538 | 0.083 | Protein kinase C delta inhibitor | 0.083 0.072 DBMET02531 | DBMET02531 | |
| 0.004 | 0.54 | 0.074 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.062 0.007 DBMET00764 0.074 0.005 DBMET02523 | DBMET02523 | |
| 0.014 | 0.552 | 0.086 | Histone deacetylase stimulant | 0.071 0.053 DBMET02538 0.086 0.038 DBMET02532 0.078 0.046 DBMET02525 | DBMET02532 | |
| 0.014 | 0.552 | 0.086 | Histone deacetylase SIRT1 stimulant | 0.071 0.053 DBMET02538 0.086 0.038 DBMET02532 0.078 0.046 DBMET02525 | DBMET02532 | |
| 0.045 | 0.588 | 0.511 | Toll-Like receptor agonist | 0.205 0.195 DBMET02535 0.473 0.037 DBMET00764 0.237 0.16 DBMET02536 0.213 0.186 DBMET02537 0.511 0.03 DBMET02523 0.248 0.151 DBMET02541 0.291 0.117 DBMET02539 0.342 0.086 DBMET02542 | DBMET02523 | |
| 0.046 | 0.588 | 0.515 | Toll-Like receptor 7 agonist | 0.476 0.037 DBMET00764 0.207 0.192 DBMET02536 0.205 0.194 DBMET02537 0.515 0.029 DBMET02523 0.215 0.183 DBMET02541 0.267 0.133 DBMET02539 0.312 0.103 DBMET02542 | DBMET02523 | |
| 0.022 | 0.594 | 0.143 | Nav1.4 sodium channel blocker | 0.099 0.078 DBMET00764 0.143 0.037 DBMET02523 | DBMET02523 | |
| 0.003 | 0.578 | 0.025 | Adenosine A1 receptor agonist | 0.025 0.016 DBMET02546 0.025 0.016 DBMET02539 0.024 0.016 DBMET02542 0.025 0.016 DBMET02533 | DBMET02533 | |
| 0.073 | 0.678 | 0.385 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET02534 0.343 0.013 DBMET02536 0.214 0.083 DBMET02537 0.373 0.009 DBMET02545 0.205 0.092 DBMET02531 0.201 0.097 DBMET02523 0.35 0.012 DBMET02529 0.385 0.008 DBMET02538 0.365 0.01 DBMET02541 0.358 0.011 DBMET02546 0.385 0.008 DBMET02532 0.374 0.009 DBMET02525 0.369 0.009 DBMET02539 0.351 0.012 DBMET02542 0.368 0.01 DBMET02533 | DBMET02532 | |
| 0.004 | 0.62 | 0.021 | Adenosine A3 receptor agonist | 0.021 0.008 DBMET02546 0.021 0.008 DBMET02539 0.021 0.008 DBMET02542 0.021 0.008 DBMET02533 | DBMET02533 | |
| 0.007 | 0.635 | 0.119 | Glutamate receptor antagonist | 0.119 0.075 DBMET02523 | DBMET02523 | |
| 0.029 | 0.721 | 0.517 | Immunomodulator | 0.38 0.05 DBMET02536 0.212 0.149 DBMET02537 0.376 0.051 DBMET02545 0.226 0.136 DBMET02531 0.436 0.034 DBMET02529 0.502 0.023 DBMET02538 0.433 0.035 DBMET02541 0.244 0.12 DBMET02546 0.517 0.021 DBMET02532 0.501 0.023 DBMET02525 0.348 0.06 DBMET02539 0.292 0.087 DBMET02542 0.36 0.056 DBMET02533 | DBMET02532 | |
| 0.004 | 0.759 | 0.041 | AMPA 2 receptor antagonist | 0.041 0.014 DBMET02523 | DBMET02523 | |
| 0.013 | 0.843 | 0.331 | Aurora-C kinase inhibitor | 0.311 0.004 DBMET02530 0.331 0.004 DBMET02531 0.177 0.028 DBMET02532 0.154 0.046 DBMET02533 | DBMET02531 | |
| 0.011 | 0.86 | 0.098 | CDK3/cyclin E inhibitor | 0.098 0.091 DBMET02531 | DBMET02531 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |